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Abstract 
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Vitiligo is an idiopathic, non-contagious and often familial depigmentation disorder 
affecting both sexes equally. The mostly progressive and patchy loss of the inherited 
skin colour is not only a cosmetical problem, it has a profound impact on the patient’s 
well-being. Stigmatisation and rejection often causes depression, self-consciousness, 
sexual problems and an impaired quality of life. 
To further substantiate earlier investigations and to introduce new aspects, we utilised 
the Dermatology Life Quality Index (DLQI), the Beck Depression Inventory (BDI) and 
the Adjustment to Chronic Skin Disorders Questionnaire (ACS) with its sub-scales on 
Social anxiety / avoidance, Helplessness and Anxious-depressive Mood in 422 patients 
and 55 healthy controls. We also included 103 children, their parents and 18 controls by 
using the Children’s Dermatology Life Quality Index (CDLQI) and an adapted version 
of the ACS. 
We found that patients with vitiligo experience high levels of stigmatisation. They have 
an impaired quality of life and are more socially anxious / avoidant, helpless and 
(anxious-) depressive compared to healthy controls. The results correlate with disease 
severity, avoidant behaviour / hiding of vitiligo and the belief that psychological stress 
influences the disease. Female patients are generally more affected. Treatment with 
pseudocatalase PC-KUS improves quality of life and reduces anxious-depressive mood.  
Children also suffer from stigmatisation and an impaired quality of life. Parents are 
more socially anxious and helpless compared to the control group.  
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3 Introduction 
 
 
3.1 Definition of vitiligo 
 
Vitiligo is an acquired, non-contagious, idiopathic, often familial and worldwide 
common depigmentation disorder. The prevalence is approximately 0.5-1% (Howitz et 
al. 1977; Mosher et al. 1979). 
Symptoms are the progressive loss of the inherited native skin or / and hair colour 
affecting the human epidermis, mucosa and the hair. As a result, white spots of 
depigmented skin occur at different locations. The whole body can be white without any 
or only little pigmentation left (Mosher et al. 1979; Hann 2000).  
This disease can be distinguished from other leukodermas by using Wood’s light (UVA 
351nm wavelength). Vitiligo spots show a yellow / green or blueish fluorescence, which 
is not the case in other depigmentation disorders. This specific fluorescence has been 
attributed to the presence of oxidised pterines in the skin (Schallreuter et al. 1994c).  
 
Although there are occasional reports about vitiligo in mainstream media (Figure 1), 
the disease is not well-known in the general population, sometimes not even in the 
medical community (McLeod 2004). Clearly education and campaigns to raise 
awareness are needed (Olasode and George 2008).  
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Figure 1: Stories about vitiligo in British tabloids and other media 
 
1- www.bbc.co.uk website (7/1/2006) 
2- The Sun  (24/11/2005) 
3- The Times (25/06/2005) 
4- Daily Mail  (06/05/2003) 
5- The Sun  (21/02/2008) 
6- The Sun  (09/04/2008) – taken from www.thesun.co.uk 
1 
2 
3
4 
5
6
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3.2 Prevalence of vitiligo according to population-based 
studies 
 
3.2.1 Review of the literature 
 
There are numerous studies of two different kinds available aiming to establish the 
prevalence of skin diseases in the general population.  
On one hand it is possible to study patients in dermatological clinics and on the other 
hand one can investigate the general population in geographically determined locations 
or use certain population groups not defined by dermatological criteria (e.g. school 
classes or statistically representative samples of a country). Both ways have advantages 
and pitfalls. 
It seems to be more common to use data from dermatological clinics, because it can be 
expected that the skin diseases are accurately diagnosed. Moreover, it is possible to 
review patients’ charts in retrospective analyses. However, it is difficult to conclude 
from these data the true prevalence in the general population since not everybody with a 
skin disease seeks medical treatment.  
The ideal way to get a more detailed picture would be a survey on all inhabitants in a 
large geographically enclosed area by experienced dermatologists. There are a few 
studies available regarding skin diseases in general (Lomholt 1964; Abdel-Hafez et al. 
2003) including one for vitiligo (Howitz et al. 1977). The thorough physical 
examination of a large representative sample from a country’s population can be equally 
exact (Johnson and Roberts 1978; Massarrat and Tahaghoghi-Mehrizi 2002). 
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3.2.2 Prevalence of vitiligo in children / adolescents 
 
Most of the studies have been carried out on school children. Only a few concerned 
enclosed geographical units (e.g. villages) or were part of investigations on all age 
groups. Here it is of interest that the prevalence rates are lower than those in the total 
population, except from India. The prevalence rates in children populations range from 
0.04 to 2.16% (Table 1). 
 
 
3.2.3 Prevalence of vitiligo in the total population 
 
The results of various studies from geographically enclosed areas, on samples 
representing the total population, on self-reported diseases and also on examinations of 
populations not defined by skin diseases (young males for military draft purposes, 
female housekeepers in Asia for work permit purposes etc) are shown in Table 2. The 
prevalence rates range from 0.06 to 2.28%.   
These numbers show that the often cited prevalence of 8.8% (Ortonne et al. 1983) is far 
too high, because this obviously referred to the prevalence of patients with vitiligo 
within one skin institute in Delhi (Behl and Bhatia 1972).  
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Table 1: Prevalence of vitiligo in children populations 
(Review of the literature) 
 
 
                                                 
1 Size of total sample examined including adults. The number of children could not be concluded from the 
paper 
% Country [n] Age 
(years) 
Comments Authors 
0.04 Brazil 9955 6-16 School children examined in Purus Valley, 
Amazonia 
(Bechelli et al. 1981) 
0.05 China 8,532 10-19 Part of a survey on representative sample of 
population of Shaanxi Province 
(Lu et al. 2007) 
0.09 Taiwan 3,273 6-11 All children of classes within age group were 
examined in 4 schools (71.87% of 
schoolchildren in Magong area) 
(Wu et al. 2008) 
0.12 Denmark 14,824 0-19 Part of a survey on the Isle of Bornholm (Howitz et al. 1977) 
0.17 India 12,481 4-15 (?) 65.8% of all pupils examined of 97 government 
and 13 private schools 
(Valia et al. 1991) 
0.22 Egypt 1356 5-16 636 disabled students from 3 caring institutions 
in  Mansura, Egypt + 720 matched healthy 
controls from nearby schools 
(Fathy et al, 2004) 
0.23 Mali 1729 <15 All children examined in two villages in a rural 
area of West Africa 
(Faye et al. 2005) 
0.24 USA 20,7491 1-17 Survey on representative sample of population (Johnson and Roberts 
1978) 
0.27 Romania 1114 6-12 All children from selected schools in Bucharest (Popescu et al. 1999) 
0.4 Tanzania 820 6-19 Children of two primary schools in Ifakara were 
examined (one complete, 62% of other) 
(Ferié 2006) 
0.4 Sweden 8298 12-17 86.3% of all school children of that age 
examined  in Västerbotten county, Northern 
Sweden 
(Larsson and Liden 
1980) 
0.4 Saudi Arabia 2239 6-17 Female pupils only from selected schools in 
Al-Khobar 
(Al-Saeed et al. 2006) 
0.43 Saudi Arabia 230 6 – 18+ All students of special schools for deaf and 
blind dermtologically examined in Asir region 
(Abolfotouh and 
Bahamdan 2000) 
0.59 Turkey 682 14-25 All male students from 2 boarding schools 
were examined by dermatologists 
(Tuncel and Erbagci 
2005) 
0.6 India 666 0-14 House-to-house study in 5 villages of Wardha 
district in Maharastra (Central India)   
(Vikas 1997) 
0.67 Italy 3125 12-17 Caucasian schoolchildren from 13 areas in 
Northern, Middle and Southern Italy, examined 
by dermatologists for atopic dermatitis – vitiligo 
found in 21 /3125 children 
(Naldi et al. 2009) 
0.9 India 3835 2-14 Skin examination of children in semi-urban 
Gorimedu region 
(Kumar et al. 1988) 
0.94 India 531 n.d. Volunteering elementary & higher secondary 
students of two schools in Pachai Malai (Tamil 
Nadu) examined for various diseases 
(Walter 1999) 
1.0 India 201 11-19  School children examined from high altitude 
tribunal area of Himachal Pradesh 
(Sharma and Sharma, 
1990) 
1.51 India 3697 5-14 Children from 4 urban schools were examined 
by a group of junior doctors 
(Sharma et al. 1986) 
1.65 India 2,613   0-15 Part of a  population survey in Surat area (Mehta et al. 1973) 
2.16 India 12,586 6-14 Children from selected schools in Chandigar, 
Northern India 
(Dogra and Kumar 
2003) 
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Table 2:  Prevalence of vitiligo in the general population 
 
% Country [n] Age 
(years) 
Comments Authors 
0.06 Faeroe 
Islands 
10,984 all ages Population survey on all inhabitants of the 7 northern  
islands 
(Lomholt 1964) 
0.09 China 42,833 all ages Survey on representative sample of population of 
Shaanxi Province 
(Lu et al. 2007) 
0.10 USA 136,816 Mean 
59.8 
Retrospective analysis of a control group in an 
investigation on Hepatitis C cases using a database 
of the Department of Veteran  Affairs (control group: 
no HCV cases, 97% males, all army personnel) 
(El-Serag et al. 2002) 
0.13 Mozambique appr 780 all ages 251 families (of 345 who reported a skin disease) 
visited by dermatology students in a slum in Beira, 
one case of vitiligo found 
(Chhaganlal et al. 2007) 
0.15 Romania 2021 all ages Survey on all inhabitants of 5 villages surrounding 2 
isolated other villages where high a prevalence of 
vitiligo was found 
(Birlea et al. 2008) 
<0.17 Ethiopia 3979 all ages 
 
House-to-house survey on 827 households in two 
rural communities in Illubabor province (Southwest), 
people with self-reported diseases examined by 
dermatologists (0.17% “mainly chloasma and  
vitiligo”)  
(Figueroa et al. 1998) 
0.17 Italy 34,740 18 years 
only 
18 years old males only from coastal regions in 
Southern Italy when examined by the Draft’s Council 
Medical Unit 
(Ingordo et al. 2007) 
0.2 USA 423 1-40 Relatives of patients from a dermatology and 
paediatric clinic + patients + volunteers from 
community through advertisements 
(Vanderhooft et al. 
1996) 
0.21 Mexico 50,000 all ages Survey on inhabitants of 41 representative 
communities of Guerrero province 
(Estrada Castañón et al. 
1992) 
0.27 Tanzania 1114 all ages Inhabitants of two villages in rural Ngara district were 
visited  
(Gibbs 1996) 
0.28 France 18,137 all ages Estimation after survey on representative sample of 
French population 
(Wolkenstein et al. 
2003) 
0.32 Saudi Arabia 1520 18-45 Female housekeepers of foreign (i.e. Asian) 
nationalities were examined for work permit issue 
(Kubeyinje and Belagavi 
1997) 
0.38 Denmark 47,033 all ages Population survey on the Isle of Bornholm  (Howitz et al. 1977) 
0.46 India  15,685 all ages Population survey in Calcutta (Das et al. 1985) 
0.49 USA 20,749 1-74 Survey on representative sample of population (Johnson and Roberts 
1978) 
0.51 Iraq 6,666 all ages Survey on 1080 houses in two areas of Basrah City, 
Southern Iraq (questionnaires and home visits) 
(Al-Rubiay and Al-
Rubiay 2006) 
0.57 Germany 350 14-86 Prevalence in a group of healthy persons serving as 
control group for a Vitiligo-Melanoma study 
(Schallreuter et al. 
1991a) 
0.6 Iran 61,137 all ages Survey on 8776 urban and 4719 rural families 
representing one thousandth of Iran’s population 
(questionnaires and family visits by physicians) 
(Massarrat and 
Tahaghoghi-Mehrizi 
2002) 
0.7 Italy 3660 >44  Self-reports of representative sample of population (Naldi et al. 2004) 
0.9 Nepal 878 1-80 39% of all inhabitants of 5 randomly chosen villages 
examined 
(Walker et al. 2007) 
1.13 India 9065 all ages Population survey in Surat area (Mehta et al. 1973) 
1.2 Denmark 584 >50 All individuals examined who were living in an 
municipal old people’s home  
(Weismann et al. 1980) 
1.2 Sri Lanka 1806 all ages Survey on 418 out of 6000 households in several 
villages of a suburban area 
(Perera et al. 2000) 
1.22 Egypt 8008 all ages Survey on inhabitants of rural areas of Assiut 
Governorate 
(Abdel-Hafez et al, 
2003) 
1.2 Australia 1037 adults Survey on adults as part of long-running health study 
in the south-west coastal town of Busselton 
(Quirk 1979) 
1.7 Uzbekistan 16,398 all ages Survey on inhabitants of 4 rural areas (Arifov et al. 2004) 
1.9 China 47,490 all ages Survey on sample of population in Anhui province (Xu et al. 2002) 
2.28 Romania 1710 all ages Survey on all inhabitants of one small isolated rural 
community 
(Birlea et al. 2003) 
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3.3 Onset of vitiligo 
 
 
 
3.3.1 Age and site of onset 
 
Vitiligo affects people of all skin colours, both sexes and all ages and it can occur at any 
time in life. However, there seems to be a peak in the second decade of patients’ life at 
about 22-24 years of age  (Das et al. 1985; Alkhateeb et al. 2003). Others suggest a 
mean age between 10 and 30 years. In 50% of patients with vitiligo the disease started 
before the age of 20 years (Mosher et al. 1979).  
According to a Danish study the onset of the disease was more frequent between the age 
of 40 to 60 years, but this study seems to be an exception (Howitz et al. 1977).  
Some reports state that the onset is earlier in males compared to females (mean age 19 
years respectively 24 years) (Das et al. 1985; Majumder et al. 1993). Other reports 
could not confirm this difference (Liu et al. 2005). 
 
Vitiligo can occur anywhere on the skin including the mucosae. However, the onset 
seems to be more frequent on exposed parts including face, neck and hands (Table 3).  
 
In a study from Libya there was a more pronounced involvement of exposed parts in 
male patients compared to females. This results could be based on the cultural 
background, where women are more covered compared to men (Singh et al. 1985). 
Taken together, vitiligo is a disease, which is often visible from the beginning to other 
people due to its location in exposed areas of the body. 
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3.3.2 Possible trigger factors 
 
For a long time it has been suggested that stress or distressing events might trigger 
the onset of vitiligo or that those could worsen the disease (Robert 1941; Barbee 
and Sumner 1951; Mosher et al. 1979). Many patients believe that stress plays a 
major role in this disease (Gieler et al. 2000; Firooz et al. 2004). 
Recently this topic has been analysed in several studies containing a considerable 
number of patients. The results showed clear differences between patients and 
control groups (see Table 4).  
Several trigger factors have been documented ranging from hormonal changes and 
physical problems to stressful life events. Moreover, some chemical agents have 
been identified. Some studies included control groups in order to mark the 
differences to patients with vitiligo. The results showed indeed that there are 
significant differences in stress-related experiences between patients with vitiligo 
and controls supporting the perception of the patients that stress has contributed to 
their disease (Table 4). 
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 Perceived trigger factor total 
[n] 
% 
patients 
% 
control 
group 
References 
 
 
Unremarkable events 41 
482 
200 
117 
650 
33 
78.0 
78.6 
60.0 
32.0 
24.0 
21.0 
n/a 
n/a 
n/a 
n/a 
n/a 
n/a 
(Mason and Gawkrodger 2005) 
(Sehgal et al. 1976) 
(Lerner 1959) 
(Salzer and Schallreuter 1995) 
(Dutta and Mandal 1969) 
(Gieler et al. 2000) 
Hormonal changes 117 39.0 n.d. (Salzer and Schallreuter 1995) 
H
or
m
on
es
 
Pregnancy 200 
400 
41 
650 
30.02 
8.0 
7.3 
2.5 
n.d. 
n.d. 
n.d. 
n.d. 
(Lerner 1959) 
(Behl and Bhatia 1972) 
(Mason and Gawkrodger 2005) 
(Dutta and Mandal 1969) 
Loss of or separation 
from a close person 
 
88 
72 
117 
n.d. 
41.0 
≈33.03 
30.0 
23.04 
4.0 
n.d. 
n.d. 
n.d. 
(Papadopoulos et al. 1998) 
(Manolache et al. 2004) 
(Salzer and Schallreuter 1995) 
Harper 1992 cited in 
(Papadopoulos et al. 1998) 
Parents’ separation 91 14.3* n.d. (Montes 2008) 
Stress at work 117 
33 
17.5 
15.2 
n.d. 
n.d. 
(Salzer and Schallreuter 1995) 
(Gieler et al. 2000) 
Relocation 88 
117 
26.0 
16.0 
13.6 
n.d. 
(Papadopoulos et al. 1998) 
(Salzer and Schallreuter 1995) 
Stressful life events 32 
54 
65.0 
60.0 
22.0 
20.0 
(Manolache and Benea 2007) 
(Manolache et al. 2004) 
(Psychological) trauma 65 
365 
57.0* 
3.8 
n.d. 
n.d. 
(Barišíc-Druško and Rucević 1997) 
(Shah et al. 2008) 
Stress 30 
21 
87 
1000 
33 
400 
60.0 
57.1∗ 
54.0 
41.0 
27.3 
7.5 
n.d. 
23.8 
39.3 
n.d. 
n.d. 
n.d. 
(Elgoweini et al. 2003) 
(Manolache et al. 2009) 
(Al-Rubaiy and Al-Rubaiy 2006) 
(Behl et al. 1994) 
(Gieler et al. 2000) 
(Behl and Bhatia 1972) 
‘Nervousness’ 
‘Emotional undertones’ 
or ‘upset’ 
200 
482 
650 
365 
15.0 
12.2. 
8.3 
2.2 
n.d. 
n.d. 
n.d. 
n.d. 
(Lerner 1959) 
(Sehgal et al. 1976) 
(Dutta and Mandal 1969) 
(Shah et al. 2008) 
Ps
yc
ho
lo
gi
ca
l c
au
se
s 
≥3 uncontrollable life events 31 16.7 2.8 (Picardi et al. 2003) 
Physical stress / trauma 650 
65 
200 
41 
33 
400 
998 
482 
365 
40.8 
30.7* 
15.0 
14.5 
9.1 
5.0 
5.0 
1.5 
0.8 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
(Dutta and Mandal 1969) 
(Barišíc-Druško and Rucević 1997) 
(Lerner 1959) 
(Mason and Gawkrodger 2005) 
(Gieler et al. 2000) 
(Behl and Bhatia 1972) 
(Tawade et al. 1997) 
(Sehgal et al. 1976) 
(Shah et al. 2008) 
Chemical agents 400 
998 
5.0 
0.4 
n.d. 
n.d. 
(Behl and Bhatia 1972) 
(Tawade et al. 1997) 
Medication / Antibiotics 400 
41 
32.5 
2.4 
n.d. 
n.d. 
(Behl and Bhatia 1972) 
(Mason and Gawkrodger 2005) 
Ph
ys
ic
al
 c
au
se
s 
Other illnesses 88 
21 
33 
650 
200 
998 
26.0 
9.5 
9.1 
5.5 
3.0 
0.3 
0.0 
0.0 
n.d. 
n.d. 
n.d. 
n.d. 
(Papadopoulos et al. 1998) 
(Manolache et al. 2009) 
(Gieler et al. 2000) 
(Dutta and Mandal 1969) 
(Denman et al. 2006) 
(Tawade et al. 1997) 
 
Table 4: Possible trigger factors (Review of the literature)  
Bold numbers are from case-control studies 
                                                 
2 only regarding exacerbating effect 
3 stated as ‘one third’ 
4 unpublished work by J. Harper (1992) cited in Papadopoulos et al 1998, no case number given 
and no control group used, bereavement was the most commonly reported life event,  
∗ in children only 
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3.4 Clinical subtypes 
 
Vitiligo can be divided into several subtypes according to extent and location of 
the white spots.  
 
3.4.1 Generalised vitiligo 
 
3.4.1.1 Vitiligo vulgaris 
 
Vitiligo vulgaris is the most common subtype of the disease. It appears with 
symmetrical distribution of white maculae, affecting about 40-80% of all patients 
(Mosher et al. 1979; Handa and Kaur 1999; Dogra et al. 2005; Liu et al. 2005). 
However, in one study only 10.5% of all patients had vitiligo vulgaris (Onunu and 
Kubeyinje 2003). The course of generalised vitiligo is unpredictable (Liu et al. 
2005) (Figure 3).  
 
3.4.1.2 Acrofacial vitiligo 
 
Acrofacial distribution includes involvement of distal extremities (hands, feet and 
ano-genital area) and the face. This subset has been documented in about 3-16% 
of all patients with vitiligo (Schallreuter et al. 1994b; Parsad et al. 2004; Zhang et 
al. 2004; Dogra et al. 2005; Liu et al. 2005). 
 
Recently it has been suggested by Liu et al that acrofacial vitiligo changes rather 
rarely to vitiligo vulgaris. These authors reported that acrofacial vitiligo remains 
stable in approximately 74% of all cases (Liu et al. 2005). 
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3.4.1.3 Vitiligo universalis 
 
Vitiligo universalis is a clinical subset where more than 80% of a patient's body 
surface is depigmented. Rarely, patients can be totally depigmented mimicking 
clinically albinism. Although this form is one of the least common subsets, it still 
occurs in 1.6%-7% of all patients (Schallreuter et al. 1994b; Kar 2001; Zhang et 
al. 2004; Liu et al. 2005; Mason and Gawkrodger 2005) (Figure 3). 
However, in the inbreeding Somavamsha Sahasrarjuna Kshatriy community in 
India, where a high prevalence of a positive family history (90.4%) exists, vitiligo 
universalis was found in 15.4% of 54 patients (Ramaiah et al. 1988). 
 
3.4.2 Localised subtypes 
 
Localised vitiligo is characterised by the appearance of one or more white 
maculae in a non-symmetrical and rather scattered manner. Depending on location 
of the appearance, localised vitiligo can be divided into the segmental and focal 
form including lip-tip vitiligo (Hann and Im 2004). 
 
3.4.2.1 Segmental vitiligo 
 
Segmental vitiligo appears unilaterally as localised single maculae in nearly 
definite dermatomes. Hence, a connection to nerves has been suggested. Sites 
most often affected are face and neck, followed by trunk and extremities (Koga 
and Tango 1988; Hann and Lee 1996; Hann and Im 2004) (Figure 3).  
In some cases, segmental vitiligo can also occur in association with vitiligo 
vulgaris resulting in mixed vitiligo (Schallreuter et al. 2008b).  
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A review of the literature shows that about 5% or more of all patients are affected 
by segmental vitiligo (Hann and Im 2004), although some reports showed 
prevalences as high as 10-14% (Kar 2001; Parsad et al. 2004; Zhang et al. 2004). 
The distribution among children, however, is usually more frequent (up to one 
third) and the onset normally earlier than non-segmental vitiligo (Handa and Kaur 
1999; Cho et al. 2000; Grimes and Billips 2000; Prćić et al. 2002; Silverberg et al. 
2004; Zhang et al. 2004). 
 
Interestingly, it has been shown that the cutaneous blood flow and adrenoceptor 
response differ in segmental vitiligo compared to other clinical subsets of the 
disease and normal healthy controls. Wu et al found a threefold increase in 
cutaneous blood flow compared to normal skin, whereas non-segmental vitiligo 
showed a 1.5-fold increase only. The authors suggest that this is caused by a 
dysfunction of the sympathetic nerves  (Wu et al. 2000). 
Finally, the progression of segmental vitiligo has been described as different from 
the vulgaris type of vitiligo. While in the majority non-segmental vitiligo can 
spread on the entire body surface during life, the segmental form spreads more 
frequently on the dermatome only and ceases often after about one year and 
remains stable for the rest of the life (Koga and Tango 1988; Hann and Lee 1996; 
Hann and Im 2004). However, as mentioned above, segmental vitiligo can occur 
together with vitiligo vulgaris (Schallreuter et al. 2008b).  
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3.4.2.2 Vitiligo focalis 
 
This subset refers to cases where one or more patches appear in a single area in random 
distribution. About 15-35% of all patients with vitiligo are affected (Schallreuter et al. 
1994b; Handa and Kaur 1999; Zhang et al. 2004; Liu et al. 2005). For some authors, 
focal vitiligo seems to be more an intermediate state rather than a distinct subtype as 
more than half of all cases develop other clinical subtypes. Recently it was reported that 
75% of vitiligo vulgaris cases start as focal vitiligo (Liu et al. 2005). 
 
 
3.4.2.3 Blaschko-linear vitiligo 
 
There are many skin diseases (genodermatoses, congenital and acquired disorders) that 
follow Blaschko’s lines. This pattern was first described by the German dermatologist 
Alfred Blaschko (Blaschko 1901) and it is thought to be a marker in development and 
growth of two unlike cell populations in the skin tissue, also called mosaicism (Figure 
4). The existence of two different cell populations may be the result of lyonisation, i.e. 
spontaneous inactivation of certain chromosomes during embryogenesis (Happle 1985). 
 
There have been single case reports of vitiligo occurring in linear or Blaschko-linear 
patterns (El Mofty 1968; Punshi 1975; Schallreuter et al. 2007) (Figure 5), but not all of 
them seem to follow exactly these lines (Bolognia et al. 1994). Khaitan found a 
blaschkoid pattern in 49.6% of 141 patients with segmental vitiligo (Khaitan et al. 
2007). 
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Figure 4: Blaschko’s lines on the human body (Jackson 1976)  
 
 
Figure 5: Blaschko-linear vitiligo on arms (B) and legs (C) co-existing with 
acrofacial vitiligo (A)  
(Schallreuter et al. 2007) 
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3.4.3     Special forms 
 
 
3.4.3.1 Trichrome / quadrochrome vitiligo 
 
This form shows clinically more than two skin colours ranging from hyperpigmented, 
hypopigmented to depigmented areas. Figure 6 shows one example of trichrome or four 
colours (quadrochrome) vitiligo.  
The importance of this phenomenon is not yet clear. It might be either a transitional 
stage in the development of active spreading vitiligo (Schallreuter, personal 
observation) or just an unusual pattern of depigmentation (Mosher et al. 1979; Hann and 
Im 2004). 
 
 
Figure 6: Trichrome vitiligo 
(with courtesy from KU Schallreuter) 
 
 
  38
3.4.3.2 Inflammatory vitiligo 
 
Sometimes, the borders of vitiligo patches can be red, raised and even scaly as an 
expression of an inflammatory process. At the same time, a mild pruritus (itching) can 
be noticeable. Eczema-like changes, the absence of melanin and the presence of 
lymphocytic and histocytic infiltrates can be observed (Hann and Im 2004). 
The significance of these raised and red borders is not yet known. It has been suggested 
that this phenomenon is an expression of the normal inflammatory process in the 
development of vitiligo (Hann and Im 2004; Sharquie et al. 2004).    
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3.5 Aetiology of vitiligo 
 
Vitiligo has generated a lot of interest and, consequently, research is ongoing worldwide 
to find the cause for this devastating disease. There are many theories trying to explain 
vitiligo including autoimmune, genetic, neural, autocytotoxic, biochemical, and 
oxidative stress mechanisms. However, a satisfying explanation for what causes the 
sudden mostly progressive loss of the inherited skin colour has not yet been found 
(Grimes 2004; Schallreuter et al. 2008a).  
 
 
3.5.1 Autoimmune hypothesis 
 
A possible autoimmune reaction of the human body against its own melanocytes is 
currently still the most popular hypothesis to explain the cause for vitiligo. It is thought 
that antibodies in a majority of patients with this disease are directed against 
melanocytes, but also against thyroid, adrenal and parietal mucosa tissue. As a result, 
melanocytes are absent after being destroyed in lesional skin of these patients 
(Naughton et al. 1983; Schallreuter et al. 1994b; Farrokhi et al. 2005; Le Poole and 
Luiten 2008).  
Antibodies are observed in 30-80% of patients (Naughton et al. 1983; Farrokhi et al. 
2005), but sometimes they cannot be detected at all (Schallreuter et al. 1994b). 
 
However, recent findings have questioned the idea that melanocytes are completely 
destroyed or absent in white patches of long-standing vitiligo. It was shown that 
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melanocytes are not only still present even after long duration of the disease, but also 
started to produce melanin again under certain conditions (Tobin et al. 2000). These 
findings raised the question whether subpopulations of melanocytes actually survive but 
are in fact not functioning. 
In summary, there are conflicting reports whether autoimmunity plays a major role in 
this disease. 
 
 
3.5.2 Genetic hypothesis 
 
In about every third patient, a positive family history of vitiligo can be documented. 
This finding suggests a possible involvement of genes in the development of vitiligo 
(Mosher et al. 1979; Majumder et al. 1993). Reports on a positive family history in 
affected individuals vary from 1.5-48% (Singh et al. 1985; Schallreuter et al. 1994b; Al-
Khawajah 1997). Based on the presence of vitiligo in families, there is an ongoing 
interest since the 1960‘s to find genetic evidence involved in this disease. During this 
course the role of certain blood groups was investigated, but these studies were 
inconclusive (Nordlund 1997).  
More recent studies tried to identify certain candidate genes or chromosomes which 
could be involved in the development of vitiligo. Recently, certain candidate genes have 
been implicated in vitiligo. However, it is clear no simple Mendelian genetics exist for 
vitiligo, but rather multiple susceptibility loci and genetic heterogeneity with possible 
differences between ethnic groups (Schallreuter 2004; Chen et al. 2005; Laberge et al. 
2005; Zhang et al. 2005). 
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One of the genes involved is the catalase gene. This data supports both the genetic and 
oxidative stress hypotheses (see chapter on oxidative stress) (Casp et al. 2002; Wood et 
al. 2008). Such genetic predisposition might be the reason for a higher susceptibility of 
melanocytes to exogenous or endogenous enviromental factors (chemicals, food 
ingredients, etc) (Nordlund 1997).  
Other susceptibility genes have been put forward including the PTPN22-1858C>T5 
(Laberge et al. 2008), the NALP16 (Jin et al. 2007), AIS1 (Fain et al. 2003) or the 
FOXD37 gene (Alkhateeb et al. 2005), most often in connection with autoimmune 
diseases. Since the data vary between patients, it is possible that different subtypes of 
vitiligo may exist. 
 
 
3.5.3 Neural hypothesis 
 
This hypothesis is based on that both melanocytes and neuronal cells derive from the 
neural crest during embryogenesis. A link between the nervous system and vitiligo as 
well as other skin diseases has been discussed for a long time (Crooker 1884). This 
hypothesis was supported by some observations in vitiligo patients. One example is 
segmental vitiligo which often follows dermatomal pattern. Moreover, depigmentation 
has been described in connection with neural diseases such as multiple sclerosis, 
syphilis or physical damage to nerves. It is thought that cutaneous nerve endings and 
their neurotransmitters influence the functionality of melanocytes (Lerner et al. 1966; 
Del Bianco et al. 2004; Hautmann et al. 2004). Increased levels of catecholamine 
                                                 
5 encodes lymphoid protein tyrosine phosphatase (Laberge et al. 2008) 
6 encodes NACHT leucine-rich-repeat protein 1, a regulator of the innate immune system (Jin et al. 2007) 
7 melanoblast developmental regulator gene in autosomal dominant vitiligo (Alkhateeb et al. 2005) 
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metabolites in urine have been documented by several groups (Morrone et al. 1992; 
Schallreuter et al. 1994d) 
However, segmental vitiligo does not always strictly follow a dermatomal pattern and 
many other clinical phenomena of vitiligo cannot be explained by this hypothesis. 
Consequently, the neuronal hypothesis can only add in parts to the pathogenesis of 
vitiligo (Nordlund and Ortonne 1998). 
 
3.5.4 Autocytotoxic hypothesis 
 
The essential part of this hypothesis is that certain precursors of melanin or chemicals 
similar to melanin can inhibit the process of melanogenesis or even destroy 
melanocytes. A severe imbalance could cause a loss of protection against such 
chemicals which in turn especially affects melanocytes (Hann and Chun 2000; 
Hautmann et al. 2004). 
Slominski et al suggested that melanocytes in vitiligo are destroyed by a cascade of 
reactions initiated by a dysregulation of melanogenesis in connection with activation of 
the melatonin receptor. These authors suggested that an uncontrolled production of free 
radicals and toxic products of melanogenesis could provoke an autoimmune response 
against exposed surface antigens leading in turn to the destruction of melanocytes 
(Slominski et al. 1989). 
 
3.5.5 Oxidative Stress hypothesis 
 
This hypothesis is based on a discovery made by Schallreuter et al who showed in vivo 
by FT-Raman spectroscopy, that patients with vitiligo have increased levels of 
hydrogen peroxide (H2O2) in the lesional and non-lesional skin leading to oxidative 
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stress in the entire epidermis in association with low epidermal catalase levels 
(Schallreuter et al. 1991b; Schallreuter et al. 1999). 
 
Physiological H2O2 levels in the epidermis are in the micromolar [µM] range. However, 
once H2O2 reaches high levels (millimolar [mM] range), a number of mechanisms in the 
skin can be altered leading to destruction / dysfunctionality of melanocytes. 
This also includes accumulation of oxidised pterins, because 6BH4,  a cofactor involved 
in melanogenesis is oxidised to 6-L-biopterin. The latter is cytotoxic to melanocytes 
(Schallreuter et al. 1994a). The presence of oxidised pterines in the skin of patients with 
vitiligo is the reason why Wood's light can be used for diagnosis of this disease, because 
the observed fluorescence is caused by oxidised pterins  (Schallreuter et al. 1994c). 
 
At the same time epidermal catalase, thioredoxin reductase and systemic glutathione 
peroxidase levels are significantly decreased. These anti-oxidant enzymes normally 
degrade high levels of H2O2. The low level of catalase is caused by oxidative 
degradation of the active site of this enzyme (Aronoff 1965; Schallreuter et al. 1991b; 
Schallreuter 2004; Maresca et al. 2006; Wood and Schallreuter 2006; Wood et al. 
2008). 
Others authors also reported that there is an imbalance in the anti-oxidant system in 
vitiliginous melanocytes (Maresca et al. 1997) as well as an increased sensitivity of 
vitiliginous melanocytes to oxidative stress, associated with the abnormal expression of 
tyrosinase-related protein TRP1 leading to early cell death (Jimbow et al. 2001). 
As mentioned above, recently the catalase gene has been implicated as a most likely 
susceptibility candidate, which would support this hypothesis (Casp et al. 2002; Wood 
et al. 2008). 
An indirect proof for this hypothesis is also that vitiligo can be treated with a topical 
application of a narrow-band UVB activated pseudocatalase (PC-KUS) leading to 
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removal of H2O2 from the epidermis. With this modality progressive de-pigmentation 
can be stopped and re-pigmentation can be achieved with good success rates 
(Schallreuter et al. 1995; Schallreuter et al. 2008b). 
 
Whether oxidative stress can fully explain the cause of vitiligo needs yet to be shown. 
However, all data generated so far revealed that the entire epidermis of patients is 
involved (i.e. lesional and non-lesional skin) in the disease process and not only 
melanocytes. Moreover, the possible connection with the catalase polymorphism 
strongly suggests that H2O2 is one of the major players in this disease (Schallreuter et al. 
2008a). 
 
 
3.5.6 Viruses and vitiligo? 
 
Besides the above-mentioned hypotheses, there have been some other suggestions to 
explain the pathogenesis of vitiligo including viral infections. It is believed that viruses 
could play a part in some autoimmune diseases like Hashimoto's thyroiditis, which is 
more frequent in patients with vitiligo compared to healthy controls (Castanet and 
Ortonne 1997).  
Implicated viruses are for example the human cytomegalovirus (CMV) (Grimes et al. 
1996; Galarza et al. 2004) or the hepatitis C virus (HCV). However, the results are 
controversial, because no significant connection could be found by other groups (Würfel 
1999; Akbayir et al. 2004; Schallreuter 2004; Jadali et al. 2005).  
In the majority of patients only a rather weak direct link can be documented between 
viral infections and the development of vitiligo. At this time, molecular mimicry cannot 
be ruled out. More investigations are necessary to support or dismiss this hypothesis 
(Schallreuter 2004). 
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3.5.7 Vitiligo and hormones 
 
There have been several reports that the onset of vitiligo is often associated with 
hormonal changes. In a report by Salzer and Schallreuter, 39% of all patients examined 
associated the beginning of their disease with hormonal changes, such as puberty, 
pregnancy, birth and menopause. This association was significant (Salzer and 
Schallreuter 1995).  
 
In this context it has been shown only recently that oestrogens can contribute to 
oxidative stress due to elevated H2O2 and semiquinone and orthoquinone levels in 
lymphocytes, finally leading to DNA damage in these cells (Anderson et al. 2003).   
Since oestrogens can be produced in the human epidermis, it was proposed that 
hormone-induced oxidative stress could add to the H2O2 pool contributing to the 
depigmentation process (Schallreuter et al. 2006).  
 
3.5.8 Other hypotheses 
 
Another hypothesis is based on the idea that melanocytes are part of the so-called 
epidermal melanin unit which includes melanocytes and keratinocytes (Fitzpatrick and 
Breathnach 1963). It was shown that stimulatory cytokines are low in the skin of 
patients with vitiligo, by contrast with inhibitory cytokines, which were significantly 
increased (Moretti et al. 2002; Hautmann et al. 2004). It is thought that these cytokines 
and / or growth factors cause an alteration of the microenvironment within this melanin 
unit leading to apoptosis of melanocytes. Therefore, vitiligo could be seen as a result of 
such alteration.  
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No difference was found between melanocytes from non-lesional skin and melanocytes 
from healthy controls regarding apoptotic mechanisms (Tobin et al. 2000; Van den 
Wijngaard et al. 2000). Furthermore, as described above, Tobin et al could show that 
melanocytes are still present in lesional skin even after long duration of vitiligo (Tobin 
et al. 2000). Moreover, when these melanocytes were established in cell culture, they 
showed normal growth and morphology. These results suggested that recovery of a 
normal homeostasis / environment is important for melanocyte function in vitiligo 
(Tobin et al. 2000). The absence of apoptosis was further confirmed in two recent PhD 
theses by Shalbaf and Abou-Alloof (PhD at the University of Bradford, 2009). 
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3.6 Treatment 
 
Vitiligo is a disease known for more than 1000 years. Similar old are attempts to treat 
this depigmentation disorder (Kopera 2000). In some old medical books from India, a 
plant mentioned to be useful is named as Bavachee (or psoralea corylifolia). Later is 
was found that it contains psoralene, a photo-sensitizing chemical compound (Morrone 
2004; Njoo and Westerhof 2004). Psoralens have been used since ancient times and 
they are still in use today in combination with UVA light or natural sun light known as 
PUVA and PUVASOL.  
In a review on vitiligo from the 1940s, Robert mentioned other treatment modalities 
reported in the literature at that time, including:  
 
• Kromayer’s lamp (a quartz lamp of mercury vapour with actinic rays),  
• Re-injection of patient’s own blood, 
• Sensitizing with acriflavine (an antiseptic) followed by quartz lamp irradiation, 
• Sun light exposure, 
• X-rays       (Robert 1941). 
 
It is obvious that already in earlier time doctors tried to treat vitiligo with irradiation or 
light exposure, a principle that is still true for today. In his own clinic the author 
apparently used several different tablets (e.g. Histamin) without observing any 
significant improvements (Robert 1941).  
 
In 1948 El Mofty was the first in modern times to investigate the efficacy of oral 
psoralen combined with sunlight, which was apparently the most effective treatment for 
vitiligo at that time (El Mofty 1968).  
 
Nowadays there is a broad range of more or less successful treatment modalities 
available often following the mentioned hypotheses about possible causes of the 
disease. Table 5 summarises the various methods.  
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 Treatment 
modality 
Possible action 
mechanism 
Side effects Success rates [n] Reference 
Psoralens + UVA 
(PUVA) 
Stimulates hypertrophy 
(enlargement), 
proliferation and enzymatic 
activity of melanocytes 
Risk of skin 
cancer 
increased 
8 out of 97 (nearly) complete 
pigmented (8.3%), 59 out of 97 had 
moderate to extensive repigmentation 
of different qualities, 30 showed none 
or only little improvement. 
97 (Kwok et al. 
2002) 
Khellin + UVA 
(KUVA) - active 
principle of the  
plant ammi 
visnaga 
Activates melanocyte 
proliferation and 
melanogenesis 
Mild nausea,  
impaired liver 
functions 
41% of patients showed good 
response (>70% repigmentation)  
after a mean of 194 treatments 
28 (Hofer et al. 
2001) 
L-phenylalanine 
+ UVA  
(PAUVA) 
Stimulates migration of 
melanocytes from adjacent 
areas 
Not stated Half of patients satisfied with results, 
11 out of 25 patients (44%) still 
repigmented 5 years after treatment 
25 (Greiner et 
al. 1994) 
Pseudo-catalase 
+ narrow-band 
UVB  (PC-KUS) 
- (bis-(Mn)(EDTA) 
bi-carbonate) 
Reduction of millimolar 
levels of epidermal H2O2 
leading to recovery from 
oxidative stress and 
repigmentation 
None 92% of patients had excellent 
repigmentation (>75%) in face, 79% 
on trunk, 73% on extremities, 9% on 
hands / feet after one year of daily 
treatment 
71 (Schallreuter 
et al. 2008b) 
Combined 
climato-therapy 
with PC-KUS at 
the Dead Sea 
Weak pseudocatalase 
activity of Dead Sea water 
supports PC-KUS 
treatment 
Exposure to 
sunlight 
Repigmentation initiated already after 
10-16 days compared to 8-14 weeks 
with PC-KUS alone 
59 (Schallreuter 
et al. 2002) 
Ph
ot
o-
ch
em
o 
th
er
ap
ies
 
Melagenina - a 
hydroalcoholic 
extract from the 
human placenta 
Accelerates the formation 
of melanin from dihydroxy-
phenylalanine (DOPA) as 
part of melanogenesis 
Not stated 62 out of 366 paediatric patients 
(16.9%) showed 71-100% 
repigmentation 
366 (Mal'tsev et 
al. 1995) 
Narrow-band 
UVB (311nm 
wavelength) 
Induces immuno-
supression, increases 
melanocyte-stimulating 
hormones, melanocyte 
proliferation and 
melanogenesis 
Increased 
risk of skin 
cancer 
53% of treated children had at least 
75% of their vitiligo repigmented, in 
6% (n=3) it was even complete 
51 (Njoo et al. 
2000) 
Climato-therapy 
at the Dead Sea 
Salty water rich in 
minerals, filtered sunlight 
to stimulate pigmentation 
Sun-induced 
skin cancer 
n.d. n.d. (Even-Paz 
1996) 
Ph
ot
ot
he
ra
pi
es
 
Excimer laser 
Targeted mono-
chromatic light 
308nm 
Similar to narrow-band 
UVB 
Increased 
risk of skin 
cancer 
23 patches from 12 patients achieved 
about 57% repigmentation, whereas 
11 patches from 6 patients received 
all 12 treatments and gained appr. 
82% pigmentation back 
18 (Spencer et 
al. 2002) 
Steroids - 
synthetic 
analogues of 
hormones of the 
adrenal cortex 
Anti-inflammatory and 
immunosuppressant 
effects 
Atrophy 
weight gain, 
insomnia, 
acne, 
menstrual 
disturbances 
In various studies good to excellent 
repigmentation has been reported in 
9-92% 
Va
r. (Stratigos 
and 
Katsambas 
2004) 
Calciopotriol - a 
synthetic 
analogue of 
vitamin D3 
Influence on growth and 
differentiation of 
melanocytes and 
keratinocytes 
Mild irritation 
of the skin 
possible 
55% had marked to complete 
repigmentation, moderate 
repigmentation in 4, rest showed only 
minimal or no improvement, none 
developed new patches 
21 (Parsad et 
al. 1999) 
Topical 
immuno-
modulators 
Tacrolimus & 
Pimecrolimus 
Limiting activation and 
maturation of T-cells by 
inhibiting calcineurin 
function. 
Site burning,  
pruritus, 
cancer 
76-100% repigmentation in 47% of 
patients on head and neck, 25% of 
patients with involvement of trunk and 
/ or extremities 
57 (Silverberg 
et al. 2004) Lo
ca
l t
he
ra
pi
es
 
Skin grafting Pigmentation up to 8mm 
around each graft 
Scarring, 
hypo- or 
hyper-
pigmentation, 
infections 
84% of participants with segmental 
vitiligo showed excellent 
repigmentation (95-100%), 6% good 
results (65-94%), only 10% showed 
poor repigmentation (0-24%) 
67 (Mulekar 
2004) 
Table 5: Selection of common treatment modalities and their success rates in the 
literature 
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3.7 Psychosocial impact of vitiligo - limitation of available data 
 
Until the end of the 1970’s only little research had been conducted on the psychosocial 
impact of vitiligo on patients’ life (Barbee and Sumner 1951). Starting with the 
pioneering work of Porter’s group, several aspects of vitiligo such as its influence on 
children, sexual relationships, self-esteem and the role of skin colour, age and patients-
doctor relationships were covered (Porter et al. 1978; Porter et al. 1979; Porter and Beuf 
1988; Porter et al. 1990; Porter and Beuf 1991; Porter and Beuf 1994). Numerous 
publications have followed since on the emotional well-being of patients and not only 
on medical aspects.  
 
However, in this context it is noteworthy that all data originate from patients who were 
associated with dermatological clinics or self-support organisations, because this is the 
easiest way to get hold of patients.   
Moreover, it can be expected that patients who seek medical treatment and / or support 
are psychosocially more affected and more desperate compared to those who do not 
bother. Therefore, the critical question was whether numbers from the literature form a 
realistic basis for the general patient population.  
 
One indication that individuals, who are members of support groups, are more affected 
was shown by Ongenae et al who investigated the impact of vitiligo and psoriasis on 
quality of life. Patients of those groups scored significantly higher compared to non-
members indicating a greater impairment of quality of life in these patients (Ongenae et 
al. 2005b). 
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To the best of our knowledge there is only one study available in the literature providing 
a hint about how many patients with vitiligo care about their disease at all. In the 1970’s 
a health examination survey was conducted in the USA to obtain data on skin 
conditions and their related medical care. This study included 20,749 persons aged 1-74 
years, who were examined by dermatologists. Vitiligo was found in 0.49% of the 
population, a result which is in agreement with the reports in the literature (Table 2 and 
Figure 2). This number confirms other data on the prevalence in the population. 
However, after the dermatologists asked for ‘skin conditions of concern’, vitiligo was 
mentioned by only 0.14% of the group (Johnson and Roberts 1978). Based on these 
data, it can be concluded that only 29% of all patients with vitiligo are actually 
concerned about their disease. This information is a big surprise. If the above study is 
representative, it is tempting to conclude that most likely all available data originate 
from concerned sufferers only.  
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3.8 The world of patients with vitiligo 
 
3.8.1 ‘What is beautiful is good’ 
 
The skin is not only the largest organ of a human being; it also provides the boundary 
between the body and the external environment. Hence this organ plays an important 
part in people's communication with others, as mirrored for example by blushing as a 
reaction to somebody, hair-rising or getting pale (Van Moffaert 1992). 
 
The skin is important for tactile communication and interaction, for instance between 
children and parents or between adults. In the early years of life some emotions are 
learned partly by skin contact, for instance bonding to the parents (Griesemer and 
Nadelson 1979; Van Moffaert 1992; Walker 2005). 
Taken together, the skin has not only biological functions, but it is also important in 
people's social interactions playing a major part in our physical appearance. 
Physical appearance and its influence on other people's opinion about strangers have 
been the subject of many earlier investigations revealing that people attribute physically 
attractive strangers: 
 
• as socially more desirable, better spouses and having happier marriages (Dion et al. 
1972), 
• as more likable, especially by men  (McKelvie and Matthews 1976), 
• as more intelligent (Zebrowitz et al. 2002). 
 
Dion summarised this phenomenon with ‘What is beautiful is good’ (Dion et al. 1972). 
Based on these concepts a link between vitiligo and and its influence on social life can 
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be made. Since our skin is important for our self-confidence and appearance, vitiligo 
and other skin diseases can significantly alter this and thus influence personal 
relationships. 
By contrast to the wide range and long history of research on skin diseases including 
biochemical backgrounds and treatment modalities there was very little research done 
on the psychosocial impact of skin diseases until the beginning of the 1980’s. 
Nowadays, a connection between skin diseases and psychosocial problems has been 
established opening the field of psychodermatology (Van Moffaert 1992; Walker 2005).  
 
 
3.8.2 Stigmatisation 
 
Stigma is a negative evaluation of a certain feature or behaviour by society. It reduces 
the affected individual to a tainted, discredited person leading to disapproval, negative 
comments, discrimination and exclusion (Goffman 1968; Bruce 2000; Chaturvedi et al. 
2005). 
 
Stigmatisation may occur as reaction to either tribal identity based on race, gender or 
religions, character blemishes including addiction and mental illness or alterations of 
the physical appearance of somebody, for example by vitiligo (Kent 2005).  
 
Stigmatisation may be encountered by the affected person in several ways. Besides open 
negative reactions and rejections, it is also possible to sense that other people with the 
same disease are stigmatised. Not always are all reactions negative, but it is important to 
realise than being the centre of unwanted attention as curiosity leads to the same effect 
(Kent 2005). 
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There are several theories why stigmatisation takes place among humans: 
 
• Altered appearances or behaviours are examples for deviations from predictability 
which may pose a threat to the smooth running of a society (Albrecht et al. 1982). 
 
• If a certain condition or behaviour is believed to be controllable (e.g. alcohol 
addiction), they are more likely to cause stigmatisation (Albrecht et al. 1982; Kent 
2005) → ‘Just World hypothesis’: people have certain conditions, because they 
must have deserved it, for example acne must be caused by bad food (Kent 2005). 
 
• An unknown skin condition could be a threat to the physical health of other people, 
because this condition could be contagious. Therefore contacts are avoided. Here an 
evolutional origin is suspected since avoidance of potential threats is seen as  
advantage for survival (Hornstein et al. 1973; Kent 2005). 
 
Baumeister developed the Social Exclusion Theory, which implies that humans have a 
fundamental motive not to be excluded by their fellows. Moreover, this theory 
emphasises that our social behaviour often reflects the attempts to enhance our chances 
of social inclusion. In fact, there are negative effects including depression, if we do not 
achieve our goals in psychosocial interaction (Baumeister and Leary 1995; Kent 2005). 
Stigmatisation is often associated with vitiligo, because other diseases appear clinically 
similar. This is also the case with leprosy which is by far more dangerous due to 
possible infection from the affected individual (Kopera 2000). One example is presented 
in Figure 7. 
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Figure 7: Leprosy of the face 
Note the striking similarity of the white spot to vitiligo (source: www.who.int/lep/en) 
 
 
In India, for example, people with vitiligo experience the same abuses and negative 
reactions, because it is believed that they have "Sweta Kushta" (white leprosy). Some 
Indian people believe that vitiligo sufferers must have "insulted teacher" (Chaturvedi et 
al. 2005) or that they must have done something punishable in their past lives (Weiss et 
al. 1992).  
A confusion of vitiligo with leprosy has also been reported from other countries, for 
instance in Nigeria resulting in stigmatisation (Onunu and Kubeyinje 2003; Olasode and 
George 2008). 
 
An overview of published data on the subject of stigmatisation is presented in Table 6. 
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Stigmatisation experiences % of [n] [n] Reference 
Subject to questions about disease 72 62 (Porter et al. 1979) 
Staring by other people 67 
57 
62 
326 
(Porter et al. 1979) 
(Porter et al. 1987) 
‘Negative comments, teasing or bullying’ 49 45 (McLeod 2004) 
Rude remarks 50 
16 
326 
62 
(Porter et al. 1987) 
(Porter et al. 1979) 
Avoided interactions 
Rejection 
13 
13 
62 
78 
(Porter et al. 1979) 
(Ongenae et al. 2005a) 
Negative effects on education and job 
opportunities 
338 77 (Borimnejad et al. 2006) 
Discrimination at work 13 
8 
62 
326 
(Porter et al. 1979) 
(Porter et al. 1987) 
 
Table 6: Frequencies of stigmatising experiences in vitiligo (review of the 
literature) 
 
 
Importantly, it was shown by Porter and Beuf that perceived stigmatisation leads to 
lower self-esteem and a higher degree of disturbance in patients with vitiligo. This 
result stresses the deep impact of stigmatisation on the affected persons (Porter and 
Beuf 1991). In this context it is noteworthy that perceived stigmatisation was the most 
influential factor accounting for 39% of variance in the assessment of quality of life 
(Kent and Al-Abadie 1996a). There are no differences in experiencing stigmatising 
encounters between both genders in a group of 45 patients with vitiligo (McLeod 2004). 
  
 
                                                 
8 Calculated by this author using numbers provided in the publication (21 out of 53 females, 4 out of 24 
males) 
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3.8.3 Vitiligo - a non-predictable disease 
 
For a long time vitiligo has been recognised as a disease with a rather unpredictable 
character. Although normally progressing with time, spreading of the disease can stop at 
any time or progress even faster. Rarely, spontaneous re-pigmentation has been 
observed (Mosher et al. 1979; Chun and Hann 1997).  
 
This lack of predictability makes it more difficult for patients to cope with the disease. 
Porter et al reported that the majority of the population investigated (n=62) were 
concerned about the progressive character of vitiligo (Porter et al. 1979). In another 
report this was 41% of 326 patients (Porter et al. 1987). 
 
It was shown that after diagnosis ‘the predominant reactions were worry about being 
different from others and finding, because vitiligo has no cure, that they were unable to 
control this difference’ (Thompson et al. 2002).  
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3.9 Psychological reactions to Vitiligo 
 
3.9.1 Depression 
 
Depression is one of the most common psychiatric disorders in patients with skin 
diseases. It can be defined as a mental disorder characterised by persisting low mood, 
change in appetite, loss of interest / pleasure in usual activities involving one or more 
episodes of such changes (Gupta and Gupta 2003).   
 
In one of the earliest investigations on psychosocial wellbeing of patients with vitiligo it 
was found that 40% of 62 participants were depressed using the Coppersmith Self-
Esteem Inventory. Depression was associated with acute and chronic embarrassment. 
The depressed patients tried “heroically” to hide their vitiligo (Porter et al. 1979). 
 
Several later publications investigated whether patients with vitiligo were more 
depressed compared to healthy controls. The results varied from none to significant 
differences.  
 
No differences were found between patients and controls in a German study with 33 
patients using the Beck Depression Inventory (BDI) (Gieler et al. 2000).  
The same outcome was confirmed for children / adolescents (n=13, 10-15 years old) 
with the Birleson Depression Scale (Prćić et al. 2006). Moreover, the depression scores 
tend to decrease with duration of vitiligo (Gieler et al. 2000).  
 
There was also no significant difference between patients and healthy controls or 
between genders using the BDI (n=21). Neither age, the presence of progressive 
  58
vitiligo, visibility of lesions nor the duration of the disease did seem to influence 
depression levels (Lee et al. 2000).  
 
Other authors, however, stressed that there are differences between patients and 
controls. Kökçam and colleagues compared 11 patients with vitiligo to sufferers from 
alopecia areata and healthy controls using the Zung Depression Scale and Symptom 
Check-List 90-R (SCL-90-R). Manifest depressive symptoms were found in 55% of the 
vitiligo group, in 36% of the alopecia group, but only in 15% of the control group 
(Kökçam et al. 1999). 
This difference was even more pronounced in an investigation from Iran, where the 
Hamilton Rating Score for Depression (HRSD) was used in 52 patients with vitiligo and 
the same number of healthy controls.  46.2% of the patients, but only 6% of the controls 
were depressed (Maleki et al. 2005). Similar results were obtained with the Minnesota 
Multiphasic Personality Inventory where scores in the subscale depression were higher 
in patients with vitiligo (n=30) compared to healthy controls (Elgoweini et al. 2003). 
 
 
3.9.2 Anxiety 
 
Gieler et al used the Intercations Anxiety Questionnaire for measuring the individual 
degree of anxiety in eight specific situations. Patients with vitiligo were more anxious in 
three out of the eight situations including fear of deviation from standard, fear from 
self-assertion and fear of challenging situations, whereas evaluating of fear of physical 
injury, fear of performance and hypochondriac fear to get a disease yielded no 
differences  (Gieler et al. 2000).  
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Kökçam et al compared 11 patients with vitiligo with sufferers from alopecia areata and 
healthy controls using the Zung Depression Scale and SCL-90-R with one subscale 
being on anxiety. Here, patients with vitiligo were more anxious than healthy controls 
(Kökçam et al. 1999). Similar results were obtained by Manolache et al who compared 
patients with vitiligo (n=54) to those with alopecia areata (n=72) and healthy controls 
(Manolache et al. 2004). Furthermore, after the introduction of the Adjustment to 
Chronic Skin Disorders Questionnaire, it was shown that female patients (n=23) were 
more socially anxious than males (n=10) (Stangier et al. 2003). 
 
There are a number of contradictory reports in the literature. No differences in anxiety 
between adolescents with vitiligo (n=33) and healthy controls (n=60) were found 
utilising the Spielberger’s Scale (Prćić et al. 2006).  The same result was reported for 
adult patients (n=22) using the Spielberger’s State and Trait Anxiety Inventory (STAI). 
No significant differences could be observed between female and male patients, 
between the age groups of younger and older than 30 years of age, and with regards to 
disease progression and visibility (Lee et al. 2000).  
 
Using one subscale of the Adjustment to Chronic Skin Disorders Questionnaire, men 
(n=79) and women (n=284) with vitiligo showed equal levels of social anxiety / 
avoidance (Schmid-Ott et al. 2007). 
 
3.9.3 Reduced Self-esteem 
 
Self-esteem is “a personal judgement of worthiness that is expressed in the attitudes the 
individual holds toward himself. It is a subjective experience which the individual 
conveys to others by verbal reports and other overt expressive behaviour” (Coopersmith 
1967). 
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In 1986, Porter et al showed that patients with vitiligo scored significantly lower on the 
Coopersmith Self Esteem Index indicating a lower self-esteem compared to healthy 
controls (Porter et al. 1986). In another study 58% of patients (n=80) believed that 
vitiligo had strongly affected their self-esteem (Firooz et al. 2004). 
 
High self-esteem before the onset of vitiligo led to less difficulties in coping with the 
disease (Porter et al. 1979). Already 30 years earlier and based on interviews with 13 
patients it was suggested that vitiligo “does not induce a change in the basic structure of 
the personality but accentuates already present personality traits” (Barbee and Sumner 
1951). 
 
A positive correlation between self-esteem (measured by Rosenberg Self Esteem Scale - 
RSES) and Quality of Life (measured with the Dermatology Life Quality Index - DLQI) 
was documented in 614 patients with vitiligo (Kent and Al-Abadie 1996a). The same 
correlation was found between self-esteem and perceived stigma (n=614) (Kent 1999). 
 
Low self-esteem in patients with vitiligo improved significantly by cognitive-
behavioural therapy (CBT) as demonstrated by Papadopoulos et al with 16 patients with 
vitiligo measured utilising the Rosenberg Self Esteem Scale (RSES). After 8-weeks of 
therapeutic counselling the mean RSES score of 30 decreased to approximately 13, 
compared to the control group where RSES scores hardly changed (Papadopoulos et al. 
1999).  
A build-up of appearance-independent competencies to improve self-esteem leads to 
better coping with this skin disease in children (Hill-Beuf and Porter 1984). 
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3.9.4 Embarrassment 
 
In 1979 Porter et al investigated psychological reactions of 62 patients to chronic skin 
disorders, using vitiligo as a model disease. Two thirds of the patients felt embarrassed 
by their disease. Approximately 53% stated that they felt socially uncomfortable, ugly 
or forced to hide their white spots by certain clothes. Younger people (<40 years) felt 
more embarrassed. There was no gender-related difference compared to older people, 
where men are less affected  (Porter et al. 1979). 
Seventy eight percent of 109 Saudi-Arabian patients with vitiligo felt embarrassed by 
the disease. Women were more affected than male patients (Al Robaee 2007). The 
percentage of Nigerian patients embarrassed by their vitiligo was with 90% even higher 
(Olasode and George 2008). 
 
From these data it can be concluded, that embarrassment is common in patients with 
vitiligo. 
 
 
3.9.5 Limited personal and sexual relationships 
 
Vitiligo can influence the patients’ sexual relationships profoundly at all levels. Many 
patients find it difficult to socialise and / or to establish relationships at all (Porter et al. 
1990). 
 
Approximately 10-15% of patients stated that vitiligo has limited either sociability or 
their potential to enter relationships (Porter et al. 1990). In a later investigation it was 
shown that vitiligo affecting the genital area has a negative effect on socialising and 
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meeting potential sexual partners. Half of the participants reported stress and general 
embarrassment in the presence of strangers and  people of the opposite sex  (Porter et al. 
1990). 
 
Another study regarding quality of life evaluated 30 patients with vitiligo who received 
treatment with narrow-band UVB light over the last 4 years. On the one hand, thirteen 
patients of this group had never experienced any problems with relationships or with 
starting new ones, and 17 patients had never had any sexual problems due to their 
vitiligo. On the other hand, these data reflect that half of the group must have had  
experienced such problems in the past (Tjioe et al. 2005). 
In an investigation on differences between the sexes regarding quality of life in Iranian 
patients (n=77), it was found that females were more affected in the DLQI sub scores 
‘interpersonal and social relationships’ and ‘sexual activity’ (Borimnejad et al. 2006). 
 
25 – 30% of all patients with vitiligo reported that their sex lives were strongly affected 
(Porter et al. 1979; Porter et al. 1990).  
It was documented that males and especially persons  
 
• with low self-esteem,  
• with higher rating of appearance as important factor  
• who are unmarried  
 
had more difficulties. Self-esteem was the most influential factor (Porter et al. 1990). 
However, several investigations could not confirm the difference between married and 
unmarried patients. Kent and Al-Abadie found no differences in DLQI measurements 
comparing patients with vitiligo living in stable sexual relationships (n=446) to those 
who were separated, divorced or who had never lived with a sexual partner at the time 
of the survey (n=167) (mean scores 4.67 vs. 5.24, p>0.1) (Kent and Al-Abadie 1996a).  
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The same result was reported in Iranian patients where no differences between married 
patients and singles were found (n=70) (Aghaei et al. 2004).   
 
Sukan and Maner compared vitiligo and chronic urticaria patients with healthy controls 
(each group n=50) to assess sexual functions using the Arizona Sexual Experience Scale 
(ASEX). The authors found that both disease groups experienced significantly more 
difficulties in sexual arousal and higher failure in attaining and maintaining sexual 
excitement. Females in the vitiligo and chronic urticaria groups had more difficulties in 
reaching orgasm compared to healthy controls. More than 60% of females, but only 
11.5% of male patients with vitiligo showed sexual difficulties compared to 16% in the 
control group (Sukan and Maner 2007).  
 
 
3.9.6 Impaired quality of life  
 
In recent years much research has been conducted on how patients with skin diseases 
might be affected regarding parts of their emotional lives, such as self-esteem or 
depression. However, for daily management and guidance of those patients in clinical 
routine, these parameters were not sufficient to get a glimpse of how this disease affects 
the daily lives. Thus, quality of life research was introduced into dermatology in the 
middle of the 1990's by Finlay and Khan (Finlay and Khan 1994). 
  
When developing their questionnaire, Finlay and Khan asked 120 patients which parts 
of their daily life were affected by their skin diseases. In the end six important 
dimensions were identified:  
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• symptoms and feelings 
• daily activities 
• leisure 
• work and school 
• personal relationships  
• treatment (Finlay and Khan 1994). 
 
 
 Based on the results of this study a subsequent questionnaire was developed called 
Dermatology Life Quality Index (DLQI), which evaluates all the dimensions as stated 
above. Quality of life is assessed by adding up each question's score which leads to a 
maximum score of 30. The higher the score, the more the quality of life is impaired  
(Finlay and Khan 1994). 
 
Besides the DLQI there are other instruments to measure quality of life in dermatology,  
for instance the Skindex (Chren et al. 1996), Freiberg Life Quality Assessment 
(Augustin et al. 2004) and the Dermatology QoL Scales (Morgan et al. 1997). 
 
Consequently, numerous studies on quality of life have been published investigating 
patients with vitiligo. These studies clearly show that patients with this disease have an 
impaired quality of life compared to healthy controls (Finlay and Khan 1994; 
Papadopoulos et al. 1999; Aghaei et al. 2004; Lewis and Finlay 2004; Hartmann et al. 
2005), and even  compared to some other skin diseases (Mechri et al. 2006). 
 
Based on the results of the DLQI it was suggested that training in assertiveness and 
assistance with building up self-confidence could have a positive effect on quality of 
life. Support in the development of social skills and confrontation with their difficulties 
were proposed to improve psychological well-being (Kent and Al-Abadie 1996a).  
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3.9.7 Other possible reactions 
 
 
Salzer and Schallreuter investigated the personality structure and a possible association 
with an impaired catecholamine metabolism. The results revealed no specific 
personality pattern. Importantly, 75% of the patients said that they felt moderately to 
intolerably disfigured and psychologically disturbed (Salzer and Schallreuter 1995). 
 
Patients with vitiligo have not less positive thoughts compared to the healthy 
population, but rather an increase in "irrational" negative thoughts. This was 
concluded from a study using the Body Image Automatic Thoughts Questionnaire, 
which includes a subscale on positive and one on negative thoughts (n=16) 
(Papadopoulos et al. 1999). 
 
In a study by Kökçam et al it was found that patients with vitiligo (n=11) were more 
paranoid compared to healthy controls (n=20) as measured with a subscale of the Zung 
Depression Scale and Symptom Check List 90-R (SCL 90-R) (Kökçam et al. 1999). 
 
Elgoweini et al found patients with vitiligo (n=30) more obsessed and hypochondriac 
compared to healthy controls as measured with the Minnesota Multiphasic Personality 
Inventory (MMPI) (Elgoweini et al. 2003). 
 
Mouzas et al reported that patients with vitiligo (n=116) suffered more frequently from 
sleep disturbances (sleepwalking, nocturnal enuresis, nightmares) compared to healthy 
controls (n=48) prior to the manifestation of the disease. The authors also claim a 
correlation between parasomnias in earlier life and the later development of vitiligo 
(Mouzas et al. 2008). 
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3.10  Factors influencing psychosocial reactions to vitiligo 
 
3.10.1 Gender 
 
Since vitiligo alters the physical appearance of the affected individual, it has been of 
interest whether there are any gender differences. There are numerous publications 
showing indeed such differences.  
  
More female than male patients with vitiligo are affected in terms of  
 
• Quality of life (Abeni et al. 2005; Ongenae et al. 2005b; Borimnejad et al. 2006; 
van Geel et al. 2006; Gajur et al. 2007; Schäfer and Augustin 2007; Sampogna 
et al. 2008),  
• Psychiatric morbidity in general (Abeni et al. 2005),  
• Helplessness (Rehme 2002; Schmid-Ott et al. 2007)  
• Retreat (Schmid-Ott et al. 2007) 
• Embarrassment (in older patients only) (Porter et al. 1979) 
• Sexual dysfunctions (Sukan and Maner 2007). 
 
However, there are also some reports which could not confirm differences regarding 
quality of life (Kent and Al-Abadie 1996a; Aghaei et al. 2004; Al Robaee 2007), 
psychiatric morbidity (Ahmed et al. 2007) or depression (Lee et al. 2000; Maleki et al. 
2005). Interestingly, perceived stigma is also independent of gender (Kent 1999; 
McLeod 2004). 
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With regards to composure, men (n=79) seem to be more affected than female patients 
(n=284) as measured with a questionnaire about experiencing skin complaints (Rehme 
2002). 
 
In general, women are more likely to visit a doctor because of their vitiligo (Ongenae et 
al. 2004), to use cosmetics or to receive support from others (Porter and Beuf 1994), 
whereas male patients seem to be more analytical and likely to attribute external and 
internal causal factors towards their vitiligo (Papadopoulos et al. 2002).  
 
3.10.2 Skin colour 
 
For a long time it has been of interest whether the inherited skin colour may influence 
people's psychological reaction to vitiligo. 
 
In this context it was hypothesised that the increased visibility of vitiligo in black 
people due to the sharp contrast may lead to an increased degree of disturbance (Barbee 
and Sumner 1951). Additionally, turning white threatens black identity. Obviously, this 
phenomenon does not apply for white people (Porter and Beuf 1991). 
 
The same authors examined 158 patients (60% white / 40% black) to establish whether 
or not there is indeed a difference in disturbance among black and white people by 
measuring self-esteem, visibility of vitiligo, perceived stigmatisation, age, gender and 
importance of appearance. The results could not establish that race, visibility, age or 
gender is significantly and directly associated with disturbance through vitiligo, but it 
was found that some of the factors mentioned have an indirect influence. Blacks are 
more likely to perceive stigmatisation (Kent 1999) which in turn has a significant effect 
on disturbance indicating that race is indirectly associated with disturbance by vitiligo. 
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Moreover, visibility is indirectly associated with disturbance, because low visibility 
means lower levels of perceived stigmatisation and higher self-esteem leading to less 
disturbance (Porter and Beuf 1991). The same authors also stress the importance of 
coping resources, for example self-esteem, which in turn prevents black people from 
being more disturbed than white people. In this study, most of the black participants 
came from a city where the majority of inhabitants were black, Therefore, supporters 
such as friends and doctors would empathise with the specific identity problem of dark 
skinned people turning white (Porter and Beuf 1991; Porter and Beuf 1994).  
 
McLeod and Kent and Al-Abadie reported that people with darker skin are more likely 
to experience stigmatisation than people with fair skin (Kent 1999; McLeod 2004). 
Non-Caucasians (n=46) showed higher DLQI means cores than Caucasians (n=567) 
(7.78 vs 4.59, p<0.001) (Kent and Al-Abadie 1996a). 
 
This result was also confirmed in a recent study. From all patients with various skin 
diseases, African Americans showed higher DLQI and Skindex-29 scores compared to 
white patients. This difference, however, is not detectable when comparing the disease 
severities. Based on this study it can be concluded that the African-American group is 
more affected, despite having the same disease severity, than Caucasians (Hackett et al. 
2008). 
 
 
3.10.3 Age  
 
One other important question was whether age has any effect on experiences and coping 
with vitiligo.  
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Younger people (<40 years) felt more embarrassed because of their vitiligo with no 
gender-related difference compared to older people, where men were less affected 
(n=62)  (Porter et al. 1979). 
 
A study on 269 patients assessed patients' disturbance using self-esteem, severity of the 
disease and perceived discrimination as variables for determination. The results showed 
that older people are better adjusted to vitiligo compared to younger people, because 
physical appearance was not so important anymore. Thus, age has a direct and 
significant effect (Porter and Beuf 1988). 
Kent and Al-Abadie found that 59% of 614 patients with vitiligo were affected in their 
life during the last 3 weeks. When compared to those who did not report any influence, 
the affected persons were younger, their quality of life was more influenced, they had a 
lower self-esteem and perceived more stigmatisation (Kent and Al-Abadie 1996b). 
 
However, the published data are conflicting. One report by Ongenae et al showed no 
significant relationship between age and the impact of vitiligo (n=102) compared to 
psoriasis (n=162) (Ongenae et al. 2005b). Uesseler could not show a correlation 
between age and social and emotional problems as measured with the Skindex-29 
(n=362) (Uesseler 2002). 
 
 
3.10.4 Duration of the disease 
 
Duration of the disease could affect quality of life. Several studies showed that long 
duration had a negative effect.  
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A direct correlation has been reported by Gajur et al (n=1023) and Schäfer and 
Augustin who found that with longer duration there were higher mean DLQI scores 
indicating a more impaired quality of life (Gajur et al. 2007; Schäfer and Augustin 
2007). Elgoweini reported a direct significant correlation between duration of vitiligo 
and obsession as measured with the Minnesota Multiphasic Personality Inventory 
(MMPI) (n=30) (Elgoweini et al. 2003). Finally, Uesseler found a positive correlation of 
duration with Skindex-29 scores (socially and emotionally affected) in 362 patients with 
vitiligo (Uesseler 2002). 
 
However, other studies could not confirm this correlation.  
 
Gieler et al found in 33 patients with vitiligo that the longer they had the disease the less 
depressed the patients became as assessed with the Beck Depression Inventory (BDI) 
(Gieler et al. 2000). Stangier et al found no statistical correlation between duration of 
the disease and mean scores in the subscales of social anxiety / avoidance, helplessness 
and anxious-depressive mood using the Adjustment to Chronic Skin Diseases (ACS) for 
assessment (n=33) (Stangier et al. 2003). Kent and Al-Abadie could also not confirm  
that higher scores in DLQI measurements correlate with time since diagnosis (n=614, 
p>0.05) (Kent and Al-Abadie 1996a). 
 
 
3.10.5 Severity of the disease 
 
In many investigations it was of interest whether the severity of vitiligo correlates with 
an improvement or worsening of emotions.  
 
In a study by Njoo et al, 51 children with vitiligo underwent one year of narrow-band 
UVB monotherapy. The Children’s Dermatology Life Quality Index (CDLQI) was 
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utilised in the beginning and at the end of the therapy. The results revealed that the 
better the repigmentation rate, the better was the improvement in quality of life (Njoo et 
al. 2000). 
Other authors also concluded that anything reducing the size and visibility of vitiligo is 
very likely to improve psychological wellbeing (Kent and Al-Abadie 1996a; Innocenti 
et al. 1997). 
Stangier found that in 33 patients with vitiligo there was a positive correlation between 
severity of the disease and mean scores in the Adjustment to Chronic Skin Diseases 
Questionnaire’s subscales social anxiety / avoidance, helplessness and anxious-
depressive mood (Stangier et al. 2003). Similar results were reported for the Skindex-29 
(n=362) (Uesseler 2002). 
 
In a thesis from Manchester University / UK, 45 patients with vitiligo were investigated 
about their disease-related social experiences. The participants were divided into four 
groups according to the severity of the disease (first group 1-25% of skin affected, 
followed by 25-50%, 51-75% and 76-100%). The majority (18 out of 23) of the group 
with least severity did not experience negativity. Based on these results it was 
concluded that the more vitiligo is visible, the more likely is the person to experience 
stigmatisation by others (McLeod 2004).  
The same has been confirmed by others who also found that patients with visible lesions 
experienced more stigmatisation (Schmid-Ott et al. 2007). 
 
In this context it is noteworthy that the objective ‘severity of a general disfigurement’ is 
not always a reliable predictor for the level of psychological adjustment, compared to 
the subjective view on the own disfigurement where a linear relationship exists (Moss 
2005; Ongenae et al. 2005a). Poorer adjustment to a visible difference is mainly 
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relevant in people with moderate severity, whereas patients with less and, surprisingly, 
more severe disease were better adjusted ("inverted U relationship"). This was 
explained by the fact that in the case of severe and minor disfigurement other people's 
reactions to the appearance are relatively consistent or trivial, whereas in the case of 
moderate severity the reactions might differ more. It was concluded that it is more 
difficult to develop an adaptive strategy (Rumsey and Harcourt 2004; Moss 2005). 
Again, the results in the literature are not conclusive. Gieler et al found no correlation 
between the size of the affected areas and levels of depression as measured by the Beck 
Depression Inventory. On the one hand, this does not necessarily support Moss' finding 
of an inverted U relationship, but on the other hand, it is not a confirmation of a linear 
relationship (the more extended the vitiligo the more affected the patient) either (Gieler 
et al. 2000). 
 
 
3.10.6 Combination of medical and psychological treatment 
 
Considering that psychological factors such as stress or life events may influence the 
onset or course of vitiligo, it has been of interest to find out whether a combination of 
medical treatment and psychological counselling could actually improve the medical 
outcome. Several studies have addressed this issue. 
Koshevenko reported that a combination of photochemotherapy with “correction of 
psychologic abnormalities” in 49 patients with vitiligo with impaired 
sociopsychological adaption lead to an by 20% increased repigmentation and to shorter 
periods of time necessary to achieve marked pigmentation (Koshevenko Iu 1989). 
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A positive influence of cognitive-behavioural therapy on impaired self-esteem, body 
image and quality of life was also shown in 16 patients with vitiligo9 (Papadopoulos et 
al. 1999). These authors found that self-esteem, body image and quality of life have 
been significantly improved into the normal range after the latter mentioned variables 
were compared after ending the treatment 5 months later. Interestingly, vitiligo lesions 
of three participants in the experimental group were reduced by up to 35%, whereas the 
vitiligo of two control group members worsened by up to 50%, the rest remained more 
or less stable. The authors suggest that medical treatment together with cognitive-
behavioural therapy may lead to better cosmetical results than medical treatment alone 
(Papadopoulos et al. 1999). However, this study can only count as a pilot study as the 
case number is very low. 
 
Parsad et al treated 150 Indian patients with vitiligo in their clinic and after finishing a 
course of medical treatment the authors grouped the patients according to whether their 
repigmentation was successful or not. The authors found that the mean DLQI score in 
the ‘successful’ group was significantly lower than that of the ‘failed’ group in the 
beginning of the trial (7.06 vs. 13.12). Therefore the authors suggested that additional 
psychological approaches might be very helpful (Parsad et al. 2003; Parsad and Kanwar 
2006). Other authors have reported similar effects (Muller 2005). 
                                                 
 
9 these 16 patients were randomly allocated into either the test group or the control group 
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3.10.7 Vitiligo in children 
 
As shown above, a considerable number of studies on the psychosocial impact of 
vitiligo have been published. However, these studies mainly concerned adult patients or 
the entire patient group. There are still few data available on psychosocial aspects in 
children, although many researchers argue that childhood vitiligo is a distinct subset of 
this disease. These reports mainly concern: 
 
• distinct clinical features of vitiligo in children in contrast to adults  
(Jaisankar et al. 1992; Kanwar et al. 1993; Behl et al. 1994; Barišíc-Druško and 
Rucević 1997; Cho et al. 2000; Prćić et al. 2002; Prćić et al. 2004; Kakourou et al. 
2005; Martin et al. 2005), 
  
• childhood vitiligo and its treatment possibilities  
(Halder et al. 1987; Halder 1997; Grimes and Billips 2000; Njoo et al. 2000; Herane 
2003; Lepe et al. 2003; Schaffer and Bolognia 2003; Kanwar et al. 2004; Silverberg 
et al. 2004; Choi et al. 2008; Pagovich et al. 2008; Schallreuter et al. 2008b; Sehgal 
2009). 
 
The psychosocial burden for children with vitiligo was first investigated by Hill-Beuf 
and Porter more than 20 years ago (Hill-Beuf and Porter 1984), but until now this 
remained one of the rare pure psychosocial investigations. The authors found children 
are indeed affected by their altered physical appearance. They emphasised that age is 
highly influential on how children can cope with the disease and that this is particularly 
difficult when they are in Junior High School age (11-14 years old) or when they move 
to another town or school. It was recommended to build up self-esteem by developing 
competencies that do not depend on appearance (Hill-Beuf and Porter 1984). 
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Prćić et al compared 33 adolescent patients with vitiligo (aged 10-15 years) to 60 
healthy controls of the same age regarding clinical symptoms, depression, anxiety and 
frequency of stressful events. The authors could not find any differences between cases 
and controls as measured with the Birleson Depression Scale, Spielberger’s Scale 
(State-Trait Anxiety Inventory) and Risk Scale. This result was explained by pre-
pubertal age and that these patients were not yet focussed on their physical appearance 
(Prćić et al. 2006).  
 
Schwartz and Sepulveda did also not find any differences between children with vitiligo 
and healthy controls using the Junior Temperament and Character Inventory (JTCI) 
apart from its harm avoidance domain. This result indicates that young patients are 
more passive, pessimistic, cautious and insecure. In addition, they also have a higher 
tendency to be easily fatigued. In another questionnaire (Qualitative Psychosocial 
Development Survey) the same group was found to be more fearful of strangers 
compared to healthy controls. Children with vitiligo reported an average of 3.2 negative 
experiences in the year before the disease onset  (Guttman 2007)10.  
 
Interestingly, one study investigated whether childhood vitiligo had any impact on adult 
life lead by the sufferers later on. Participants were 232 patients with vitiligo who 
developed the disease before the age of 20 years and 201 healthy controls. Both groups 
were asked to fill out several questionnaires11 and to answer questions about any 
negative experiences due to vitiligo during childhood.  
                                                 
 
 
 
10 Unpublished study cited by Guttman 2007 
11 the Course of Life questionnaire, the Skindex-29 (quality of life questionnaire specific to skin diseases), 
and the Dutch-language version of the SF-36 (short form health survey) 
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The data showed no differences between patients and controls in any of the 
questionnaires used. However, when comparing patients with negative experiences 
(n=91) to the remaining ones, patients who had more frequently vitiligo on their arms, 
feet and genitals, scored lower in the ‘social development’ domain, and reported 
significantly poorer health-related quality of life as measured with the SF-36 and 
Skindex-29. These patients avoided intimacy and social activity and tended to do things 
alone.  
Most importantly, patients with negative experiences wished, that they had had more 
information about the disease and its treatment, more coaching and contacts with fellow 
sufferers and also more psychological support (Linthorst Homan et al. 2008).  
 
It has been of interest whether there are any factors probably triggering childhood 
vitiligo. There are some hints in the literature such as parents’ separation (Montes 
2008), stress (Manolache et al. 2009), psychological trauma (Barišíc-Druško and 
Rucević 1997), but also physical stress / trauma (Barišíc-Druško and Rucević 1997). 
Others have also recognised and mentioned the psychosocial impact of vitiligo on 
children (Halder 1997; Herane 2003), but it is evident that more research needs to be 
done.  
 
Recently, the introduction of the Children's Dermatology Life Quality Index (Finlay and 
Khan 1994; Lewis-Jones and Finlay 1995) as an easy-to-use instrument created more 
possibilities for research in childhood vitiligo. However, only a few reports on this 
entity have been published, for example one on the effect of NB-UVB treatment (Njoo 
et al. 2000) or one  comparing children with vitiligo to healthy controls (Guttman 2007).  
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4 Aim 
 
By contrast with the plethora of biochemical and biological research data, little had been 
done on the psychological problems related to vitiligo until the end of the 1970's. Since 
then, many aspects have been targeted, for example problems regarding self-esteem, 
depression, body image, quality of life, age, sexual relationships and skin colour.  
Surprisingly, anxiety and helplessness have hardly been explored. The latter is clearly 
important, because reduction of helplessness was highly rated by 1023 German patients 
with vitiligo associated with self-support organisations (Gajur et al. 2007). 
 
In this situation it was tempting to fill some of these gaps by introducing the Adjustment 
to Chronic Skin Disorders Questionnaire which has rarely been used in vitiligo and 
which evaluates social anxiety / avoidance, helplessness and anxious-depressive mood. 
Also, since there is no agreement in the literature on the role of depression in these 
patients, we  decided to follow up this aspect with appropriate tools. Moreover, since 
the DLQI scores in the literature vary to a great deal, we wanted to examine this 
parameter in a controlled environment, i.e. in the Institute for Pigmentary Disorders in 
Greifswald / Germany and Bradford / UK. 
 
To address these questions in more detail, we decided to use several questionnaires to 
be answered by adult patients, children patients, their parents and healthy controls. 
 
Patients were enrolled with the Institute for Pigmentary Disorders (IFPD) in Greifswald 
in association with the Ernst Moritz Arndt University of Greifswald / Germany and the 
University of Bradford / UK, at the annual meeting of the American Vitiligo Research 
Foundation and by a German self-support group for vitiligo. 
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Both the latter groups filled out their questionnaire anonymously.  The patient group 
from the IFPD is rather unique because these patients have to travel to Greifswald in 
Germany, and they do have to pay their fees for enrolment and treatment. Considering 
these circumstances, it is tempting to conclude that those patients are clearly determined 
to combat their vitiligo, because they should have experienced severe stress or 
stigmatisation due to course of their disease. 
 
• One study group were children and adolescents and their parents.  We wanted to 
investigate the impact of vitiligo on quality of life in children, and to explore 
children’s experiences, behaviour and demographic features.  
• The second group were adult patients. Our aim was here to explore experiences, 
behaviour, demographic features and the impact of vitiligo on quality of life, on 
possible depression and their coping with the disease in adults.  
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5 Materials and methods 
 
5.1 Questionnaires 
 
This study was designed as a cross-sectional and case-control study. 
 
We utilised three different questionnaires. For the evaluation of the impact on quality of 
life we used the Dermatology Life Quality Index (DLQI) for adults and the 
Children’s Dermatology Life Quality Index (CDLQI) for patients between 8-14 years 
old. In order to follow coping with chronic skin diseases, we utilised the Adjustment to 
Chronic Skin Disorders Questionnaire (ACS). For assessment of depression we 
utilised the Beck Depression Inventory. 
 
These validated questionnaires were chosen, because they are  
 
• widely used (DLQI, CDLQI, BDI),  
• available in the English and German language (DLQI, CDLQI, BDI)  
• recommended for measurement of coping with chronic skin diseases (ACS) 
(Augustin et al. 2000).  
 
Importantly, while DLQI, CDLQI and BDI offer many opportunities to compare our 
results with those from the literature, there are only a few publications using the ACS in 
vitiligo. Therefore, it was expected that those data could introduce new insights into the 
psychosocial influence of vitiligo. To the best of our knowledge, the dimensions 
helplessness and anxious-depressive mood (both ACS sub-scales) have not been 
explored so far. 
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Each questionnaire used in this investigation was made available either in a German or an 
English language version as required. The English versions of the ACS have been translated 
from German into the English language in a cooperation between two native German 
speakers living in the UK, and one native English speaker with knowledge of the German 
language. All translators had a scientific background. The first draft of the questionnaire 
was tested on some patients regarding English-language problems and comprehensibility, 
and subsequently necessary changes were made. With regard to the Children's Dermatology 
Life Quality Index, both the English and the German version have been used as provided 
from the original authors (Lewis-Jones and Finlay 1995). Besides the main standard 
questionnaires as mentioned above, some other questions were included: 
 
• Demographical questions 
Age of the patient, age at disease onset, gender, skin phototype and status of patient 
(enrolled or not enrolled with the Institute for Pigmentary Disorders). 
 
• Disease-related questions 
Family history, self-assessment of disease severity on dominant body parts, where the 
first spot appeared, the presence of grey hair on scalp or in eyelashes / eyebrows, state 
of disease (spreading, stable, re-pigmenting). 
 
• Beliefs 
What could influence vitiligo? (psychological stress, other diseases or injuries) 
 
• Behaviour and experiences 
Typical stigmatising experiences including being asked questions by others, having 
been picked on or being subject to nasty comments, avoidance of situations, hiding of 
the white spots in front of other people, activities including hobbies or sport.  
 
The DLQI, BDI and also some single questions were added later on to the questionnaire. 
Consequently the numbers of patients analysed differ between the scores and sub-scores. 
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5.1.1 Dermatology Life Quality Index (DLQI) 
 
The Dermatology Life Quality Index was developed by Finlay and Khan in the 
beginning of the 1990’s. The authors aimed for an easy-to-use questionnaire sufficient 
for daily medical practice.  
 
In the beginning of its development, 120 Patients at a Welsh dermatological clinic were 
asked to identify essential parts of everybody’s daily life that will most certainly be 
affected by a skin disease. The following items emerged: 
 
• Symptoms (itching, irritation, pain, sore…), 
• Feelings (self-consciousness, embarrassment…), 
• Daily activities (shopping, gardening…), 
• Leisure activities (swimming, social life…), 
• Work or school (career affected, colleagues make fun…), 
• Personal relationships (making new ones, sexuality…), 
• Treatment (messy, smelly, makes clothes greasy). 
(Finlay and Khan 1994). 
 
The subsequently created Dermatology Life Quality Index consists of 10 questions, all 
of them related to the parts mentioned above. Each item has four choices to answer: 
 
Very much   - scores 3 
A lot    - scores 2 
A little    - scores 1 
Not at all (or Not relevant)  - scores 0 
 
The sum of the total score can range from 0 to 30. The higher the score, the more 
quality of life is impaired within the preceding 7 days. 
 
Thirteen years after its introduction, the DLQI had been translated into at least 55 
languages, validated several times and had widely been used in more than 33 different 
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skin disorders (Lewis and Finlay 2004; Basra et al. 2008). The use of the DLQI offers 
therefore many possibilities to compare obtained data.   
 
Recently Gajur suggested to group the DLQI scores to evaluate the subgroups in more 
detail (Gajur 2008). These cut-offs allow more insights into the quality of life of 
patients (Table 7). 
     
DLQI scores Outcome of quality of life 
0-1 Not influenced 
2-5 Little influenced 
6-10 Moderately influenced 
11-20 Severely influenced 
21-30 Extremely influenced 
 
Table 7: Levels of impaired quality of life (Gajur 2008) 
 
 
 
5.1.2 Adjustment to Chronic Skin Disorders Questionnaire (ACS) 
 
For measuring the impact of vitiligo on adults, a slighty adapted version of the 
Adjustment to Chronic Skin Disorders Questionnaire has been employed.  
 
The original questionnaire was developed to evaluate specific dimensions (see below) 
for coping with chronic skin diseases by using in total 51 items (Stangier et al. 1996). 
We extended this questionnaire by demographic and disease-related questions such as 
age, sex, duration and severity of the disease.  
The patients rate the validity of each item / statement by choosing one of five 
possibilities as answer, 1 = not at all, 2 = hardly ever, 3 = quite, 4 = mostly and 5 = 
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totally. The specific coping behaviour of the participants is based on the sum of marked 
answers which are compared to validated scales provided in the manual or to other 
publications (Stangier et al. 1996). 
 
The Adjustment to Chronic Skin Disorders questionnaire contains 6 main sub-scales, 
but we used only three in this project. The other scales (itch-scratch cycle, seeking 
information and limitation of quality of life) were excluded. The itch-scratch cycle and 
seeking information were regarded as irrelevant for vitiligo. The quality of life scale is 
redundant because this was explored with the DLQI. The excluded questions were 
mostly left blank and only in a few cases replaced by others to keep the whole 
questionnaire as short as possible. 
 
The remaining scales used for this project were: 
 
• Social anxiety / avoidance (15 items): concerns mainly coping with the visibility 
of the skin disease, especially emotional and social anxiety, cognitive and 
behavioural reactions to the experiences in social interaction. Increased scores in 
this scale indicate social anxiety and avoidance of situations where negative 
reactions or comments are expected by the patients, but also feelings of loss of 
attractiveness or feelings of disfigurement. 
 
• Helplessness (9 items) means feelings of loss of control regarding course of 
disease, and also hypochondriac worries that the disease might get worse. This is 
expressed by increased scores within this dimension. 
 
• Anxious-depressive mood (8 items) concerns emotional and physical symptoms, 
which are not directly linked to the skin disease. Increased scores indicate 
depressive and anxious symptoms in terms of an adjustment disorder (Stangier 
et al. 1996). 
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5.1.3 Beck Depression Inventory (BDI) 
 
The Beck Depression Inventory was developed in 1961 as a 21-question multiple choice 
questionnaire to measure depression levels (Beck et al. 1961).  The evaluation is based 
on self-reports about specific symptoms of depression. Each of the 21 items consists of 
four possibilities to answer graded from 0 to 3.  Participants have to mark those 
adequately to their situations. All scores are added up and the total sum of up to 63 can 
be compared with standard cut-offs, which are 
0-9 -  no depression 
10-18 -  mild-moderate depression 
19-29 -  moderate-severe depression 
30-63 -  severe depression. 
 
Since it is possible to mark more than one statement in each item, it is recommended to 
use the highest score.  
The BDI has been widely employed and validated since its introduction.  Hence it offers 
many possibilities to compare the scores from this thesis to the literature. 
 
 
5.1.4 Children’s Dermatology Life Quality Index (CDLQI)  
 
The questionnaire used for the evaluation of children contains 32 items, including the 
10 unchanged questions taken from the Children Dermatology Life Quality Index 
(CDLQI).  
 
The CDLQI was chosen because  
 
• it contains 10 questions only and is easy to use, even for younger children, because  
there is a cartoon version available of this questionnaire (Holme et al. 2003), 
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• it has been validated in children with skin diseases (Lewis-Jones and Finlay 1995), 
• it is widely used in different countries (Njoo et al. 2000; Chuh 2003) and diseases 
and, thus, provides many possibilities to compare the results. 
 
The complete children questionnaire contains four parts. 
 
1. General information 
In the first part the child is asked to give some general information about its person 
including gender, age, skin colour, the most preferred season of the year and whether it 
has a hobby or it is involved in sportive activities. Especially the sportive activities are 
expected to give an indication, whether the children hide their vitiligo or not. Wearing 
certain sport dresses, changing clothes or having a shower in the sport facilities might 
reveal to others that the child has something different to others. Similar is the question 
concerning the season. If a child likes the summer, this indicates that it is not afraid to 
show the spots or to avoid summer-typical clothes. 
 
2. Characteristics of the child's vitiligo 
The second part is to find out some characteristics of the child's vitiligo such as duration 
of disease, family history and whether any treatment has been tried before. Furthermore, 
this section contains a drawn shape of the human body where the child is asked to mark 
the location and size of their vitiligo, which in turn provides an indication of the 
severity of the disease. 
 
3. Children's Dermatology Life Quality Index  
This part contains the complete and unchanged Children's Dermatology Life Quality 
Index as developed by Lewis-Jones and Finlay (Lewis-Jones and Finlay 1995). 
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This questionnaire measures the impact of the skin disease on the quality of life within 
the last week using the dimensions of: symptoms and feelings, leisure, school or 
holidays, personal relationships, sleep and treatment. It is not only possible to find out 
how much the quality of life is impaired compared to healthy controls or other skin 
diseases, it also gives an indication which part of the daily life is disturbed by the 
disease. 
The CDLQI contains 10 questions, with four graded options to answer: very much 
(scores 3), quite a lot (2), only a little (1) and not at all (0). The CDLQI is calculated by 
adding up each item's score resulting in a maximum score of 30. The higher the score, 
the more the quality of life is impaired (Finlay and Khan 1994). 
 
Dimension Questions Questions in 
original CDLQI 
Maximum score 
Symptoms and feelings 12, 13 1, 2 6 
Leisure 15, 16, 17 4, 5, 6 9 
School or holidays 18 7 3 
Personal relationships 14, 19 3,8 6 
Sleep 20 9 3 
Treatment 21 10 3 
 
Table 8: Evaluation of CDLQI, related questions and maximum score (Lewis-
Jones and Finlay 1995) 
 
 
 
4. Feelings and experiences 
Since the CDLQI explores influences within the last week, we have included questions 
about feelings and experiences of the child in general and also of earlier periods than 
one week ago. This part concerns feelings of disturbance, certain behaviour patterns 
such as hiding of the white spots in front of other people or avoidance of situations, 
furthermore, experiences such as stigmatising encounters, bullying and also who gave 
support in such situations and who would be the first person to seek support from. 
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The non-CDLQI questions are mostly to be answered by ticking the cycle at the answer, 
which suits most the child's feeling and experiences. It is either a yes-no-answer or a 
variety of options completed sometimes by an open possibility to answer. The 
questionnaire contains only a few items where the answer has to be written down, such 
as age, hobbies / sport and alternative options in experiences and feelings. The 
evaluation is not to be done with a scoring system, instead the aim is to get results for 
every single item, which then can be related to other factors such as the scoring in the 
CDLQI. 
The first drafts of this questionnaire were tested on a limited number of children. Some 
changes were made to improve the comprehensibility, especially with regard to the 
English language. Once this was done, no difficulties in understanding for children 
older than 7 years have been observed. Average time for filling in was as short as 5 to 
15 minutes. 
Taken together, the children’s questionnaire measures how much the quality of life of 
an affected child is impaired by vitiligo. This is completed by demographic data and 
knowledge about disease-related experiences and feelings. 
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5.1.5 Parents’ questionnaire 
 
Our investigation of the parents of children with vitiligo was based on an adapted 
version of the Adjustment to Chronic Skin Disorders Questionnaire. The itching-
scratching-circle dimension has been replaced by additional questions, for example to 
evaluate the frequency of how often parents examined their child for new white spots. 
Moreover, all questions of the original survey, where participants had to rate feelings 
toward their own disease were changed, allowing analysis of the parents feeling toward 
their children's vitiligo. All items of the anxious-depressive mood dimension remained 
completely unchanged, because this dimension concerns feelings and emotions in 
general. 
The interpretation of the entire questionnaire needs caution since the mentioned items 
were changed. The results could reveal an indication in terms of the dimensions of the 
original questionnaire including social anxiety  /  avoidance, helplessness, anxious - 
depressive mood. However, the evaluation included also single item analysis. 
 
Some more questions have been added regarding demographic data not only on the 
parents but also on the child's disease including age, gender, site of onset, duration, 
observed features (poliosis, Koebner phenomenon), possible trigger factors for their 
child's vitiligo and family history. 
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5.2 Participants 
 
For this thesis it was possible to include an international patient population:  
 
o All new patients of the German and UK Institute for Pigmentary Disorders, which 
is specialised on research and patient care for the pigmentation disorder vitiligo, 
were asked to take part voluntarily in this investigation. This institute offers its 
service to patients from all over the world. Therefore the study included not only 
German patients, but also individuals from the UK, the US, and from other 
countries as far as India and Australia. It is obvious that these patients are very 
determined to treat their vitiligo because they make a huge effort by travelling long 
distances and by paying all expenses themselves in order to start the treatment 
modality offered. Importantly, the patients are asked to fill in the questionnaire 
before they are seen by the doctor and before they are introduced to the treatment 
modality. This procedure enables us to compare the results to those patients who 
were already enrolled in the institute and who were already undergoing treatment 
for their vitiligo with narrow-band UVB activated pseudocatalase PC-KUS. 
 
o As already indicated, during clinic sessions patients who were already enrolled and 
who had started their treatment were also asked to take part. 
 
o We also asked at their annual meeting members of the American Vitiligo Research 
Foundation. This included children, their parents and adults. 
 
o Finally, an announcement source was published on the website of a German 
patient-support organisation (Vitiligo-Portal). Everybody (children and their 
parents) who were willing to take part and had contacted the organisation was sent 
a questionnaire by the secretary of this organisation in a pre-stamped envelope, 
which was then returned anonymously. 
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Parents were normally asked to let their children fill in the questionnaire on their own 
and not to interfere with them. 
 
This wide-ranging patient / parent population gives the opportunity to compare not only 
the possible influence of nationality / language and skin colour, but also the influence of 
treatment and its duration.  
 
 
5.3 Control group 
 
Healthy controls were most often friends or partners of patients when the latter were 
seen for an appointment at the Institute for Pigmentary Disorders. They were asked to 
fill out the same basic questionnaires, with only some slight changes in the demographic 
section. 
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5.4 Statistical analysis 
 
 
The following statistical tests have been used in this thesis: 
 
• Independent Sample T-Test (also called Student’s T-test) has been used to 
measure for differences between means of two groups within the population 
 
• Mann-Whitney-U-test compared two groups within a population when there was 
no normal distribution of scores 
 
• One-way analysis of variance (ANOVA) test was used to measure differences 
between two or more independent groups 
 
• Kruskal-Wallis-test was utilised to compare two or more groups within a 
population when there was no normal distribution of scores 
 
• Paired sample T-Test compared two (related) samples 
 
• 2-tailed Wilcoxon signed-rank test compared two related (paired) samples when 
there was no normal distribution (non-parametric) 
 
• Pearson Chi-Square test tested a null hypothesis for the frequency distribution 
of certain events (e.g. distribution of patients or experiences) observed in a 
sample consistent with a particular theoretical distribution 
 
• Pearson correlation analysis measured linear correlation between two variables 
 
For statistical analysis SPSS 14.0 for Microsoft Windows has been used (SPSS inc, 
Chicago, Illinois, USA). 
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Before starting evaluation of all the questionnaires main and sub-scores, it is necessary 
to find out whether to use mean or median. For this, skewness analysis has been 
employed and the following skewness coefficients and subsequent appropriate standard 
tendencies have been established: 
 
 
• DLQI       1.351 → Median 
 
• ACS (Adults) 
o Social anxiety / avoidance   0.408 → Mean possible 
o Helplessness     0.094 → Mean possible 
o Anxious-depressive Mood   0.417 → Mean possible 
 
• BDI       1.114 → Median 
 
• CDLQI       2.109 → Median 
 
• ACS (Mothers) 
o Social anxiety / avoidance   0.864 → Median 
o Helplessness     0.605 → Median 
o Anxious-depressive Mood   0.730 → Median 
 
• ACS (Fathers) 
o Social anxiety / avoidance   0.920 → Median 
o Helplessness     1.096 → Median 
o Anxious-depressive Mood   1.195 → Median 
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6 Results  
 
 
6.1 Adult patients and control population 
 
 
6.1.1 Control group 
 
The study included 55 healthy controls. Fourty one were males (74.5%) and 14 were 
females (25.5%). The mean age was 48.2 years, the median was 45.0 years ranging 
from 21 to 79 years. Thirty three controls (60.0%) used the German-language 
questionnaires and 22 used the English-language questionnaire (40.0%).  
The vast majority of the control group had fair skin, only 6 had darker skin phototypes 
IV and V (10.9%) (Figure 8).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Distribution of skin phototypes in the control group (n=55) 
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The control group was dominated by males, whereas the adult patient group had more 
females (***p<0.001, Pearson Chi-Square test). Controls were also older (*p=0.005, 2-
sided Independent Sample T-test). Both groups were matched with regards to skin 
phototype groups (I-III vs. IV-VI) and language of questionnaires used (all p>0.05, 
Pearson Chi-Square test). 
 
Since the DLQI and ACS questionnaires were designed to assess the impact of skin 
diseases in general and not just vitiligo, it was important to evaluate the presence / 
absence of any skin diseases in the control group. The results revealed that 24% (n=11) 
of our healthy controls had a skin disease. Moreover, 46% (n=5) of those controls with a 
skin disease also said that their condition was visible to others. 
 
 
6.1.2 Available data 
 
Our study included a total of 422 adult patients with vitiligo. However, this number 
only applies to the Adjustment to Chronic Skin Disorders Questionnaire and basic 
socio-demographic questions (age, gender, skin colour, enrolled / not enrolled with the 
IFPD, age of disease onset, disease severity), because these had been used from the 
beginning of this project. 
Some of the questions were included from the start, but were not answered by all the 
patients or their answers could not be used due to incomplete marking. These parts 
include family history as well as influence of psychological stress, other diseases and 
injuries. 
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Two important parts were added later to this project: the Dermatology Life Quality 
Index (n=164)12 and the Beck Depression Inventory (n=123). The same applies to the  
questions about prevalence of grey hair, site of disease onset, hobby / sport, 
stigmatisation experiences, avoidant behaviour. 
For all the above reasons, the numbers of patients differ between the parts of this thesis 
and also between the questionnaires. 
 
6.1.3 Patients 
 
This study included 422 adult patients with vitiligo. 136 were males (32.2%) and 286 
were females (67.8%). The mean age of the group was 43.1 years, the median age 43.0 
years (SD 12.2) ranging from 17-70 years. More than half of the patients were middle 
aged (57%, 30-49 years old, n=241), only a few were younger than 20 years (n=17, 
4%). The distribution of different age groups is shown in Figure 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Distribution of age groups in our patient population (n=422) 
 
                                                 
12 The total score is available for 164 questionnaires, whereas the single items’ scores were included for 
90 patients 
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The duration of the disease was 18.7 years (mean), median was 16.0 years (SD 12.73). 
More than half of the patients used the German-language version of the questionnaires 
(n=243, 57.6%), while 42.4% (n=179) used the English-language version. 
258 patients (61.1%) were already enrolled with the Institute for Pigmentary Disorders 
and were undergoing treatment with narrow-band UVB activated pseudocatalase PC-
KUS, whereas 164 patients visited the institute for the first time (38.9%). 
 
The vast majority of our patient population had fair skin phototypes II and III (85%, 
n=354). The remaining 68 patients had darker skin (skin phototypes IV-VI) (Figure 
10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Distribution of skin phototypes (Fitzpatrick classification) in the adult 
patient population (n=422) 
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6.1.4 Disease status and severity 
 
Since the progression of vitiligo is rather unpredictable, it was important to establish the 
status of vitiligo in our patient population, i.e. whether the white spots were currently 
actively spreading, re-pigmenting or remaining stable at the time when the study took 
place. We found that the disease was progressing in nearly half of the patients (46%, 
n=120). One third of the group (33%, n=84) had stable vitiligo, whereas 54/258 (21%) 
were re-pigmenting (Figure 11). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 11: Disease status in our patient population (n=258) 
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less frequently progressive vitiligo. These differences were borderline significant (2-
sided Pearson Chi-Square test, p=0.059, Figure 12). 
 
 
 
 
 
 
  
Figure 12: Frequencies of disease status in patients enrolled and not enrolled with 
the Institute for Pigmentary Disorders (IFPD) 
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To further characterise our patient population, we asked the patients to self-assess the 
severity of vitiligo on six dominant body parts. If the disease was present on the 
mentioned parts, then they could chose between slightly and severely affected. Self-
assessment of all the body parts with vitiligo revealed that the face was the least often 
severely affected part in this patient population, whereas hands were most often chosen 
as severely affected (Table 9).  
 
 
 
Body area         Disease  
                          severity N % 
1 262 71.8 Face 
(n=365) 2 103 28.2 
1 145 49.5 Neck 
(n=293) 2 148 50.5 
1 89 23.7 Hands 
(n=376) 2 287 76.3 
1 172 50.1 Arms 
(n=343) 2 171 49.9 
1 174 51.2 Trunk 
(n=340) 2 166 48.8 
1 208 59.1 Legs 
(n=352) 2 144 40.9 
 
Table 9: Self-assessed disease severity on different body parts 
Disease severity: 1 - little, 2- severe 
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6.1.5 Family history and affected family members 
 
Evaluation of a family history for vitiligo and exact information on who has / had the 
disease in the family is helpful to follow a genetical pattern of the disease. Perhaps, in 
the end of the day this information might add more information to what could cause 
vitiligo. 
In our adult patient group there was a positive family history of vitiligo in 37.8% 
(n=107 out of 283 who answered this question). Table 10 shows a break-down of who 
else in the family had vitiligo. In correlation to other family members, the mother was 
most often affected (23 out of 101, 22.8%) followed by the father, siblings and the 
grand-parents.  
 
 Relatives N % 
 Mother 23 22.8 
 Father 11 10.8 
  Brother 7 7.0 
 Grandmother 7 7.0 
 Grandfather 6 5.9 
 Uncle 6 5.9 
 Sister 5 5.0 
  Son / daughter 5 5.0 
  Aunt 4 4.0 
  Great-grandmother/-father 4 4.0 
  Cousin 4 4.0 
  Grandmother + brother 3 3.0 
  Aunt + cousin 3 3.0 
  Uncle + cousin 3 3.0 
  Sister + cousin 2 1.9 
  Son + grandmother 2 1.9 
  Grand aunt + grand uncle 2 1.9 
  Mother + aunt 2 1.9 
  Grandfather + uncle 1 1.0 
  Niece 1 1.0 
  Total 101 100.0 
 Missing 6  
 
Table 10: Frequencies of family members with vitiligo 
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6.1.6 Age of disease onset 
 
The mean age of disease onset in the literature is often around the 20th year of age (Das 
et al. 1985; Alkhateeb et al. 2003). In our adult patient group the mean age was 24.4 
years (n=422) ranging from 0.5 to 63 years. The frequency of disease onset in different 
age groups is shown in Figure 13. According to our results, vitiligo occurred in all age 
groups, but there is a peak in the age group between 10-19 years. 
  
 
 
 
Figure 13: Age groups according to disease onset (n=422) 
  
 
 
 
 
It has been reported that the mean age of disease onset might differ between genders 
(Majumder et al. 1993). We found indeed that the age of disease onset is significantly 
earlier in male patients compared to females (means 22.4 vs. 25.3, *p<0.05, 
Independent Sample T-Test, Table 11).  
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At the same time it was tempting to explore other socio-demographic subgroups of our 
adult patient group as well. In some cases we found significant differences regarding 
age of disease onset: 
1. Patients who do not believe that psychological stress or other diseases are involved in 
vitiligo, were younger when the disease started (**p<0.005 and *p<0.05 respectively). 
2. Patients who developed vitiligo earlier in life are more likely to avoid certain 
situations because of their vitiligo (**p<0.005). All differences were measured with a 
two-sided Independent Sample T-Test and a Mann-Whitney-U-test (Table 11).  
 
 
 
 
 Subgroups  N 
Mean 
age of 
onset 
(years) 
Median 
age of 
onset 
(years) SD 
 
p value 
Male 136 22.4* 21.0 11.96 Gender 
  Female 286 25.3* 24.0 14.07 
0.038(1) 
>0.05 (2) 
I-III 354 24.5 22.0 13.68 Skin phototype                fair skin 
dark skin IV-VI 68 23.9 24.0 12.45 
>0.05 
Yes 107 22.2 18.0 13.90 Positive family history 
  No 176 24.5 23.5 13.46 
>0.05 
Yes 214 25.5** 25.0*** 12.4 Psychological stress 
No 82 20.4** 16.0*** 13.7 
0.003(1) 
0.001(2) 
Yes 59 20.7 18.0 12.8 Vitiligo caused by injuries 
(Koebner phenomenon) No 98 24.7 24.0 13.4 
>0.05 
Yes 24 27.7* 25.5 13.1 Vitiligo caused by other diseases 
No 112 21.4* 20.5 12.5 
0.049(1) 
0.056(2) 
German 97 24.9 21.0 14.61 Language of questionnaire 
English 70 22.7 20.5 12.75 
>0.05 
Yes 79 21.5** 20.0** 11.65 Have you ever avoided certain 
situations because of your vitiligo? Never 40 29.1** 29.0** 14.04 
0.002(1) 
0.004(2) 
 
Table 11: Age of disease onset in socio-demographic subgroups of the patient 
population 
(1) two-sided Independent Sample T-Test;  (2) Mann-Whitney-U-test  
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6.1.7 Location of onset 
 
 
Some earlier publications reported that the initial sites of onset are often exposed parts of 
the body, i.e. face, neck or legs (Singh et al. 1985). Therefore, we wanted to find out 
whether this also applied to our study group. The most frequent sites of onset in our adult 
patient group were hands (26%, n=68/262). If face and neck are counted as one part, as 
often done in in the literature (Akrem et al. 2008; Wu et al. 2008), then this would be the 
most common site of onset (26.7%, n=70/262) (Table 12). 
 
 
 Initial site of onset N % 
Hands 68 26.0 
Face 49 18.7 
Neck 21 8.0 
Genitals 16 6.1 
Legs 15 5.7 
Stomach 13 5.0 
 
Arms 11 4.2 
  Feet 11 4.2 
  Knees 10 3.8 
  Back 9 3.4 
  Chest 9 3.4 
  Arms + face 6 2.3 
  Hands + face 6 2.3 
  Hips 5 1.9 
  Hands + legs 4 1.5 
  Neck + genitals 3 1.1 
  Hips + hands 2 0.8 
  Neck + hands 2 0.8 
  Chest + arms 2 0.8 
  Total  262 100.0 
 
Table 12: Frequency of body areas where the first spot appeared 
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6.1.8 Progressive vitiligo can itch 
 
Pruritus is often related to disease progression on sites where vitiligo will be developed 
shortly after (Schallreuter et al. 2008b). From 111 patients who answered this question 
there were 38 (34.3%) who had experienced pruritus in our adult group (Table 13). 
 
 
 
 
  Answers N % 
Not at all right 54 48.6 
Hardly ever right 19 17.1 
Quite right 23 20.7 
Mostly right 11 9.9 
Totally right 4 3.7 
 
My skin itches 
sometimes before a 
new spot appears  
Total 111 100.0 
 
Table 13: Frequency of pruritus before the development of new spots 
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6.1.9 Patients’ perceptions of trigger and worsening factors for 
vitiligo 
 
 
 
Many factors have been implicated as a trigger or as a worsening factor in vitiligo. Our 
interest was focussed on what patients think regarding involvement of psychological 
stress, other diseases or injuries (Koebner phenomenon) in their vitiligo. The results are 
shown in Figure 14.  
Almost three quarters of patients (n=214, 72%) felt that psychological stress is involved 
in their vitiligo. Sixty patients (38%) related their vitiligo to injuries (Koebner 
phenomen) and 25 patients (18%) connected their vitiligo to other diseases. 
 
 
 
 
Figure 14: Perceived trigger / worsening factors  
72%
n=214
28%
n=83 38%
n=6062% n=98 
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82%
n=113
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  106
 
6.1.10 Prevalence of grey hair on the scalp and in eyelashes / 
eyebrowes 
 
 
 
Premature greying of the scalp hair (canities praecox) is characterised by the onset of 
greying before the age of 25 years (Mosher et al. 1979). Lerner associated this early 
greying with vitiligo. He suggested self-destruction of melanocytes by melanin 
precursors (either a phenol or a catechol derivative or the phenol-tyrosinase complex) as 
the common cause (Lerner 1971). In addition, the complete loss of hair colour in a 
bundle of scalp hair (poliosis) was also assessed.  
 
The prevalences of canities praecox and poliosis are shown in Table 14 and Table 15.   
Crosstabulation shows that about one third of patients <30 years did have grey hair on 
their scalps (33.3%, n=3 in the group <20 years; 37.5%, n=12 in the group of 20-29 
years old patients). The numbers for older age groups are less important as it becomes 
normal with age to have grey hair. 
The numbers for poliosis are similar. One third of the patients <20 years had poliosis on 
the eyelashes / eyebrows (33.3%, n=3), whereas this was 41.9% of the 20-29 years old 
(n=13). The frequency of poliosis does not significantly differ between age groups. 
Hence, this phenomenon seems to be a general symptom in vitiligo. 
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Age groups (years) 
  Grey scalp hair <20 20-29 30-39 40-49 50-59 60-70 Total 
N 3 12 47 64 25 22 173  
Yes % of age group 33.3* 37.5* 67.1 68.1 64.1 81.5 63.8 
N 6 20 23 30 14 5 98 
 
 
 
No % of age group 66.7 62.5 32.9 31.9 35.9 18.5 36.2 
Total N 9 32 70 94 39 27 271 
 
Table 14: Prevalence of grey hair on the scalp in different age groups of patients 
(n=271) 
*Canities praecox as this phenomenon concerns people younger than 25 years only by definition 
 
 
 
 
 
 
 
  
 
Age groups (years)   
  Poliosis <20 20-29 30-39 40-49 50-59 60-70 Total 
 N 3 13 26 35 11 11 99 
  
 
Yes % of age group 33.3 41.9 44.8 41.2 34.4 44.0 41.3 
  N 6 18 32 50 21 14 141 
  
 
No % of age group 66.7 58.1 55.2 58.8 65.6 56.0 58.8 
Total N 9 31 58 85 32 25 240 
 
 
Table 15: Prevalence of poliosis in eyelashes / eyebrows in the patient population 
(n=240) 
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6.1.11 Evaluation of leisure time activities 
 
Since daily activities may influence the psychological strength and the coping process 
in patients’ life, we used sport and hobbies as representative parameters for further 
analysis. 
The data from 124 patients revealed that 77% (n=96) are involved in sport or had 
hobbies (Table 16). However, 23% (n=28) were neither doing any sport nor did they 
have any hobby. 
Taken together, the majority of our patient group had no difficulties with an active 
leisure time. 
 
 
 
Question Answer N % 
Yes 96 77.4 
No 28 22.6 
Do you do any 
sports or do you 
have a hobby? Total 124 100.0 
 
Table 16: Frequency and percentage of patients with active leisure time 
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6.1.12 Stigmatisation experiences 
 
 
 
Stigmatisation has been shown to be an influential factor in coping with skin diseases. 
Therefore, we included two questions to find out how often our patient population had 
experienced typical situations of stigmatisation. These questions concerned  approaches 
/ questions and nasty comments by other people. 
Figure 15 shows that 89% (n=110) of our patients were approached by other people and 
/ or were asked questions about the disease, whereas only 11% (n=13) lacked these 
experiences.  
 
 
 
 
 
Figure 15: Frequency of patients who experienced approaches and questions by 
other people about their vitiligo (n=123) 
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The picture regarding nasty comments is different. One quarter of our patients (24%, 
n=31 out of 123) had experienced other people picking on them or making nasty 
comments. Only one patient had experienced this even very often.   
 
 
 
 
 
Figure 16: Frequency of patients who had been picked on because of their vitiligo 
(n=123) 
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6.1.12.1 Stigmatisation differs between patient groups 
 
At this point it was tempting to further analyse these data about which socio-
demographic subgroups were more strongly affected by stigmatisation and which 
factors played a role when patients were stigmatised. Table 17 summarises our findings 
regarding approaches / questions by strangers and other people.  
 
Our results show a significant difference between female and male patients. Female 
patients are much more likely to experience such approaches / questions very often, 
whereas our male patients reported more often that they were never asked questions 
about the disease (Table 17). 
Moreover, the severity of vitiligo on legs and hands is influential on how often such 
stigmatisation was experienced. Patients with severly affected legs and hands are more 
likely to become subjects to questions and remarks by other people, whereas patients 
with only minor vitiligo are targeted less often. Neither disease severity on any of the 
other body parts nor language of questionnaire were influential. Interestingly, even skin 
colour did not play a role as reported earlier (Porter and Beuf 1991) (Table 17).
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A second typical stigmatisation experience is that strangers make nasty comments 
or pick on individuals with vitiligo. We found that this kind of stigmatisation is 
hardly influenced by demographic characteristics. One significant difference was 
found between patients with severly affected arms and those with only minor 
vitiligo on their upper extremities. The latter group was less likely to become 
subject to nasty comments very often or sometimes (**p<0.005, Chi-Square test, 
Table 18). There was no significant difference between any of the other 
subgroups investigated (age groups, gender, skin colour, all p>0.05, Pearson Chi-
Square test) (Table 18), apart from age at disease onset. We found that patients 
with a disease onset before the age of 20 years were more likely to experience 
nasty comments compared to patients with a disease onset later on in life 
(*p=0.021, 2-sided Pearson Chi-Square test) (Figure 17).  
 
Taken together, stigmatisation experiences are frequent in the life of patients with 
vitiligo, especially in women, but also in patients with severly affected hands, legs 
or arms and in patients with a disease onset before the age of 20 years. 
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6.1.13 Avoidant behaviour 
 
Next we wanted to know whether and how often our patients hide their white spots in 
front of other people. We also included whether our patients would avoid certain 
situations because of their vitiligo. Finally, our interest was to find out whether this 
behaviour was different in the subgroups of our patients. Hiding white spots or avoiding 
certain situations can be indicators of avoidant behaviour, which in turn mirrors altered 
self-confidence.  
 
With regards to frequency of hiding the white spots, our results revealed that 37% 
(n=45) of our patients had never or only rarely hidden their white spots. More than one 
third of the population (35%, n=43) had done this quite often and 28% (n=35) even very 
often (Figure 18).  
 
 
 
 
Figure 18: Frequencies of how often patients have hidden their white spots (n=123) 
28% 
10%
27%
35% 
(n=12) 
(n=33) 
(n=43) 
(n=35) 
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Further exploration of common hiding strategies revealed that almost half of them 
(46.4%, n=45/97) preferred a combination of covering by clothes and using certain 
body positions and camouflage. This strategy was followed by several single strategies 
including hiding the white spots under clothes (23.7%, n=23), using camouflage and 
certain body positions. Least often mentioned were other strategies, without any further 
specification (Table 19).  
 
Our further interest was to explore whether there were any differences between the 
socio-demographic subgroups of our patients. The results revealed that there were no 
significant differences in all subgroups except for gender (Table 21). Female patients 
were more likely to hide their white spots very often (*p=0.045, Pearson Chi-Square 
test). Disease severity, age, age of disease onset, language, skin colour or presence / 
absence of a family history had no influence on avoidant behaviour of our patients (all 
p>0.05, Pearson Chi-Square test). 
 
 
 
 
 Question Answers N % 
Combination of clothes, 
positions, camouflage 
45 46.4 
Under clothes 23 23.7 
Camouflage 16 16.5 
Body positions 10 10.3 
Others (not specified) 3 3.1 
How have you 
hidden your white 
spots? 
 
Total 97 100.0 
 
Table 19: Hiding strategies of patients with vitiligo (n=97) 
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While there were only 10% of our patients who had never hidden their white spots, the 
picture regarding avoidance of situations is different. We found that 35% (n=42) of our 
patients had never avoided any situations because of their vitiligo. However, the 
remaining patients mentioned several situations which they tended to avoid. Most often 
mentioned were shaking hands / getting undressed in changing rooms (39.8%, n=31), 
followed by swimming / bathing (24.4%, n=19) and other situations (11.5%, n=9). 
Shaking hands alone was reported less often (Table 20). 
As shown in Table 22, there were no significant differences within any of the 
subgroups regarding avoidance of situations (skin colour, language, family history, 
disease severity, age, age of disease onset - all p>0.05, 2-sided Pearson Chi-Square 
test). 
 
 
 Question Answers N % 
Shaking hands, undressing in 
changing rooms 
31 39.8 
Swimming / bathing 19 24.4 
Others (not specified) 9 11.5 
Undressing in changing rooms 6 7.7 
Swimming / bathing, undressing in 
changing rooms 
5 6.4 
Shaking hands 3 3.8 
Swimming / bathing, sports, 
undressing in changing rooms 
3 3.8 
Swimming / bathing,sports 2 2.6 
 
 
 
Have you ever 
avoided certain 
situations 
because of 
your vitiligo? 
Total  78 100.0 
 
Table 20: Avoided situations in patients’ life 
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6.2 Dermatology Life Quality Index (DLQI) 
 
6.2.1 Comparison to healthy controls 
 
In order to measure the true effect of vitiligo on the daily life of patients, it was 
necessary to compare the data of our patients to healthy controls under the same life 
circumstances13. The results show that patients with vitiligo (n=164) scored 
significantly higher in the Dermatology Life Quality Index compared to healthy controls 
(n=55) with mean scores of 5.5 (SD 5.27) vs. 0.7 (SD 1.98) and median scores 4.0 vs. 
0.0 (both differences ***p<0.001, 2-sided Independent Sample T-Test and Mann-
Whitney-U-test). The patient group also showed a wider range of scores (Figure 19). 
 
 
 
 
 
Figure 19: DLQI scores for patients (n=164) and healthy controls (n=55) (medians, 
***p<0.001)  
                                                 
 
 
13 as mentioned above, the control group was recruited from friends and family members of the patients 
***
Scores >10  
– severly impaired Quality of life 
 
 
Score 2-10  
– moderately impaired quality of 
life 
 
 
 
Scores 0-1  
– Quality of life not impaired 
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In this context it is noteworthy that members of the control group with a skin disease 
(n=11) also scored higher compared to the 44 healthy individuals without any skin 
disease (means 2.2 vs. 0.2, medians both 0.0, **p=0.002 with an Independent Sample 
T-test, p=0.046 with a Mann-Whitney-U-test). This result emphasises that a skin disease 
clearly influences quality of life in affected individuals. 
 
Since the DLQI contains 10 items only, further analysis is necessary to obtain more data 
than just the central tendencies. Our data show that the DLQI scores are clearly 
positively skewed (Figure 20), which means that there are much more patients with low 
scores than one would expect considering the mean and median scores mentioned 
above. The skewness coefficient calculated is 1.351 confirming that there is no standard 
distribution.   
By comparison, the DLQI scores of healthy controls are also positively skewed. 
However, their mean and median scores are very low, so that the high number of 
controls who scored zero are no surprise (Figure 21). 
 
Moreover, given that a DLQI score of 0-1 indicates that quality of life is not impaired 
(Gajur 2008), we can conclude that 42 out of 164 patients in our group (25.6%) were 
not affected by their disease (Table 23). Furthermore, another 59 patients (36.0%) 
scored between 3 and 5, which is in agreement with minor impact on patients’ quality of 
life (Gajur 2008).  
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DLQI scores Impact on 
quality of life 
N % 
0-1 None 42 25.6 
2-5 Minor 59 36.0 
6-10 Moderate 37 22.6 
11-20 Severe 23 14.0 
21-30 Extreme 3 1.8 
 
Table 23: DLQI scores in our patient group (n=164) according to Gajur’s grouping 
order (Gajur 2008) 
 
 
 
 
This result implies that about 60% (n=101) of our patients were not or only little 
affected by their vitiligo. This is in sharp contrast to our personal impression that these 
patients had been suffering by their disease. Consequently, the question remains 
whether all questionnaires have really been filled out honestly.  
To complete the picture, we found that only 22.6% (n=37) of the adult patient group 
were moderately and 15.8% (n=26) were severly affected in their quality of life by 
vitiligo. This results warrants further investigation and calls published data in the field 
in question. 
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Figure 20: Distribution analysis of patients’ DLQI scores (n=164) 
 
 
 
 
 
 
Figure 21: Distribution of DLQI scores of healthy controls (n=55) 
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6.2.2 DLQI scores in patient subgroups  
 
In order to further analyse the Dermatology Life Quality Index, our interest went 
towards evaluation of whether there were any differences / effects between 
demographic or other subgroups regarding the DLQI scores. 
  
As shown in Table 24, we could not find any significant differences between subgroups 
of our patient population. Hence, our results imply that language of the questionnaire, 
gender, skin colour, age group, presence / absence of a family history of vitiligo, an 
actively spent leisure time and disease severity on most of the body parts did not 
influence the DLQI outcome. There were two exceptions: patients who think that 
psychological stress is involved in triggering or exacerbating vitiligo (median 5.0, 
n=47) had increased DLQI scores compared to those who did not have this feeling 
(median 1.0, n=24). This difference was highly significant (**p=0.002, Mann Whitney-
U-test). In addition we found that patients with extensive vitiligo on the trunk (n=58, 
self-assessment) scored significantly higher in the DLQI compared to the 65 individuals 
with only minor disease (medians 4.5 vs. 3.0, *p<0.05, Mann-Whitney-U-test). This 
result indicates an influence of disease severity on the DLQI outcome (Table 24).  
 
Patients who were treating their vitiligo at home with NB-UVB activated 
pseudocatalase PC-KUS (n=51) scored a mean of 4.3 in the DLQI, which is lower than 
the mean score of 6.0 for new patients (n=113). This difference is significant 
(*p=0.049) but only if the mean is used. A non-parametric analysis revealed no 
significant difference (medians 3.0 vs. 4.0, p>0.05, Mann-Whitney-U-test). It can be 
concluded that treatment with NB-UVB activated pseudocatalase PC-KUS improves 
quality of life, albeit there is no strong effect. 
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Dermatology Life Quality Index 
 
Subgroups N Median Mean SD p value 
German 95 3.0 5.2 5.413 Language English 69 4.0 5.9 5.059 >0.05 
Male 61 3.0 4.6 4.573 Gender Female 103 5.0 6.1 5.588 
0.077(1) 
0.083(2) 
< 35 years 47 4.0 5.3 4.460 Age  > 35 years 117 4.0 5.6 5.577 >0.05 
I-III 137 4.0 5.5 5.380 Skin phototypes IV-VI 27 4.0 5.5 4.710 >0.05 
Yes 57 4.0 5.3 5.117 Family history No 104 4.0 5.7 5.436 >0.05 
       
Yes 47 5.0*** 5.8*** 4.866 Psychological stress  No 24 1.0*** 2.3*** 2.472 
0.001(1) 
0.002(2) 
Yes 32 4.0 5.2 4.930 Koebner phenomenon No 36 2.0 4.0 4.060 >0.05 
Yes 9 5.0 5.3 4.153 Vitiligo caused by other 
diseases No 44 2.0 4.0 4.393 >0.05 
       
Little 105 5.0 5.9 5.316 Face  Severe 39 2.0 4.8 5.072 >0.05 
Little 59 4.0 5.9 5,388 Neck Severe 47 5.0 6.5 5.324 >0.05 
Little 37 4.0 5.8 5.441 Hands  Severe 108 4.0 5.7 5.352 >0.05 
Little 69 4.0 5.1 4.392 Arms Severe 58 5.0 6.6 6.087 >0.05 
Little 65 3.0* 4.4* 3.893 Trunk  Severe 58 4.5* 6.6* 5.988 
0.017(1) 
0.047(2) 
Little 79 4.0 5.4 5.437 Di
se
as
e s
ev
er
ity
 (s
elf
-a
ss
es
se
d)
 
Legs  Severe 51 5.0 6.6 5.475 >0.05 
       
Yes 95 3.0 5.1 5.227 Do you do any sports or do 
you have a hobby? No 28 4.5 5.1 4.447 >0.05 
 
 
Table 24: DLQI scores in several subgroups of patient population 
All significances were measured with a 2-sided Independent Sample T-test(1) and a  
Mann-Whitney-U-test(2). 
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Next we analysed the data of all the socio-demographic subgroups according to their 
grouped DLQI scores. Confirming our earlier findings, we could not establish any 
differences between the groups, including age, gender, age of disease onset, 
involvement of body sites, actively spent leisure time, skin colour and family history 
(all p>0.05, Pearson Chi-Square test).  
Notably, patients who think that psychological stress is involved in vitiligo were more 
often found in the higher DLQI score groups 11-20 and 21-30 (100.0%, n=5) compared 
to the lower scores 0-1 and 2-5 (55.6%, n=25/45, *p<0.05, Table 25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 25: Analysis of grouped DLQI scores in adult patients 
Significance was measured with a Pearson Chi-Square test. 
 
 
Psychological 
stress involved 
in vitiligo? 
Groups of 
DLQI Scores 
Yes No 
0-1 N 
% 
11 
45.8 
13 
54.2 
2-5 N 
% 
14 
66.7 
7 
33.3 
6-10 N 
% 
17 
81.0 
4 
19.0 
11-20 N 
% 
5 
100.0 
0 
0.0 
21-30 N 
% 
-- -- 
p value  *0.029 
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6.2.3 DLQI and the influence of stigmatising experiences 
 
Stigmatisation has been described as highly influential on quality of life measurements 
(Kent and Al-Abadie 1996a). Therefore, we wanted to know whether this applied to our 
patient population as well by comparing the DLQI scores regarding experiences of 
being approached / asked by others and regarding picking on / nasty comments.  
 
Our results show that approaches / questions by others have a significant effect on 
DLQI (*p=0.014, one-way ANOVA test; *p<0.05, Kruskal-Wallis-test). However, there 
is no clear-cut tendency, because the highest DLQI score was in the group of patients 
who had not experienced approaches / questions, whereas the lowest score was in those 
who were approached / asked sometimes. Patients who were asked very often scored in 
the middle range (Table 26). 
There was no significant difference within the patient group regarding experiences of 
picking on / nasty comments (p>0.05, one-way ANOVA and Kruskal-Wallis-test, Table 
26).  
 
Question Answer N 
Mean 
DLQI 
Median 
DLQI SD 
p value 
 
1 27 5.4** 4.0 4.749 
2 84 4.5** 3.0 4.441 
Have you ever been approached by 
others, or have you been asked 
questions about your vitiligo? 3 13 8.8** 8.0 7.463 
0.014(1) 
>0.05(2) 
       
1 1 3.0 n.d. 0.0 
2 29 6.3 6.0 5.863 
Have you ever been picked upon, or 
has anybody ever been nasty to you 
because of your vitiligo? 3 93 4.8 3.0 4.729 
>0.05(1) (2) 
 
Table 26: Influence of stigmatisation experiences on DLQI scores 
Significances were measured with a one-way ANOVA test(1) and a Kruskal-Wallis-test(2). 
 
1 - Yes, very often,     2 - Yes, sometimes,      3 - No 
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6.2.4 DLQI scores and avoidant behaviour 
 
Since dermatology quality of life measurements determine how many and how much 
essential daily activities are limited by a skin disease, we were interested whether there 
were indeed any associations between DLQI scores and avoidant behaviour. For this 
purpose we chose hiding of the white spots in front of other people and avoidance of 
situations, where the disease might be exposed.   
 
First we analysed the correlation between frequencies of hiding vitiligo and DLQI 
scores. The results revealed that an increased frequency of hiding the white spots  
correlates with increased DLQI scores (Figure 22). Patients who were hiding their 
vitiligo very often showed the highest median DLQI scores (8.0, n=35), followed by 
quite often (4.0, n=43) and very rarely (2.0, n=33). The lowest median DLQI score was 
found in the group of patients who had never hidden their white spots (1.0, n=12). The 
difference between the groups is highly significant (***p<0.001, Kruskal-Wallis-test). 
This tendency is also confirmed by analysis of the grouped DLQI scores (Table 27).  
 
In the groups with high DLQI scores (11-20 and 21-30), which indicate severely 
impaired quality of life, there were more patients hiding their white spots quite often 
and very often (100.0%, n=16) compared to the lower DLQI score groups (41.2%, n=14 
out of 37). The difference is highly significant (**p=0.001, Pearson Chi-Square test) 
(Table 27). 
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Figure 22: DLQI and hiding vitiligo (n=124, ***p<0.001)  
 
 
 
 
 
The results regarding avoidance of situations were similar. Patients who had avoided 
situations because of their vitiligo (n=79) had much higher median DLQI scores (5.0 vs. 
2.0) compared to those who never avoided anything (n=40). The difference is highly 
significant (***p<0.001, Mann-Whitney-U-Test, see Figure 23). 
A comparison of patients with higher (11-20 and 21-30) and with lower DLQI score 
groups (0-5) yielded the same tendency. There were n=12/13 patients in the higher 
score groups avoiding situations because of their disease (92.3%), but this proportion 
was much smaller in the group with scores ranging from 0 to 5 (54.5%, n=42/77, Table 
27). This difference was significant (*p=0.006, Chi-Square test). 
D
LQ
I m
ed
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n 
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e 
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Figure 23: DLQI and avoidant behaviour (n=119, ***p<0.001)  
 
 
 
 
Ever avoided situations 
because of vitiligo? 
 Have you ever hidden your white 
spots? 
Groups of 
DLQI 
Scores Yes Never N  Never Very 
rarely 
Quite 
often 
Very 
often 
N 
0-1 N 
% 
15 
44.1 
19 
55.9 34 
 7 
20.6 
13 
38.2 
10 
29.4 
4 
11.8 34 
2-5 N 
% 
27 
62.8 
16 
37.2 43 
 4 
9.1 
12 
27.3 
20 
45.4 
8 
18.2 44 
6-10 N 
% 
23 
82.1 
5 
17.9 28 
 1 
3.4 
8 
27.6 
8 
27.6 
12 
41.4 29 
11-20 N 
% 
10 
90.9 
1 
9.1 11 
 0 
0.0 
0 
0.0 
5 
35.7 
9 
64.3 16 
21-30 N 
% 
2 
100.0 
0 
0.0 2 
 0 
0.0 
0 
0.0 
0 
0.0 
2 
100.0 2 
p value  *p=0.006   **p=0.001  
 
Table 27: Analysis of avoidance behaviour in groups of DLQI scores 
Significances were measured with a Pearson Chi-Square test 
 
 
***
(n=79)                                            (n=40) 
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6.2.5 Influence of disease severity in male and female patients 
 
 
When we analysed the DLQI scores separately for each body part for male and female 
patients, there were no differences between genders (data not shown, all p>0.05, 
Independent Sample T-test and Mann-Whitney-U-test), apart from the face.  
The results revealed that women with severe facial vitiligo had significantly increased 
DLQI scores (mean 6.3, n=21) compared to male patients (3.1, n=18, *p=0.043, 2-sided 
Independent Sample T-test). There was no difference between male and female patients 
with minor facial vitiligo (Figure 24).  
 
 
 
 
 
Figure 24: Mean DLQI scores and the influence of slightly or severely affected 
faces (self-assessment) in male and female patients with vitiligo (n=144) 
 
5.1 
n=39 
6.4 
n=66
3.1 
n=18
6.3 
n=21 
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6.2.6 Duration of vitiligo has no influence on quality of life 
 
 
Since there is no agreement in the literature on whether duration of vitiligo correlates 
with total DLQI scores, we tested whether there was such correlation in our patient 
population. 
Pearson correlation analysis yielded a correlation coefficient of 0.006 (n=164), which 
means that there was neither a significant positive nor negative correlation between 
mean total DLQI scores and duration of the disease (p>0.05).  
Moreover, we also found that none of the single DLQI items correlated with duration of 
disease (n=89, all p>0.05), except for question 2 (embarrassment, self-consciousness) 
where a negative correlation was present (-0.269, *p=0.011, Pearson correlation 
analysis). Hence, the longer patients had vitiligo, the less embarrassed or self-conscious 
they were.  
Taken together, we can conclude that the duration of vitiligo has no influence on quality 
of life of affected individuals. This is rather surprising, because patients appear 
frequently very disturbed at their first visit at the Institute for Pigmentary Disorders. 
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6.2.7 Single items analysis 
 
Apart from differences between subgroups as measured with the total DLQI score, it 
has been of interest whether there were any significant differences in the 10 single items 
of this questionnaire. This analysis allowed a more detailed insight into the life of our 
patients. For this purpose we evaluated 90/164 randomly chosen DLQI questionnaires. 
The results showed no significant influence (p>0.05) of 
 
• gender(1) (3), 
• language of questionnaire(1) (3),  
• age groups(2) (4),  
• groups of age at disease onset(2) (4),  
• beliefs that other diseases or injuries are involved in triggering vitiligo(1) (3),  
• presence of grey hair on scalp or in eyelashes / eyebrows(1) (3),  
• stigmatising experiences (having been picked on) (2) (4), 
• self-assessed disease severity on face, neck, legs and hands(1)(3) 
 
 
 
The results are based on the following tests of significance:  
(1) 2-sided Independent Sample T-test 
(2) one-way ANOVA test,  
(3) Mann-Whitney-U-test  or  
(4) Kruskal-Wallis-test. 
 
Since all the scores are rather low in each single item, evaluation using the median  
would yield almost only zero values. Therefore the mean has been chosen for 
presentation of the results. 
 
When comparing the means of all DLQI single items, we could show that vitiligo had 
the strongest effect on feelings of embarrassment / self-consciousness (score 1.0), 
followed by wearing clothes (0.6), social / leisure activities (0.5) and relationships with 
partners / friends / relatives (0.5). The least affected items were doing sports and work / 
studying (each 0.2, Figure 25). 
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Next we analysed whether the DLQI single items were influenced by any other 
demographic characteristics.  
 
We found differences between patients undergoing treatment with NB-UVB activated 
pseudocatalase PC-KUS and new patients from the Institute for Pigmentary Disorders 
(Table 28). The treated group was less affected in their daily activities such as shopping 
or gardening (*p<0.05, Independent Sample T-test). However, the treatment itself 
(**p<0.005) and physical symptoms (*p<0.05, Mann-Whitney-U-test) affected patients 
more compared to new patients. Interestingly, there were no further significant 
differences (p>0.05, 2-sided Independent Sample T-test and Mann-Whitney-U-test). 
It can be concluded that the treatment offered by the Institute for Pigmentary Disorders 
can improve essential parts of patients’ daily life. 
 
 
A comparison of patients with different skin colours revealed that those with darker 
skin felt limited in their sportive activities (Table 29, **p<0.005, Mann-Whitney-U-
test). It is surprising that sport is harder on patients compared to shopping / gardening 
or even sexual relationships.  
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          DLQI items                             Patient status N Mean  SD p value 
1 41 0.2 .525 Question 1 
Physical symptoms 2 49 0.4 .492 
>0.05(1) 
0.041(2) 
1 41 1.2 1.085 Question 2 
 Embarrassment, self-consciousness 2 49 0.9 .696 
>0.05 
1 41 0.5* .978 Question 3 
Shopping, home / garden activities 2 49 0.2* .391 
0.049(1) 
>0.05(2) 
1 41 0.6 .942 Question 4 
Clothes 2 49 0.7 .925 
>0.05 
1 41 0.5 .951 Question 5 
Social / leisure activities 2 49 0.5 .767 
>0.05 
1 41 0.1 .400 Question 6 
Sport 2 49 0.3 .645 
>0.05 
1 41 0.2 .511 Question 7 
Work / studying 2 49 0.2 .456 
>0.05 
1 41 0.5 .951 Question 8 
Partners / friends / relatives 2 49 0.5 .679 
>0.05 
1 41 0.3 .693 Question 9 
Sexual difficulties 2 49 0.3 .689 
>0.05 
1 41 0.3* .672 Question 10 
Treatment 2 49 0.6* .643 
0.022(1) 
0.002(2) 
1 41 4.5 5.168 Total DLQI 
2 49 4.5 3.577 
>0.05 
 
Table 28: Comparison of DLQI scores in patients from IFPD and other sources 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
 
1- New patients  
2- Treated patients (IFPD)   
  137
  
DLQI items                       Skin phototype groups N Mean   SD p value 
I-III 75 0.3 .514 Question 1 
Physical symptoms IV-VI 15 0.5 .519 
>0.05 
I-III 75 0.9 .859 Question 2 
 Embarrassment, self-consciousness IV-VI 15 1.3 .947 
>0.05 
I-III 75 0.3 .684 Question 3 
Shopping, home / garden activities IV-VI 15 0.5 .660 
>0.05 
I-III 75 0.6 .954 Question 4 
Clothes IV-VI 15 0.7 .855 
>0.05 
I-III 75 0.5 .795 Question 5 
Social / leisure activities IV-VI 15 0.9 1.144 
>0.05 
I-III 75 0.2** .456 Question 6 
Sport IV-VI 15 0.6** .870 
0.004(1) 
0.002(2) 
I-III 75 0.2 .501 Question 7 
Work / studying IV-VI 15 0.2 .376 
>0.05 
I-III 75 0.4 .738 Question 8 
Partners / friends / relatives IV-VI 15 0.7 .947 
>0.05 
I-III 75 0.4 .668 Question 9 
Sexual difficulties IV-VI 15 0.3 .855 
>0.05 
I-III 75 0.5 .704 Question 10 
Treatment IV-VI 15 0.3 .480 
>0.05 
I-III 75 4.2 4.145 Total DLQI 
IV-VI 15 5.9 5.257 
>0.05 
 
Table 29: Comparison of DLQI scores in fair vs. dark skin 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
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Influence of a positive family history of vitiligo on quality of life (DLQI) 
 
Although a family history of vitiligo is present in about 38% of the patients, this has 
hardly been linked to quality of life in the literature. Therefore, our aim was to explore 
any possible differences between patients with and without somebody else in the family 
with the disease. Single item analysis of the DLQI showed that patients with a positive 
family history are less affected regarding sexual difficulties (Table 30, *p=0.04 
Independent Sample T-Test, p=0.55 Mann-Whitney-U-test).  
 
 
  
 
DLQI items                                Family history  N Mean   SD p value 
Yes 24 0.3 .565 Question 1 
Physical symptoms No 61 0.3 .501 >0.05 
Yes 24 0.9 .830 Question 2 
 Embarrassment, self-consciousness No 61 1.1 .939 >0.05 
Yes 24 0.3 .737 Question 3 
Shopping, home / garden activities No 61 0.3 .750 >0.05 
Yes 24 0.4 .717 Question 4 
Clothes No 61 0.7 1.015 >0.05 
Yes 24 0.4 .711 Question 5 
Social / leisure activities No 61 0.6 .903 >0.05 
Yes 24 0.1 .282 Question 6 
Sport No 61 0.3 .623 >0.05 
Yes 24 0.1 .282 Question 7 
Work / studying No 61 0.3 .545 >0.05 
Yes 24 0.4 .881 Question 8 
Partners / friends / relatives No 61 0.5 .808 >0.05 
Yes 24 0.1* .282 Question 9 
Sexual difficulties No 61 0.4* .784 
0.04(1) 
0.055(2) 
Yes 24 0.5 .834 Question 10 
Treatment No 61 0.4 .620 >0.05 
Yes 24 3.5 3.401 Total DLQI 
No 61 4.9 4.734 >0.05 
 
Table 30: DLQI scores in presence vs. absence of a positive family history of 
vitiligo (single item analysis) 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
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Influence of psychological stress on quality of life (DLQI) 
 
Earlier in this thesis, we showed that the perception of psychological stress influencing 
vitiligo has a strong effect on the total DLQI score. It was tempting to further analyse 
this finding to see which parts of the daily life are exactly impaired. As shown in Table 
31, we found that those patients are more affected in almost all single items of the 
DLQI except for physical symptoms, work / studying and treatment itself (significances 
vary from ***p=0.001 to *p=0.05, Independent Sample T-test and Mann-Whitney-U-
test).  
  
 
DLQI items                   Psychological stress N Mean   SD p value 
Yes 45 0.3 .522 Question 1 
Physical symptoms No 24 0.3 .532 >0.05 
Yes 45 1.2* .960 Question 2 
 Embarrassment, self-consciousness No 24 0.7* .761 
0.02(1) 
0.025(2) 
Yes 45 0.5* .919 Question 3 
Shopping, home / garden activities No 24 0.0* .204 
0.012(1) 
0.006(2) 
Yes 45 0.9** 1.027 Question 4 
Clothes No 24 0.2** .482 
0.002(1) 
0.001(2) 
Yes 45 0.8* .997 Question 5 
Social / leisure activities No 24 0.3* .532 
0.019(1) 
0.023(2) 
Yes 45 0.3 .668 Question 6 
Sport No 24 0.0 .204 
>0.05(1) 
0.05(2) 
Yes 45 0.3 .549 Question 7 
Work / studying No 24 0.1 .448 >0.05 
Yes 45 0.8* .908 Question 8 
Partners / friends / relatives No 24 0.2* .658 
0.011(1) 
0.003(2) 
Yes 45 0.5 .757 Question 9 
Sexual difficulties No 24 0.2 .565 
>0.05(1) 
0.035(2) 
Yes 45 0.5 .727 Question 10 
Treatment No 24 0.3 .550 >0.05 
Yes 45 6.0** 4.864 Total DLQI 
No 24 2.2** 2.472 0.001 
 
Table 31: Single item analysis of DLQI regarding psychological stress 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
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Avoidant behaviour and quality of life (DLQI) 
 
It was also of interest to see which parts of the daily life are particularly impaired in 
patients who tend to avoid situations because of their vitiligo. It can be suspected that 
those activities are affected where patients fear to meet strangers or become subjects to 
questions. We found indeed that patients with avoidant behaviour scored significantly 
higher in daily activities (shopping / gardening), wearing clothes because of vitiligo and 
sport (Table 32, all *p<0.05, Mann-Whitney-U-test and Independent Sample T-test). In 
all the other items we found no significant differences. 
   
 
DLQI items                      Situations avoided? N Mean   SD p value 
Yes 59 0.4 .517 Question 1 
Physical symptoms Never 28 0.2 .499 >0.05 
Yes 59 1.0 .820 Question 2 
 Embarrassment, self-consciousness Never 28 0.9 .956 >0.05 
Yes 59 0.4* .763 Question 3 
Shopping, home / garden activities Never 28 0.1* .262 
0.046(1) 
0.041(2) 
Yes 59 0.8* .979 Question 4 
Clothes Never 28 0.3* .723 
0.025(1) 
0.014(2) 
Yes 59 0.6 .929 Question 5 
Social / leisure activities Never 28 0.3 .612 >0.05 
Yes 59 0.3* .650 Question 6 
Sport Never 28 0.0* .189 
0.035(1) 
0.028(2) 
Yes 59 0.2 .434 Question 7 
Work / studying Never 28 0.2 .568 >0.05 
Yes 59 0.5 .878 Question 8 
Partners / friends / relatives Never 28 0.4 .621 >0.05 
Yes 59 0.4 .717 Question 9 
Sexual difficulties Never 28 0.2 .548 >0.05 
Yes 59 0.5 .626 Question 10 
Treatment Never 28 0.4 .780 >0.05 
Yes 59 5.0 4.620 Total DLQI 
Never 28 3.0 3.394 
0.052(1) 
0.03(2) 
 
Table 32: Single item analysis of DLQI regarding avoidance of situations 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
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Self-assessed disease severity and quality of life 
 
Although the disease severity on arms of the patients did not influence the total DLQI 
score, there were some significant differences when looking at the questionnaire’s 
single items. Our results yielded that patients who judge their own vitiligo on their arms 
as severe are more affected regarding wearing clothes (*p<0.05, Independent Sample T-
test and Mann-Whitney-U-test), while all other items showed no significant differences 
(Table 33). The disease severity on the other body parts did not play a role, possibly 
because they are either always (trunk) or only rarely covered (face or hands).  
Moreover, disease severity on the trunk did not influence the item wearing of clothes, 
but rather the one on sexual difficulties. Patients whose trunk was only slightly affected 
by vitiligo, had a less impaired sexual life (Table 34, *p<0.05, Mann-Whitney-U-test). 
This is somewhat obvious, because the trunk would only be exposed to others in 
intimate situations. Other situations, where this might happen would be sport or 
swimming, but these activities are easier to avoid. 
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Self-assessed disease severity ARMS N Mean   SD p value 
1 34 0.3 .448 Question 1 
Physical symptoms 2 32 0.3 .523 
>0.05 
1 34 0.9 .851 Question 2 
 Embarrassment, self-consciousness 2 32 1.2 .920 
>0.05 
1 34 0.2 .654 Question 3 
Shopping, home / garden activities 2 32 0.4 .911 
>0.05 
1 34 0.4* .743 Question 4 
Clothes 2 32 0.9* 1.045 
0.021(1) 
0.02(2) 
1 34 0.4 .779 Question 5 
Social / leisure activities 2 32 0.6 .801 
>0.05 
1 34 0.1 .288 Question 6 
Sport 2 32 0.3 .592 
0.053(1) 
>0.05(2) 
1 34 0.1 .327 Question 7 
Work / studying 2 32 0.3 .581 
>0.05 
1 34 0.6 .985 Question 8 
Partners / friends / relatives 2 32 0.5 .762 
>0.05 
1 34 0.4 .779 Question 9 
Sexual difficulties 2 32 0.4 .712 
>0.05 
1 34 0.6 .743 Question 10 
Treatment 2 32 0.3 .653 
>0.05 
1 34 4.0 3.717 Total DLQI 
2 32 5.2 4.568 
>0.05 
  
Table 33: Single item analysis of DLQI regarding disease severity on arms 
Significance was measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
 
1- Little affected 
2- Severely affected 
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Self-assessed disease severity TRUNK N Mean   SD p value 
1 34 0.3 .462 Question 1 
Physical symptoms 2 24 0.4 .584 
>0.05 
1 34 1.1 .977 Question 2 
 Embarrassment, self-consciousness 2 24 0.7 .624 
>0.05 
1 34 0.4 .884 Question 3 
Shopping, home / garden activities 2 24 0.2 .381 
>0.05 
1 34 0.5 .861 Question 4 
Clothes 2 24 0.9 1.018 
>0.05(1) 
0.054(2) 
1 34 0.4 .652 Question 5 
Social / leisure activities 2 24 0.5 .779 
>0.05 
1 34 0.2 .359 Question 6 
Sport 2 24 0.3 .608 
>0.05 
1 34 0.2 .479 Question 7 
Work / studying 2 24 0.2 .509 
>0.05 
1 34 0.4 .786 Question 8 
Partners / friends / relatives 2 24 0.5 .780 
>0.05 
1 34 0.2 .521 Question 9 
Sexual difficulties 2 24 0.5 .722 
>0.05(1) 
0.027(1) 
1 34 0.5 .706 Question 10 
Treatment 2 24 0.5 .779 
>0.05 
1 34 4.1 3.599 Total DLQI 
2 24 4.6 3.599 
>0.05 
  
Table 34: Single item analysis of DLQI regarding disease severity on trunk 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
  
 
1- Little affected 
2- Severely affected 
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Stigmatisation experiences and DLQI 
 
Finally, it was our interest to find out which parts of the daily life are impaired if 
patients with vitiligo had experienced stigmatisation, i.e. approaches or questions about 
the disease by others. Interestingly, patients who had never been approached or asked 
were more affected in their relationships to partners / friends / relatives and sexual 
relationships. Patients who had some experiences, showed the lowest scores in the 
mentioned categories (Table 35, *p<0.05, one-way ANOVA test and Kruskal-Wallis-
test). There were no further differences in any of the other DLQI single items.  
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  Have you ever been approached by others 
because of your skin disease, or have you 
been asked questions about your vitiligo? N Mean  SD p value 
1 23 0.4 .573 
2 58 0.3 .496 
Question 1 
Physical symptoms 
3 8 0.3 .463 
>0.05 
1 23 1.2 1.043 
2 58 0.9 .782 
Question 2 
 Embarrassment, self-
consciousness 3 8 1.1 .991 
>0.05 
1 23 0.6 1.158 
2 58 0.2 .425 
Question 3 
Shopping, home / garden 
activities 3 8 0.4 .518 
>0.05 
1 23 0.7 .974 
2 58 0.6 .862 
Question 4 
Clothes 
3 8 1.0 1.195 
>0.05 
1 23 0.4 .783 
2 58 0.5 .753 
Question 5 
Social / leisure activities 
3 8 1.3 1.282 
>0.05 
1 23 0.3 .619 
2 58 0.1 .348 
Question 6 
Sport 
3 8 0.6 1.188 
>0.05 
1 23 0.3 .559 
2 58 0.1 .395 
Question 7 
Work / studying 
3 8 0.4 .744 
>0.05 
1 23 0.7 .974 
2 58 0.3 .664 
Question 8 
Partners / friends / relatives 
3 8 1.0 1.069 
>0.05(1) 
0.046(2) 
1 23 0.5 .790 
2 58 0.2 .585 
Question 9 
Sexual difficulties 
3 8 0.8 .886 
>0.05(1) 
0.019(2) 
1 23 0.5 .846 
2 58 0.4 .624 
Question 10 
Treatment 
3 8 0.5 .535 
>0.05 
1 23 5.6 5.080 
2 58 3.6 3.283 
Total DLQI  
3 8 7.3 6.902 
>0.05 
 
Table 35: Single item analysis of DLQI regarding approaches / questions  
Significances were measured with a one-way ANOVA test(1) and a Kruskal-
Wallis-test(2). 
 
1 - Yes, very often, 2 - Yes, sometimes, 3 - No 
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6.3 Coping with vitiligo 
 
 
6.3.1 Impaired coping in adults with vitiligo 
 
 
In order to test the direct influence of vitiligo on coping with this skin disease, we 
compared all main scores of the Adjustment to Chronic Skin Disorders Questionnaire 
(ACS) between patients (n=422) and healthy controls (n=55). 
 
Patients with vitiligo scored a mean of 38.7 (SD 13.67) and a median of 37.0 for social 
anxiety / avoidance, which is much higher compared to the control group (mean 19.0, 
SD 7.81, median 16.0). The difference is highly significant (***p<0.001,  Mann-
Whitney-U-Test and 2-sided Independent Sample T-test, Figure 26).  
The same applied to helplessness. The patients’ mean score was 27.7 (median 27.0, SD 
8.22), whereas healthy controls scored only a mean of 13.5 (median 12.0, SD 6.04), 
which is significantly lower (***p<0.001, Mann-Whitney-U-Test and 2-sided 
Independent Sample T-test).  
Finally, even in anxious-depressive mood, the only scale not specified for skin diseases, 
patients with vitiligo scored much higher (mean 20.2, median 20.0, SD 6.61) than the 
control group (mean 14.6, median 14.0, SD 6.05). This difference proved to be 
significant, too (***p<0.001,  Mann-Whitney-U-Test and 2-sided Independent Sample 
T-test) (Figure 26).  
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Figure 26: ACS sub-scores of patients (n=422) and healthy controls (n=55) 
 
***
***
***
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Patients’ scores had a wider range compared to the control group (Figure 26). This 
result reflects the heterogeneity in coping strategies of patients with vitiligo. 
 
However, there were no differences within the control group when analysed for the 
influence of skin diseases on coping. Members of the control group with a skin disease 
(n=11) and controls without any skin disease (n=33) did not differ in any subscale (all 
p>0.05, Mann-Whitney-U-test and Independent Sample T-test). This result further 
supports that vitiligo had a particularly strong effect on coping compared to the mix of 
various skin diseases present in our control group. 
 
The following distribution and skewness analysis of the data allowed a more detailed 
insight. Figure 28 shows a normal distribution for helplessness scores. This result is 
confirmed by the calculated skewness coefficient of 0.094, which is the lowest of all 
questionnaires used in this thesis. Social anxietey / avoidance and anxious-depressive 
mood are slightly more positively skewed (coefficients of 0.408 and 0.417, respectively) 
(Figure 27 and Figure 29).   
As already shown with the use of the DLQI, there are more patients with rather low 
ACS scores, but this tendency is not as pronounced as in the DLQI measurements. 
Patients with extremely high ACS scores are still a minority. Importantly, there were 
only 3 patients who showed the highest possible score for helplessness, which is 45. 
Nobody of the patients scored the same for social anxiety / avoidance or anxious-
depressive mood (Figure 27 and Figure 29).   
 
Based on our results it is tempting to conclude that the central tendencies (median and 
mean) of the ACS do reflect the group’s well-being better than the ones for the DLQI. 
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The same can be concluded after distribution and skewness analysis of the control 
group’s scores. There are high skewness coefficients for social anxiety and helplessness 
(3.036 and 2.318, n=55) (Figure 27 and Figure 28), whereas the one for anxious-
depressive mood is much lower (0.58) (Figure 29). These results confirm that the vast 
majority of healthy controls do not have difficulties regarding their skin appearance. 
Interestingly, anxious-depressive mood, the only scale of this questionnaire not 
specified for skin diseases, seems to be more scattered, suggesting that this emotion is 
also relevant in healthy controls. 
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Figure 28: Distribution of helplessness scores of patients (n=422) and controls 
(n=55) 
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Figure 29: Distribution of anxious-depressive mood scores in patients (n=422) and 
healthy controls (n=55) 
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6.3.2 ACS sub-scores in different age groups 
 
Since it has been described in the literature that vitiligo is less of a problem in older 
people compared to the younger ones, we wanted to determine if this applies to our 
patient group as well.  
We employed Pearson correlation analysis between the ACS sub-scores and age. The 
results yielded the following correlation coefficients (n=422): 
 
• Social anxiety / avoidance  -0.099* (p=0.042) 
• Helplessness    -0.126* (p=0.01) 
• Anxious-depressive mood  -0.103* (p=0.035) 
 
All sub-scores correlate significantly negatively with age, meaning that in our 
population the older the patients are, the less affected they are in terms of the ACS main 
scales. Therefore this result confirms earlier reports. 
 
Figure 30 shows the scores for different age groups. There is a significant difference 
between age groups for social anxiety / avoidance (**p=0.016), helplessness  
(**p=0.01) and anxious-depressive Mood (**p=0.005) as measured with a Kruskal-
Wallis-test. The 20-29 years old patients showed the highest median scores, whereas 
they were lowest in the older group (50-59 years old). 
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6.3.3 ACS sub-scores in different age groups of disease onset 
 
It has also been of interest whether the age at disease onset was influential on the ACS 
scores. 
Pearson correlation analysis between all ACS sub-scores and age at disease onset 
yielded the following coefficients (n=422): 
 
• Social anxiety / avoidance  -0.199* (p=0.014) 
• Helplessness    -0.076   (p>0.05) 
• Anxious-depressive mood  -0.079   (p>0.05) 
 
 
Only for social anxiety / avoidance there is a significant negative correlation, which 
implies that the younger the age at disease onset, the higher the scores. Helplessness and 
anxious-depressive mood do not correlate with age of disease onset. 
 
To complete the picture, Figure 31 shows the scores for different age groups with 
regards to disease onset. There is a significant difference between age groups in social 
anxiety / avoidance (*p=0.018), helplessness  (*p=0.035) and anxious-depressive mood 
(*p=0.007) as measured with a Kruskal-Wallis-test. Overall, the group with a disease 
onset between 12 and 19 years of age showed the highest median scores, whereas the 
lowest were found in the group >60 years. 
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6.3.4 ACS sub-scores depending on stigmatising experiences 
 
Stigmatisation has been described as highly influential on quality of life measurements. 
Therefore, we embarked to find out whether this also applied to social anxiety / 
avoidance, helplessness and anxious-depressive mood by comparing these scores in 
association with stigmatising experiences of approaches / questions and nasty 
comments by other people. 
 
We found that there is a weak significant influence of approaches / questions on social 
anxiety / avoidance depending on whether this had happened very often (n=27), 
sometimes (n=83) or never (n=13) (*p=0.044 one-way ANOVA test, p=0.055 Kruskal-
Wallis-test).  However, there is no clear tendency, because the highest median score was 
in the ‘very often’ group (41.0),  followed by ‘No’ (40.0) and the lowest score being in 
the ‘sometimes’ group (33.0). These differences are not present in helplessness and 
anxious-depressive mood (always p>0.05, one-way ANOVA test and Kruskal-Wallis 
test). The results are shown in Figure 32. 
 
Figure 33 shows the results regarding nasty comments / picking on individuals. Patients 
who had been picked on sometimes (n=29) showed higher median scores for social 
anxiety / avoidance compared to the 93 individuals who never made such experiences 
(39.0 vs. 33.0, *p=0.009). The same applied to anxious-depressive mood (medians 22.0 
vs. 18.0, *p=0.042, both Mann-Whitney-U-test), but not to helplessness (29.0 vs. 25.0, 
p>0.05, Mann-Whitney-U-test). One patient had experienced this kind of stigmatisation 
very often, but this case has been left out for statistical reasons. 
In summary, these results show that coping with vitiligo is clearly influenced by 
stigmatisation experiences.  
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Figure 32: Median ACS sub-scores regarding frequencies of stigmatising 
experiences (approaches and questions by others)  
 
 
 
 
Figure 33: Median ACS sub-scores in patients with and without stigmatisation 
experiences (nasty comments)  
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6.3.5 ACS scores and avoidant behaviour 
 
Similar to the DLQI evaluation, it was our interest to explore how those patients were 
coping with their disease, who tended to hide their white spots in front of other people 
and who had avoided certain situations. 
 
Our results revealed that there was a highly significant and positive correlation between 
frequencies of hiding vitiligo and median ACS sub-scores (Figure 34). Patients who 
hide their vitiligo very often (n=35) scored highest in social anxiety / avoidance (median 
50.0), helplessness (35.0) and anxious-depressive mood (22.0). This was followed by 
the quite often group (n=43, medians 39.0, 29.0 and 21.0, respectively) and patients who 
had very rarely hidden their white spots (n=33, medians 39.0, 21.0 and 16.0). The 
lowest scores were found in the group of patients who had never concealed their vitiligo 
(n=12, medians 20.0, 18.0 and 16.0, respectively). The difference between the four 
groups was highly significant in all sub-scales of the ACS  (***p<0.001 as measured 
with a Kruskal-Wallis-test).  
 
Next we wanted to know whether avoiding situations because of vitiligo makes a 
difference in coping with this chronic skin disease (Figure 35). The results showed that 
patients who had indeed avoided certain situations because of their vitiligo (n=79), 
showed much higher median scores in social anxiety / avoidance (39.0), helplessness 
(29.0) and anxious-depressive mood (21.0) compared to the 39 patients who had never 
done this (medians 27.0, 21.0 and 16.0, respectively). The difference between both 
groups was highly significant in social anxiety / avoidance and helplessness (both 
***p<0.001) and significant in anxious-depressive mood (*p=0.01, both significances 
measured with a Mann-Whitney-U-test). The clear difference in the outcome of social 
anxiety / avoidance between both groups of patients provided more validation of this 
ACS sub-scale, because patients indeed avoided situations when they scored high. 
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Figure 34: Influence of hiding the disease on median ACS scores 
 
 
 
 
 
 
Figure 35: Influence of avoidant behaviour on median ACS scores 
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6.3.6 Influence of duration of disease 
 
Similar to quality of life it was our interest to find out whether or not patients were more 
affected by longer duration of vitiligo.  
Pearson correlation analysis yielded the following correlation coefficients between 
duration in years and the ACS scales for our patient group (n=422): 
 
• Social anxiety / avoidance   0.03   (p>0.05) 
• Helplessness    -0.41   (p>0.05) 
• Anxious-depressive mood  -0.015   (p>0.05) 
 
Based on these results we can conclude that none of the mentioned ACS sub-scores 
correlated significantly (positively or negatively) with the duration of the disease 
(p>0.05). Hence, coping with vitiligo is not influenced by how long the patients actually 
have vitiligo. 
 
 
6.3.7 Median ACS scores in several subgroups of patient 
population 
 
Next we analysed whether any socio-demographic or other characteristics of the patient 
group influenced the outcome of the ACS questionnaire. This has been done separately 
for each of the sub-scales.  
 
Table 36 shows the results regarding social anxiety / avoidance. Our analysis of this 
part yielded that basic demographic features such as being younger or older than 35 
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years, skin colour, presence or absence of a family history of vitiligo and language did 
not influence the results of this scale (p<0.05, Mann-Whitney-U-test and 2-sided 
Independent Sample T-test).  
Also, patients who were undergoing treatment with NB-UVB activated pseudocatalase 
PC-KUS (n=259) showed no difference in their social anxiety / avoidance scores 
compared to new patients (n=164, medians 36.0 vs. 39.0, p>0.05, Mann-Whitney-U-
test). However, we found that female patients (n=286) scored significantly higher than 
male patients (n=136). The difference between their medians of 39.0 and 34.0 is 
significant (*p<0.05, Mann-Whitney-U-test). 
Interestingly, we found again higher scores in patients who think that psychological 
stress influences vitiligo (n=211) compared to the remaining 81 patients, who did not 
think so (medians  39.0 vs. 35.0, *p=0.018, Mann-Whitney-U-test).   
Finally, extended vitiligo on neck, arms, trunk and legs can make our patients more 
socially anxious / avoidant. Patients with a severe disease scored much higher. Facial 
vitiligo or heavily affected hands were not of any influence (details in Table 36). 
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Social Anxiety / Avoidance 
 
Subgroups N Mean  Median SD p values 
German 94 37.4 36.0 13.194 Language of questionnaire 
English 69 38.9 36.0 15.382 >0.05 
New patient 163 39.8 39.0 14.215 Treatment status 
Enrolled with IFPD 259 38.1 36.0 13.294 >0.05 
Male 136 35.9** 34.0* 12.388 Gender 
Female 286 40.1** 39.0* 14.063 
0.004(1) 
0.006(2) 
< 35 years  107 40.0 38.0 14.357 Age groups 
> 35 years 315 38.4 37.0 13.404 >0.05 
I-III 353 38.4 36.0 13.631 Skin phototypes 
IV-VI 69 41.0 42.0 13.688 >0.05 
Yes 108 39.1 38.0 13.866 Family history 
No 176 38.9 37.5 13.884 >0.05 
        
Yes 211 40.1* 39.0* 12.702 Psychological stress  
influential No 81 36.0* 35.0* 13.566 
0.017(1) 
0.018(2) 
Yes 60 37.7 36.5 12.537 Vitiligo caused by injuries 
No 97 37.8 36.0 12.983 >0.05 
Yes 24 39.5 36.0 13.891 Vitiligo caused by other 
diseases No 111 37.1 36.0 12.478 >0.05 
        
Little 258 39.0 38.0 13.490 Face  Severe 101 40.6 39.0 13.754 >0.05 
Little 142 39.1* 37.0* 13.985 Neck  Severe 146 42.3* 41.0* 13.201 
0.049(1) 
0.043(2) 
Little 88 38.2 36.0 14.227 Hands  Severe 281 39.6 38.0 13.554 >0.05 
Little 169 36.3*** 34.0*** 12.875 Arms  Severe 167 43.5*** 43.0*** 13.344 <0.001
(1)(2) 
Little 172 36.1*** 35.0*** 12.238 Trunk  Severe 162 42.9*** 41.0*** 13.866 <0.001
(1)(2) 
Little 203 38.1** 35.0** 13.508 
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Legs  Severe 142 42.6** 41.0** 13.429 0.002
(1)(2) 
        
Yes 95 36.7 35.0 12.945 Do you do any sports or do 
you have a hobby? No 27 40.3 39.0 16.186 >0.05 
 
Table 36: Median Social Anxiety / Avoidance scores in several subgroups of the 
patient population 
Significances were measured with a 2-sided Independent Sample T-test (1)and a Mann-
Whitney-U-test(2).      
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The results regarding helplessness and anxious-depressive mood are similar. As shown 
in Table 37 and Table 38, women with vitiligo (n=286) felt much more helpless and 
anxious-depressive compared to male patients (n=136). The differences between their 
median scores (29.0 vs. 26.0 and 21.0 vs. 16.5, respectively) are highly significant 
(**p<0.005 and ***p<0.001, Mann-Whitney-U-test).   
 
Perceived psychological stress was again influential on well-being of our patients. 
Members of the group who agreed to that this factor is influential (n=211), scored much 
higher in helplessness and anxious-depressive mood compared to the remaining 81 
patients who did not think so (medians 29.0 vs. 26.0 and 21.0 vs. 17.0). These 
differences are significant (***p<0.001 in anxious-depressive mood and *p<0.05 in 
helplessness, Mann-Whitney-U-test). 
 
The results in Table 37 and Table 38 also show that disease severity on different body 
parts influences coping with vitiligo. Patients with severe vitiligo on their arms and 
trunk were more helpless and anxious-depressive compared to those patients with only 
minor vitiligo. Moreover, when patients had extended vitiligo on their legs, they were 
also more helpless (significances range from ***p<0.001 to *p<0.05, Mann-Whitney-
U-test, details in Table 37 and Table 38).  
 
Finally, when we looked at patients who were treating their vitiligo with NB-UVB 
activated pseudocatalase PC-KUS (n=259), we found them less anxious-depressive 
compared to those patients not undergoing treatment (n=163). The difference between 
both median scores (19.0 vs. 20.5) was significant (*p<0.05), but this was not the case 
in helplessness (p>0.05, Mann Whitney-U-test). 
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Helplessness 
 
Subgroups N Mean  Median SD p values 
German 94 26.7 25.5 7.772 Language of questionnaire 
English 69 28.5 28.0 9.198 >0.05 
New patient 163 28.3 29.0 8.102 Treatment status 
Enrolled with IFPD 259 27.3 27.0 8.280 >0.05 
Male 136 25.9** 26.0** 7.865 Gender 
Female 286 28.5** 29.0** 8.267 0.003
(1)(2) 
< 35 years  107 28.9 28.0 8.713 Age groups 
> 35 years 315 27.3 27.0 8.008 >0.05 
I-III 353 27.5 27.0 8.064 Skin phototypes  
IV-VI 69 28.8 29.0 8.910 >0.05 
Yes 108 27.8 27.0 7.633 Family history 
No 176 28.2 29.0 8.773 >0.05 
        
Yes 211 28.8* 29.0* 7.947 Psychological stress  
influential No 81 25.8* 26.0* 8.183 
0.005(1) 
0.013(2) 
Yes 60 27.8 26.5 7.793 Vitiligo caused by injuries 
No 97 27.9 29.0 8.622 >0.05 
Yes 24 29.2 30.0 8.283 Vitiligo caused by other 
diseases No 111 27.1 27.0 8.500 >0.05 
        
Little 258 28.0 28.0 8.272 Face  Severe 101 28.0 28.0 8.360 >0.05 
Little 142 27.9 28.0 8.384 Neck  Severe 146 28.8 29.5 8.208 >0.05 
Little 88 27.2 27.0 8.071 Hands  Severe 281 28.0 28.0 8.231 >0.05 
Little 169 26.7** 26.0** 7.669 Arms  Severe 167 29.5** 30.0** 8.395 0.002
(1)(2) 
Little 172 26.8* 27.0* 8.032 Trunk  Severe 162 28.8* 29.0* 8.343 
0.024(1) 
0.038(2) 
Little 203 27.3* 27.0* 7.861 
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Legs  Severe 142 29.1* 29.0* 8.315 
0.04(1) 
0.032(2) 
        
Yes 95 27.1 26.0 8.139 Do you do any sports or do 
you have a hobby? No 27 28.3 30.0 9.272 >0.05 
 
Table 37: Median Helplessness scores in several subgroups of the patient 
population 
Significances were measured with a 2-sided Independent Sample T-test (1) and a Mann-
Whitney-U-test(2).  
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Anxious-depressive mood 
 
Subgroups N Mean  Median SD p values 
German 94 20.4 20.0 6.368 Language of questionnaire 
English 69 19.6 18.0 7.993 >0.05 
New patient 163 21.3* 20.5* 7.001 Treatment status 
Enrolled with IFPD 259 19.5* 19.0* 6.279 
0.009(1) 
0.023(2) 
Male 136 18.2*** 16.5*** 6.286 Gender 
Female 286 21.2*** 21.0*** 6.560 <0.001 
< 35 years  107 20.9 20.0 6.924 Age groups 
> 35 years 315 20.0 20.0 6.511 >0.05 
I-III 353 20.2 20.0 6.505 Skin phototypes groups 
IV-VI 69 20.2 20.0 7.229 >0.05 
Yes 108 20.3 20.0 6.268 Family history 
No 176 20.5 20.5 7.217 >0.05 
        
Yes 211 21.4*** 21.0*** 5.948 Psychological stress  
influential No 81 17.5*** 17.0*** 6.103 <0.001
(1)(2) 
Yes 60 20.3 20.0 5.565 Vitiligo caused by injuries 
No 97 19.3 20.0 6.610 >0.05 
Yes 24 21.4 22.0 7.672 Vitiligo caused by other 
diseases No 111 19.0 19.0 6.062 >0.05 
        
Little 258 20.6 20.0 6.422 Face  Severe 101 20.0 19.0 6.231 >0.05 
Little 142 20.4 21.0 6.544 Neck  Severe 146 21.2 20.0 6.483 >0.05 
Little 88 20.6 20.0 7.047 Hands  Severe 281 20.5 20.0 6.376 >0.05 
Little 169 19.0*** 19.0*** 6.006 Arms  Severe 167 21.9*** 22.0*** 6.645 <0.001
(1)(2) 
Little 172 19.1*** 19.0*** 6.250 Trunk  Severe 162 21.7*** 22.0*** 6.333 <0.001
(1)(2) 
Little 203 20.0 20.0 6.357 
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Legs  Severe 142 21.2 21.0 6.940 >0.05 
        
Yes 95 19.9 19.0 6.851 Do you do any sports or do 
you have a hobby? No 27 20.6 20.0 7.313 >0.05 
 
Table 38: Median Anxious-depressive Mood scores in several subgroups of the 
patient population 
Significances were measured with a 2-sided Independent Sample T-test (1) and a Mann-
Whitney-U-test(2). 
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6.4 Beck Depression Inventory (BDI) 
 
 
6.4.1 Comparison of patients and healthy controls 
 
Since there is no agreement in the literature about the role of depression in vitiligo, it 
was our interest to find out, how depressive our patients are compared to healthy 
controls.  
A direct comparison of both groups’ scores yielded that the median BDI score of the 
patients (5.0, n=123) was higher than in the control group (3.0, n=51, *p=0.02, Mann-
Whitney-U-test). However, comparison of the means (6.8 vs. 5.1) showed no significant 
difference (p>0.05, Independent Sample T-test, Table 39). 
Since the skewness coefficient is 1.114, there is no normal distribution of our patients’ 
BDI scores.  
 
Taken together, we can conclude that our patients are generally more depressed than 
healthy controls.  
 
 
Groups N Mean Median SD p value 
Patients 123 6.8 5.0* 6.689  
Healthy controls 51 5.1 3.0* 7.242 
>0.05(1)
0.02(2)
 
 
Table 39: BDI scores in patients with vitiligo and healthy controls 
Significances were measured with 2-sided Independent Sample T-test(1) and Mann-
Whitney-U-test(2). 
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A more detailed assessment of whether patients are more depressed is based on the 
distribution of cases throughout the BDI categories (not depressed, moderately 
depressed, etc). The results of this analysis are presented in Table 40 showing that less 
patients than controls are in the no depression category (72.4% / n=89 vs. 82.4% / 
n=42) and more patients than controls are mild-moderately depressed (21.1% / n=26 vs. 
13.7% / n=7) and moderately-severely depressed (5.7% / n=7 vs. 2.0% / n=1). However, 
these differences are not statistically significant as measured with the Pearson Chi-
Square test (p>0.05, Table 40). 
 
Taken together, patients with vitiligo are more depressed compared to healthy controls. 
However, the difference is statistically weak and cannot be confirmed by distribution 
analysis of cases in the BDI categories. 
 
 
 
 
 
 
    BDI categories Patients 
Healthy 
controls 
N 89 42 No depression 
  % 72.4 82.4 
N 26 7 Mild-moderate depression 
% 21.1 13.7 
N 7 1 Moderate-severe depression 
% 5.7 2.0 
N 1 1 
 
Severe depression 
% 0.8 2.0 
 Total N 123 51 
 
 
Table 40: Frequencies of cases in BDI categories in patients and healthy controls 
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6.4.2 BDI scores in several subgroups of the patient population 
       
Next we loked at differences between demographic or other subgroups of our patient 
group.  
The results are listed in Table 41 and show that most of the characteristics were not 
influential on levels of depression, i.e. age group, skin colour, presence / absence of a 
family history of vitiligo, Koebner phenomenon and disease severity on most of the 
body parts (all p>0.05, Mann-Whitney-U-test). 
However, we found a median score of 7.0 of our female patients (n=77), which was 
much higher than the median score of our male patients (2.5, n=46). This difference is 
highly significant (**p=0.001, Mann-Whitney-U-test).  
Since there was a strong effect of perceived psychological stress on DLQI and ACS 
scores, we were interested whether this was also the case in the BDI. The results further 
supported that there is indeed a strong effect, because patients, who believed that 
psychological stress is influential (n=44), scored much higher in the BDI compared to 
those patients who did not think so (n=24). The difference between the median scores 
(8.0 vs. 2.5) is highly significant as measured with a Mann-Whitney-U-test 
(***p<0.001, Table 41). 
As mentioned above, disease severity on different body parts proved not to be 
influential, apart from the trunk. Patients with extended vitiligo on their trunk (n=36) 
were much more depressed compared to patients with only minor vitiligo (n=50) based 
on their median BDI scores (7.0 vs. 3.0, *p=0.008, Mann-Whitney-U-test). 
Interestingly, patients who used the German-language questionnaire (n=72) scored 
higher in the BDI than those who filled out the English version (n=49, medians 7.0 vs. 
3.0, *p=0.013, Mann-Whitney-U-test). This difference was not observed in the other 
questionnaires.      
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Beck Depression Inventory 
 
Subgroups N Mean Median SD p values 
German 72 7.7 7.0* 6.552 Language of questionnaire 
English 49 5.6 3.0* 6.849 
>0.05(1) 
0.013(2) 
New patient 74 7.7 6.5 7.374 Treatment status 
Enrolled with IFPD 49 5.4 3.0 5.267 
0.06 
Male 46 4.5** 2.5** 5.913 Gender 
Female 77 8.2** 7.0** 6.782 
0.003(1) 
0.001(2) 
< 35 years  37 6.1 4.0 6.464 Age groups 
> 35 years 86 7.1 5.5 6.802 
>0.05 
I-III 100 6.8 5.0 6.272 Skin phototypes 
IV-VI 21 7.0 2.0 8.746 
>0.05 
Yes 37 5.7 4.0 5.851 Family history 
No 81 7.3 5.0 6.871 
>0.05 
        
Yes 44 9.1*** 8.0*** 6.703 Psychological stress  
influential No 24 3.4*** 2.5*** 3.437 <0.001
(1)(2) 
Yes 30 6.4 5.0 5.957 Vitiligo caused by injuries 
No 36 6.5 5.0 5.710 
>0.05 
Yes 9 6.8 5.0 7.085 Vitiligo caused by other 
diseases No 44 6.6 5.0 5.955 
>0.05 
        
Little 76 6.5 4.0 6.865 Face  Severe 32 7.7 7.0 6.855 
>0.05 
Little 38 7.4 5.0 6.533 Neck  Severe 35 6.5 5.0 7.640 
>0.05 
Little 26 7.0 6.0 6.155 Hands  Severe 78 6.8 4.5 6.688 
>0.05 
Little 48 6.1 4.0 5.904 Arms  Severe 43 7.3 6.0 7.210 
>0.05 
Little 50 4.6* 3.0* 5.126 Trunk  Severe 36 8.3* 7.0* 7.162 
0.007(1) 
0.008(1) 
Little 53 6.5 4.0 6.447 
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Legs  Severe 38 7.5 5.5 7.240 
>0.05 
        
Yes 86 7.0 5.0 7.069 Do you do any sports or do 
you have a hobby? No 22 6.4 5.0 5.473 >0.05 
 
Table 41: BDI scores in several subgroups of the patient population 
Significances were measured with a 2-sided Independent Sample T-test (1) and a Mann-
Whitney-U-test(2). 
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6.4.3 Influence of gender 
 
As already shown in Table 41, female patients showed significantly increased BDI 
scores compared to males. Therefore, we wanted to know how female and male patients 
are distributed throughout the BDI categories.  We performed crosstabulation (Table 
42), which revealed that many more women than men are mild-moderately depressed 
(29.9% / n= 23 vs. 6.5% / n=3) and more men than women are not depressed (87.0% / 
n=40 vs. 63.9% / n=49). There are no differences regarding moderate-severe depression 
and severe depression. The differences in all categories between women and men are 
significant as measured with the Pearson Chi-Square test (*p=0.016).  
 
Based on the median scores and the distribution of cases in the BDI categories, we can 
conclude that women with vitiligo are generally more depressed compared to male 
patients. 
 
Gender 
       BDI categories Male Female 
N 40 49 Not depressed 
  % 87.0 63.6 
N 3 23 Mild-moderate depression 
% 6.5 29.9 
N 3 4 Moderate-severe depression 
% 6.5 5.2 
N 0 1 
 
 
 
 
 
Severe depression 
  % 0.0 1.3 
Total N 46 77 
 
 
Table 42: Distribution of females and males in BDI categories 
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6.4.4 Influence of age on BDI scores 
 
Our next aim was to find out whether levels of depression of patients with vitiligo 
depended on their age.  
Pearson correlation analysis between age in years and the BDI scores yielded a 
correlation coefficient of 0.089 (n=123) indicating that there is neither a negative nor 
positive correlation between BDI scores and age (p>0.05).  
Next we looked at single age groups to test whether the members of any age group are 
more depressed (Table 43). We found indeed a significant difference between the age 
groups analysed (*p<0.05, Kruskal-Wallis-test). However, there is no clear tendency. 
The lowest BDI score was found in the youngest patients (n=4, <20 years old, median 
1.0) followed by the middle-aged patients (30-39 years, n=34, median 4.0 and 40-49 
years old, n=42, median 3.0). Interestingly, patients between 20 and 29 years as well as 
between 60 and 70 years scored highest in the BDI (median 8.5 / n=16 and 9.0 / n=10, 
respectively).  
 
Taken together, levels of depression do not automatically increase or decrease with age. 
Teenagers and middle-aged patients were least depressed.  
 
Age groups (years) N Mean Median SD p value 
<20 4 1.3 1.0 1.500 
20-29 16 10.4 8.5 7.126 
30-39 34 5.7 4.0 5.572 
40-49 42 5.5 3.0 5.899 
50-59 17 8.0 7.0 7.778 
60-70 10 10.1 9.0 8.825 
0.03(1) 
0.023(2) 
 
Table 43: BDI scores in different age groups 
Significances were measured with a one-way ANOVA test(1) (means) and Kruskal-
Wallis-test(2)   
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6.4.5 Influence of age of disease onset on BDI scores 
 
It has also been of interest whether age at disease onset had any influence on 
depression. In order to assess this, we performed Pearson correlation analysis, which 
yielded a correlation coefficient of 0.071 (n=122) again indicating that there is neither a 
positive nor a negative correlation between BDI scores and age of disease onset 
(p>0.05).  
Although there is no linear correlation, it might still be possible that certain age at 
disease onset groups are more prone to depression. Therefore, we examined the BDI 
scores of each group in more detail. There are apparent differences between patients 
with a disease onset in their teenage years (12-19 years, n=30, median BDI score 3.5) 
and patients with an onset after their 40th birthday (40-59 years, n=15, median 7.0, 
Table 44). However, these differences are not significant as measured by a Kruskal-
Wallis-test. 
 
Taken together, age at disease onset does not influence levels of depression, because 
there is neither a linear correlation nor are there any groups of age at disease onset more 
depressed than others. 
 
 
Age at onset  
(years) N Mean Median SD p value 
0-11 19 6.4 5.0 5.910 
12-19 30 6.2 3.5 6.727 
20-39 57 7.4 5.0 7.114 
40-59 15 6.7 7.0 6.519 
>60 1 0.00 0.0 -- 
>0.05 
 
 
Table 44: BDI scores in different groups of age at disease onset  
Significances measured with a one-way ANOVA (means) and Kruskal-Wallis-test. 
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6.4.6 Influence of duration of disease 
 
Next we asked the question whether duration of vitiligo has any influence on levels of 
depression. For this purpose we performed Pearson correlation analysis and calculated a 
correlation coefficient of 0.011 (n=122) which implied that there is neither a positive 
nor a negative significant correlation between levels of depression and duration of the 
disease (p>0.05).  
 
6.4.7 BDI and avoidant behaviour 
 
Since there was a strong association between avoidant behaviour, especially hiding 
white spots, and both the other questionnaires’ scores, we wanted to know whether this 
also applied to the  Beck Depression Inventory. 
 
 
Hiding of white spots correlates with depression 
 
 A comparison of median BDI scores depending on frequencies of hiding vitiligo 
(Figure 36) revealed that the more often patients hide their white spots in front of other 
people the more depressed these patients are. Patients, who had done this very often, 
scored highest in the BDI (median 8.5, n=32), followed by the quite often group 
(median 5.5, n=38) and the very rarely group (median 3.0, n=26). The lowest score was 
found in patients, who had never hidden their white spots (median 1.0, n=13). The 
difference between the scores is highly significant as measured with a Kruskal-Wallis-
test (***p<0.001).  
To further substantiate this finding, we analysed the distribution of patients with 
different frequencies of hiding vitiligo throughout the BDI categories (Table 45).  The 
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results revealed that the more often vitiligo was hidden, the more likely these patients 
can be found in mild-moderate-severe depression categories and less likely in the not 
depressed category. These differences are significant (Pearson Chi-Square test, 
*p=0.016) (Table 45).  
 
 
Figure 36: Influence of hiding the disease on median BDI scores 
 
 
 
  
 
 
Table 45: Distribution of patients in BDI categories according to frequency of 
hiding vitiligo 
 
Have you ever hidden your white spots? 
       BDI categories Never 
Very 
rarely 
Quite 
often 
Very 
often 
N 13 24 26 17 Not depressed  
% 100.0 92.3 68.4 53.1 
N 0 2 10 9 Mild-moderate depression 
% 0.0 7.7 26.3 28.1 
N 0 0 2 5 Moderate-severe depression  
% 0.0 0.0 5.3 15.6 
N 0 0 0 1 
 
Severe depression 
% 0.0 0.0 0.0 3.1 
N 13 26 38 32 Total 
 % 100.0 100.0 100.0 100.0 
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The second indicator of avoidant behaviour in this thesis is, whether patients had 
avoided situations because of their vitiligo. In order to find out whether such behaviour 
could influence depression levels, we compared the median BDI scores of patients who 
had avoided situations (5.5, n=70) to those who had never done this (3.0, n=35). The 
difference between both scores was significant (*p<0.05, Mann Whitney-U-test).  There 
is no significantly different distribution of both groups in the BDI categories (data not 
shown, p>0.05, Pearson Chi-Square test). 
It can be concluded that patients with vitiligo, who tend to avoid situations because of 
their disease, are more depressed. 
 
 
 
 
Subgroups N Mean BDI Median SD p value 
Yes 70 7.7*** 5.5* 7.158 Have you ever avoided certain 
situations because of your vitiligo?  Never  35 4.7*** 3.0* 4.892 
<0.001(1) 
<0.034(2) 
 
Table 46: BDI and avoidant behaviour  
Significances were measured with a 2-sided Independent sample T-test (1) and a Mann-
Whitney-U-test(2). 
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6.5 The outcome of our study 
 
Finally, we wanted to know whether the results from the three adult questionnaires 
utilised in this thesis were supporting one another. In order to achieve this aim, we 
employed Pearson correlation analysis for each questionnaire against the two other 
questionnaires. 
The results are shown in Table 47. We found a positive correlation for all items of 
interest (**p<0.005). 
 
Taken together, patients with vitiligo had an impaired quality of life along with 
increased levels of social anxiety / avoidance, helplessness, anxious-depressive mood 
and depression. This result indicates that patients are most likely affected in multiple 
ways.  
 
 
 DLQI 
Social 
Anxiety / 
Avoidance 
Helplessness 
Anxious-
depressive 
mood 
BDI 
DLQI 
-- 
 
    
Social Anxiety / 
Avoidance 
0.768** 
(n=164) 
--    
Helplessness 
0.676** 
(n=164) 
0.840** 
(n=422) 
--   
Anxious-
depressive mood 
0.565** 
(n=164) 
0.659** 
(n=422) 
0.615** 
(n=422) 
--  
BDI 
 
0.527** 
(n=122) 
0.517** 
(n=122) 
0.475** 
(n=122) 
0.661** 
(n=122) 
-- 
 
Table 47: Correlations of all questionnaires with one another (Pearson correlation 
coefficients) 
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6.6 Children patient population and control group 
 
 
6.6.1 Controls 
 
Eighteen children without vitiligo or other skin diseases served as controls. 13 were 
girls and 5 were boys. They were enrolled with a private paediatric practice and were 
treated for diseases not affecting the skin.  The mean age of the control group was 9.3 
years, median 9 years ranging from 6 to 13 years.  All controls were German-speaking 
and had fair skin phototypes II or III (Fitzpatrick classification). 
The control group was sex-matched to our patient group (p>0.05, Chi-Square test), but 
different regarding  
 
• age (slightly younger, p=0.022, Independent Sample T-Test; p=0.026, Mann-
Whitney-U-test),  
• language (p<0.001, Chi-Square test) and 
•  skin phototypes (p=0.003, Chi-Square test). 
 
 
6.6.2 Children / adolescents of the patient group 
 
A total of 103 children and adolescents, aged from 5 to 17 years (mean age 11.1, 
median 11.0 years, SD 3.226) took part in this project. Fourty were boys (38.8 %) and 
63 were girls (61.2 %). 
The majority of participants (n=79, 76.7%) was not enrolled with the Institute for 
Pigmentary Disorders. The remaining 24 children (23.3%) were already enrolled and 
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undergoing treatment for vitiligo using narrow-band UVB activated pseudocatalase PC-
KUS. 
The German-language questionnaire was used by 61 participants (59.2%), whereas the 
remaining 42 children used the English-language questionnaire (40.8%). 
 
The majority of participating children had fair skin phototypes I-III (69.3%, n=70/101). 
About one third (n=31, 31%) had the darker skin phototypes IV to V (Figure 37). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37: Distribution of skin phototypes in the patient population (n=101, n=2 
missing) 
  
44% 
21%29% 
4% 2% (n=4) 
(n=21) 
(n=45) 
(n=29) 
(n=2) 
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6.6.3 Disease severity 
 
 
Disease severity was assessed by the parents. The results revealed that the legs were 
most often mentioned as severely affected, followed by trunk and hands. Least often 
mentioned were face and arms (Table 48). 
 
 
 Body parts affected N % 
1 58 72.5 
2 22 27.5 
Face  
Total 80 100.0 
Not affected or missing 23  
Total 103  
1 29 59.2 
2 20 40.8 
Neck  
 
Total 49 100.0 
Not affected or missing 54  
Total 103  
1 26 45.6 
2 31 54.4 
Hands  
 
Total 57 100.0 
Not affected or missing 46  
Total 103  
1 38 59.4 
2 26 40.6 
Arms  
 
Total 64 100.0 
Not affected or missing 39  
Total 103  
1 36 45.0 
2 44 55.0 
Trunk  
 
Total 80 100.0 
Not affected or missing 23  
Total 103  
1 27 32.5 
2 56 67.5 
Legs  
 
Total 83 100.0 
Not affected or missing 20  
Total 103  
 
Table 48: Disease severity in children as assessed by their parents 
 
1- Slightly affected, 2- Severely affected 
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6.6.4 Disease onset in children 
 
Similar to the adults, we wanted to find out where the first spot appeared on the affected 
child. It was our special interest whether this was also predominantly on exposed parts 
as it was documented in the adult population. The location most often mentioned by the 
parents was the trunk (20.3%, n=12), followed by the legs (15.3%, n=9) and equally 
knees and head (10.2%, n=6 each). Least often mentioned as single body parts were 
hands and feet (Table 49). 
In conclusion, the most common sites of disease onset in children were not the exposed 
parts as in the adult group. 
  
 
 Body parts N % 
 Trunk 12 20.3 
 Legs 9 15.3 
 Knees 6 10.1 
 Head 6 10.1 
 Back 5 8.5 
 Arms 3 5.1 
  Genitals 3 5.1 
  Neck 3 5.1 
  Feet 2 3.4 
  Trunk + face 2 3.4 
  Legs + anogenital area 2 3.4 
  Neck + genitals 1 1.7 
  Back + grey hair 1 1.7 
  Knees + grey hair 1 1.7 
  Legs + back 1 1.7 
  Trunk + genitals 1 1.7 
  Hands 1 1.7 
  Total 59 100.0 
Missing 44  
Total 103  
 
Table 49: Sites of disease onset in the children population 
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6.6.5 Leisure time activities 
 
Besides typical demographic data we also wanted to know more about children’s leisure 
time. The main aim was to identify possible coping resources, for instance number of 
friends or active / passive leisure time activities.  
 
Leisure time is strongly connected to friendships. The question how many best friends 
the children had, was answered by only one child with ‘none’ (1%), 35 said they had ‘a 
few’ (32%) and about two thirds of the children had ‘many’ (n=67, 65%). There was no 
significant difference to the group of healthy children (p>0.05, Chi-Square test, Figure 
38), where 33% (n=6) had a few friends and 61% (n=11) had many friends. One child of 
the control group also had no friend (6%).  
 
 
 
 
Figure 38: Numbers of best friends of patients (n=103) and healthy controls (n=18) 
 
 
34%
64% 
2% 
61% 
33%
6% 
Children patients Children control group 
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The vast majority (n=90/101, 89.3%) of our children confirmed that they had a hobby or 
that they did sports in their leisure time. Only 11 children (10.7%) denied this.  There 
was no difference between girls and boys (n=35/40, 87.5% vs. n=55/61, 89.1%, 
respectively, p>0.05, Pearson Chi-Square test) (Figure 39).  
Importantly, our young patients did not do significantly less sport / hobbies compared to 
healthy controls (89.1%, n=90/101 vs. 100%, n=18, p>0.05, Pearson Chi-Square test, 
Figure 39).  
 
 
 
 
 
 
 
Figure 39: Sports / hobbies in boys and girls of the patient group (n=101) and 
healthy controls (n=18)  
 
89% 
11% 
100%
12% 
88% 90%
10%
Answers
Children patients Children control group 
(n=40) (n=61) 
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We then looked at how many different hobbies / sports our children were involved in 
our children’s lives. Data were available from 66/90 children with an actively spent 
leisure time. 24 participants neither stated what they did nor how many hobbies they 
had. About half of the former group had one hobby / preferred sport (n=36/66, 54.5%). 
More than one quarter (n=19/66, 28.9%) had two hobbies. Only a few children were 
very active as indicated by claiming 4 or more hobbies or sports (n=3/66, 4.5%, Table 
50).  
 
Numbers 
of hobbies 
N % 
  1 36 54.5 
  2 19 28.9 
  3 8 12.1 
  4 1 1.5 
  6 2 3.0 
  Total 66 100.0 
 
Table 50: Frequencies of how many hobbies children stated 
 
 
 
Next we wanted to know what exactly our children did in their leisure time. The results 
are listed in Table 51 and indicate that there is a striking diversity of activities. 
Importantly, sportive activities, where vitiligo patches might be revealed to others, were 
on the top of the list, i.e. football (7.6%, n=5), gymnastics (6%, n=4), martial arts and 
dancing (each n=4, 6%). 
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  Hobbies or sports mentioned N % 
 Football 5 7.6 
 Gymnastics 4 6.1 
 Martial art 4 6.1 
 Dancing 4 6.1 
 Dancing + making music 3 4.5 
 Handball 3 4.5 
 Football, gymnastics 2 3.0 
 Ballet 2 3.0 
 Swimming 2 3.0 
 Fitness, tennis 2 3.0 
 Football, tennis 2 3.0 
  Hip hop, dancing 1 1.5 
  Swimming, gymnastics 1 1.5 
  Swimming, riding, trampoline, equestrian vaulting, reading, playing 1 1.5 
  Judo, football 1 1.5 
  Riding, dancing, animals and plants 1 1.5 
  Basketball, singing, dancing 1 1.5 
  Riding, judo 1 1.5 
  Playing the clarinet, judo 1 1.5 
  Tennis 1 1.5 
  Chess 1 1.5 
  Riding 1 1.5 
  Hockey 1 1.5 
  Tennis, cycling, snowboarding 1 1.5 
  Dancing, riding 1 1.5 
  Reading 1 1.5 
  Inline-skating 1 1.5 
  Kart racing, martial art 1 1.5 
  Gymnastics, cycling, playing the violin 1 1.5 
  Scouting + badmington + dance 1 1.5 
  Basketball, football, fishing, rugby, swimming, watching TV 1 1.5 
  Tennis + playing the piano 1 1.5 
  Karate 1 1.5 
  Surfing, tennis, snowboarding 1 1.5 
  Basketball 1 1.5 
  Playing the piano, organ, writing 1 1.5 
  Fishing 1 1.5 
  Swimming, horse riding 1 1.5 
  “Bosseln” (unique east Frisian road sport) 1 1.5 
  Athletics 1 1.5 
  Dancing, badmington 1 1.5 
  Socialising 1 1.5 
  Football, tennis, cricket, rugby 1 1.5 
  Running 1 1.5 
 Total 66 100.0 
 
 
Table 51: Distribution of hobbies and sportive activities in our children group 
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We then analysed which season of the year the children liked best. We hoped to get a 
hint, whether they particularly liked or disliked those seasons (spring, summer) when 
short clothes might reveal their vitiligo to others (Figure 40). A comparison of both 
groups yielded a significant difference between patients and healthy children with, 
unexpectedly, patients preferring summer and spring (n=80/99, 80.8% vs. n=9/18, 
50.0%). There were no differences regarding autumn and winter. Overall, the 
differences between patients and controls are highly significant (***p<0.001, Pearson 
Chi-Square test).  
 
 
 
 
Figure 40: Analysis of the preferred seasons of the year in children patients (n=99) 
and healthy controls (n=18)  
 
 
62% 
18%
3% 
1% 
11% 
5% 
27%
11% 
33% 
17% 
6% 
6%
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However, interpretation of these results need to be done with caution, since our control 
group were children who had other diseases at the time of our investigation. This could 
lead to a false difference, especially with regards to their attitudes to the seasons. 
 
 
6.6.6 Family history and affected relatives 
 
To establish how many participants had somebody else in the family with vitiligo is 
important when searching for possible (e.g. genetical) causes for the disease. We found  
a positive family history of vitiligo in 33% (n=34) of participating children. Similar to 
the adult group, mothers and fathers were mentioned most often (20.6% / n=7 and 
14.9% / n=5). Table 52 shows a breakdown who else in the families had vitiligo. 
 
 
 
  N % 
Mother 7 20.6 
Father 5 14.9 
Sister / brother 4 11.8 
Grandfather 4 11.8 
Aunt 3 8.8 
Grandmother 2 5.9 
Father & sibling 2 5.9 
Father and aunt 1 2.9 
Grand aunt 1 2.9 
Mother + father 1 2.9 
Uncle 1 2.9 
Mother + grandmother 1 2.9 
Cousin + grandfather 1 2.9 
Mother + sibling 1 2.9 
 
Total 34 100.0 
 
Table 52: List of family members who also had vitiligo 
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6.6.7 Earlier treatments for vitiligo 
 
At the time when the participants filled out the questionnaires, only 8.7% (n=9) of all 
children had not been to a doctor because of their vitiligo. Of those 94 children who 
went to a doctor, 81% (n=76) had received some kind of treatment for vitiligo. When 
asked about which treatment modality was tried, a broad range of more or less 
successful treatment modalities was mentioned by the children (Table 53). 
 
This variety of treatment modalities reflects the current situation for patients with 
vitiligo. Many methods are attached to one of the hypotheses which try to explain 
vitiligo. As long as there is no scientific agreement on what exactly causes vitiligo, 
many treatments will remain available on the market.  
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 Treatment modalities N % 
 ‘Cream’ 10 13.6 
 Steroids 6 8.1 
 Radiation 6 8.1 
 UVB light 3 4.1 
 Elidel 3 4.1 
 Protopic 3 4.1 
 Homoeopathy 3 4.1 
 Dermavate 2 2.7 
 Cream and light 2 2.7 
 Dr. Shimshoni (Germany) 2 2.7 
 Protopic, UVB light, Dr. Matschurat (Germany) 2 2.7 
 Vitamins, steroids, radiation 2 2.7 
 UVB, Dead Sea 2 2.7 
 Protopic + Elidel 2 2.7 
 ‘Unanni’ /Indian treatment 2 2.7 
  Homoeopathy / calcium 1 1.4 
  Radiation, oxygen, special diet, cream 1 1.4 
  Vitamins + amino acids 1 1.4 
  PUVA + Protopic 1 1.4 
  Tablets 1 1.4 
  UVB, Protopic, Advantan 1 1.4 
  Saltwater bath + light therapy 1 1.4 
  Vitix, Protopic, light 1 1.4 
  Vitix + light 1 1.4 
  Elidel + UVB light 1 1.4 
  UVB, tablets and cream 1 1.4 
  Folic acid + vitamin B12 1 1.4 
  Laser 1 1.4 
  UVB, pseudocatalase, vitamins, supplements 1 1.4 
  Aloe vera 1 1.4 
  Vitamins, enzymes, radiation 1 1.4 
  Laser + cream 1 1.4 
  Vitix + Elidel + Protopic 1 1.4 
  Dead Sea 1 1.4 
  Protopic + Elidel + steroids 1 1.4 
  Protopic + Tazara 1 1.4 
  Protopic + Elidel + steroids + UVB light 1 1.4 
  Others 1 1.4 
  Total 73 100.0 
 
Table 53: Treatments received earlier by participating children 
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6.6.8 Attitudes towards vitiligo 
 
An important part of this project was to find out what the children think about their 
disease. Besides the Children’s Dermatology Life Quality Index, we included some 
direct questions about their thoughts.  
 
The first question was whether our children felt bothered by their disease. The answers 
showed that 29% of the children were not bothered by vitiligo (n=30/103). One quarter 
of the group was indeed bothered (25%, n=26), whereas 46% (n=47) felt this sometimes 
(Figure 41). If the two latter groups are taken together, then we found that 70% (n=73) 
felt at least sometimes bothered by their vitiligo.  
There was no significant difference between boys and girls (p>0.05, Chi-Square test, 
Figure 42). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 41: Levels of disturbance in children with vitiligo 
 
46%
29%
25%
(n=30) 
(n=26) 
(n=47) 
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Figure 42: Levels of disturbance in boys (n=40) and girls (n=63) with vitiligo 
 
 
 
 
 
A rather indirect question was about which spots the children preferred to disappear 
first. We postulated that the difference between spots visible to others and all spots 
might give a hint about the importance of the disease in children’s relations to other 
people (Table 54). Three quarters of children (73.5%, n=72/99) wished that all of their 
spots would disappear, only a minority would chose only those visible to others (16.3%, 
n=16/99). A few children preferred specific spots to disappear, for example legs and 
trunk+arms (each 2% / n=2). 
Taken together, our results indicate that for the children vitiligo is important as a 
disease, but it has no strong impact on their inter-personal relationships.   
 
 
 
 
 
 
50% 
n=20 
28%
n=11
22%
n=9
43%
n=27
30% 
n=19 
27% 
n=17 
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Question Answers N % 
All spots 72 73.5 
Those visible to other people 16 16.3 
Others, such as… 10 10.2 
Legs 2 2.04 
Trunk + arms 2 2.04 
Elbows and knees 2 2.04 
Knees, feet and elbows 1 1.02 
Knees, lower abdomen 1 1.02 
Legs, genitals, trunk, hands 1 1.02 
 
 
 
If you could 
have a wish 
which spots 
should 
disappear first? 
 
Genitals 1 1.02 
Total 98 100.0 
Missing 5  
 
Table 54: Preferences of children on which spots should disappear first 
 
 
 
 
 
 
 
 
 
Finally, we asked how important it was to the children that their white spots disappeared 
one day. Here we hoped to get an impression about basic thoughts about the disease 
(Figure 43). The vast majority of children wished that their white spots would 
disappear one day (79%, n=79/100, 3 missing). However, 17 children neither wished 
that nor did they care about it (17%). There was no significant difference between girls 
and boys as measured with a Pearson Chi-Square test (p>0.05, Figure 43). 
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Figure 43: Importance to children (n=100) that the white spots should disappear 
one day 
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6.6.9 Children’s behaviour and experiences 
 
This part includes questions about avoidant behaviour (as indicator if and how much 
children’s life is limited), and stigmatisation (questions by others, nasty comments,  
bullying, physical violence), because these factors have been shown to be highly 
influential on quality of life measurements.   
 
In our group there is a clear majority of children who had never avoided any situations 
because of their vitiligo (70.4%, n=69/98, n=5 missing). There are differences between 
the genders with girls being more likely to avoid situations (38%, n=23/60) compared to 
boys (16%, n=6/38; *p=0.014, Pearson Chi-Square test) (Figure 44). 
 
 
 
 
Figure 44: Avoidant behaviour in children with vitiligo (n=98) 
 
(n=60) (n=38) 
70%
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30%
n=29
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n=6 
84% 
n=32 
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Furthermore, we wanted to know which situations exactly were avoided by the children, 
because this has rarely been reported in the literature.  
The children of our group particularly avoided swimming / bathing (44.8%, n=13/29), 
followed by undressing in changing rooms (13.8%, n=4/29) and talking to other people 
(7%, n=2/29). Some children stated two or more different situations (Table 55). 
 
 
 
     Question                           Answers N % 
Swimming / bathing 13 44.8 
Undressing in changing rooms 4 13.8 
Talking to other people 2 7.0 
Swimming / bathing  
+ sports 
2 7.0 
Swimming  / bathing  
+ undressing in changing rooms 
2 7.0 
Doing sports 1 3.4 
Shaking hands 1 3.4 
Avoiding sun in summer 1 3.4 
Swimming / bathing  
+ sports  
+ talking to other people  
+ wearing shorts in summer 
1 3.4 
Swimming / bathing  
+ sports  
+ talking to other people  
+ undressing in changing rooms 
1 3.4 
 
 
 
 
 
 
 
Have you ever 
avoided certain 
situations because 
of your vitiligo? 
Swimming / bathing  
+ shaking hands  
+ undressing in changing rooms 
1 3.4 
  Total 29 100.0 
 
Table 55: Frequencies of avoided situations 
Multiple answers were possible. 
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We then looked at possible reasons for avoidant behaviour. Consequently, we set 
avoidant behaviour in relation to socio-demographic and disease-related characteristics 
(skin colour, gender, new patients / enrolled with the IFPD etc). There were no 
differences regarding any of the subgroups (all p>0.05, Pearson Chi-Square test) with 
two exceptions: 
Children who felt bothered by their vitiligo reported more often to have avoided 
situations (62.5%, n=15/24) compared to those who did not care about the disease 
(24.1%, n=7/29). This difference was highly significant (***p<0.001, Pearson Chi-
Square test, Table 56). This result indicates that the question about being bothered has 
been answered honestly. 
 
 
 
Do your white spots bother you?   
 No Yes Sometimes 
N 7 15 7 Yes 
  %  24.1 62.5 15.6 
N 22 9 38 
Have you ever avoided 
certain situations because 
of your vitiligo? Never 
  %  75.9 37.5 84.4 
Total N 29 24 45 
 
Table 56: Avoidant behaviour depending on levels of disturbance by vitiligo 
 
  
 
 
Moreover, we also tested whether avoidant behaviour depended on stigmatising 
experiences. While there was no relation to approaches / questions (p>0.05, Pearson 
Chi-Square test), the picture regarding nasty comments is different. The results showed 
that the more often our children had experienced that they were picked on, the more 
likely they were to avoid situations because of their vitiligo (Table 57). Almost two 
thirds of all children who had been picked on stated that they had avoided situations 
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(62.5%, n=5/8), whereas this was 17.3% only in the group who were never subjects to 
nasty comments (n=9/52). This difference was significant as measured with a Pearson 
Chi-Square test (*p=0.008). 
 
 
 
Have you ever been picked on because of your 
vitiligo? 
  
  
  
  Yes, very often Yes, sometimes No 
Yes N 5 15 9 
  %  62.5 39.5 17.3 
Never N 3 23 43 
Have you ever 
avoided certain 
situations because 
of your vitiligo?   %  37.5 60.5 82.7 
Total N 8 38 52 
 
 Table 57: Avoidant behaviour depending on stigmatising experiences 
 
 
 
 
 
 Although stigmatisation has been shown to be influential on children with vitiligo 
(Linthorst Homan et al. 2008), this phenomenon has hardly been investigated so far in 
children with this disease. Therefore, we included questions about how often and what 
kind of stigmatisation was experienced by our children group.  
Importantly, we found that only 6% of participating children (n=6/99) had not 
experienced that other people made comments about the white spots and / or asked 
questions about their disease. A considerable proportion had experienced this even very 
often (41%, n=41/99, Figure 45). Girls were more frequently asked questions very often 
compared to boys (46% / n=28/61 vs. 34% / n=13/38), but this difference was not 
significant (p>0.05, Pearson Chi-Square test). 
Taken together, stigmatisation on a low level is a very common experience of boys and 
girls with vitiligo. 
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Experiences of nasty comments or that our children were picked on were not as frequent 
as questions / approaches by other people. We found that about half of our children 
group had experienced nasty comments (8% / n=8/99 very often and 39% / n=39/99 
sometimes). Girls (n=61) seemed to have experienced this more frequently (52% / 
n=32/61 very often + sometimes) compared to the 38 boys (40%, n=15/38). However, 
the difference is not significant (p>0.05, Pearson Chi-Square test, Figure 46).  
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A third indicator of stigmatisation concerns bullying. The vast majority of our children 
had not been bullied because of their vitiligo (81%, n=34/42, Figure 4714). However, 
14% reported that they had been bullied quite often (n=6/42) and another 5% said that 
this happened even very often (n=2/42). Nobody of the boys was bullied very often, 
whereas 12% had experienced this quite often (n=2/17). The numbers are higher for the 
girls (8% / n=2/25 very often and 16% / n=4/25 quite often). Nevertheless, the 
difference between boys and girls is not significant (p>0.05, Pearson Chi-Square test) 
(Figure 47). 
 
 
 
 
 
Figure 47: Frequencies of bullying because of vitiligo 
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Almost no child had ever experienced physical violence because of its vitiligo. One 
child out of the 56 German children, who were exclusively asked this question, reported 
to have been beaten once. Taken together, physical violence because of vitiligo among 
children is extremely rare.  
 
 
 
  
6.6.10 Support 
 
We had not only the intention to obtain data on (negative) experiences, but also on 
levels of support our children received. Support by other people seems to be important, 
for example to prevent situations from escalating or to prevent or limit any long-term 
effects on a child’s emotions.  
 
We therefore asked our children, who exactly supported them in those situations when 
they were being bullied, picked on or otherwise subject to stigmatisation. Table 58 
shows who mostly came to help the children. The results revealed that about one third 
of children with vitiligo had never experienced support in critical situations (30.8%, 
n=24/78). Secondly, if support was given by somebody, friends and members of the 
family were the most important sources of help in those situations (first three ranks 
n=47/54, 87%, Table 58). Occasionally, other persons were mentioned, for example 
teachers (n=3), strangers or a clerk in a department store (each n=1). 
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  N % 
No 24 30.8 
Yes, by friends  
+ members of family 
18 23.1 
Yes, by friends 17 21.8 
Yes, by members of family 12 15.4 
Yes, by friends  
+ members of family  
+ teachers 
3 3.7 
Yes, by others 1 1.3 
Yes, by friends 
+ members of family  
+ strangers 
1 1.3 
Yes, by members of family  
+ teachers 
1 1.3 
 
 
 
Have you ever 
received help in 
those situations of 
being picked upon 
or being bullied? 
Yes, by members of my family  
+ by a clerk in a department store 1 1.3 
  Total 78 100.0 
Missing 25  
Total 103  
 
Table 58: List of supporting persons in critical situations 
 
 
 
 
 
We focussed not only on persons who actually helped children with vitiligo, we also 
wanted to know who were the preferred contacts in the case of a problem with 
somebody because of the disease. The majority of our children group would seek 
support from their mothers or their parents in general (46.3%, n= 25/54 and 16.7%, 
n=9/54, respectively). Other sources such as fathers, teachers (n=2 each)  and sisters 
(n=1) were mentioned less often (Table 59). 
Only 3 children (5.6%) said that they would not contact anybody when they just had a 
problem with somebody else because of their vitiligo. 
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   Question                        Answer N % 
Mother 25 46.3% 
Parents 9 16.7% 
My best friend(s) 5 9.3% 
Mother and best friend 3 5.5% 
I would never tell anybody 3 5.5% 
Family 2 3.6% 
Father 2 3.6% 
Sister 1 1.9% 
Family + school friends 1 1.9% 
Mother + teacher 1 1.9% 
Parents + teachers 1 1.9% 
 
 
Which person 
would you 
contact first 
when you just 
had a problem 
with another 
person because 
of your vitiligo? 
  
Best friend + sister 1 1.9% 
  Total 54 100.0% 
Missing 49  
Total 103   
 
Table 59: Contacts of first choice for children after critical situations  
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6.7 Children’s Dermatology Life Quality Index scores 
  
6.7.1 CDLQI main score 
 
The Children’s Dermatology Life Quality Index has been filled out by 103 children. 
The mean score for this population was 2.7 (SD 3.504), the median 1.0. These scores 
are significantly higher than the ones of the 18 members of the control group (mean 0.6 
and median 0.0, **p=0.004, Mann-Whitney-U-test and *p=0.014, Independent Sample 
T-test). The patients’ scores also showed a wider range (Figure 48). 
  
 
 
 
 
 
 
Figure 48: CDLQI scores from children with vitiligo (n=103) and healthy controls 
(n=18) 
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We then applied distribution and skewness analysis to obtain more details about the 
disease-related quality of life of the young patients and controls. Figure 49 and Figure 
50 show that the scores are clearly positively skewed, which is confirmed by the 
calculated skewness coefficient of 2.109 for the patients. 
This result indicates that there were much more scores below the mean of 2.7 than 
above. Consequently, the median of 1.0 is the more appropriate number to reflect the 
central tendency of quality of life in our patient group. 
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Figure 49: Distribution analysis of CDLQI scores of children with vitiligo (n=103) 
 
 
 
 
Figure 50: Distribution analysis of CDLQI scores of healthy controls (n=18)  
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Similar to our adult population, we grouped the children according to their CDLQI 
scores (Table 60). The results revealed that about 88% of our children group are hardly 
affected in their quality of life (50.5%, n=52 not affected and 37.9%, n=39 minor 
impairement). Seven children had a moderately impaired quality of life (6.8%), whereas 
there were only 5 children (4.9%) whose quality of life was severely affected by vitiligo 
(Table 60).  
 
 
 
 
CDLQI scores Impact on quality of life N % 
0-1 None 52 50.5 
2-5 Minor 39 37.9 
6-10 Moderate 7 6.8 
11-20 Severe 5 4.9 
21-30 Extreme 0 0.0 
 
Table 60: CDLQI scores in our patient group (n=103) according to Gajur’s 
grouping order (Gajur 2008) 
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6.7.2 Single item analysis of the CDLQI for several subgroups of 
children population 
 
Single item analysis of the CDLQI can provide much more detailed information than 
the main score alone as each of the 10 questions can be linked to a essential part of 
children’s daily life (friendships, school, going out / playing, wearing of clothes etc). 
Therefore, all 10 single items were investigated regarding demographic and other 
factors. 
 
Single item analysis revealed no influence of the following charcteristics on quality of 
life:   
 
• whether children went to a doctor before,  
• whether or not they were enrolled with the Institute for Pigmentary Disorders, 
• gender and skin colour, 
• how many best friends the children had, 
• how important it was to the children that their white spots would disappear one day 
 
(data not shown, all p>0.05, Mann-Whitney-U-test and Independent sample T-test).  
 
A comparison of all 103 patients’ scores yielded that vitiligo had the strongest effect on 
emotional reactions, i.e. embarrassment, sadness, upset (mean 0.5), followed by 
outdoor activities (0.4 in swimming / other sports, 0.3 in going out  / hobbies and 
wearing clothes / shoes). The least influenced parts were friendships (0.0) and sleep 
(0.1). Surprisingly, there was a high score in physical symptoms (0.4), even though 
vitiligo normally does not cause any physical sensations, apart from occasional itching 
in actively spreading vitiligo (Figure 51). 
21
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Interestingly, when analysing for differences between German and English-speaking 
children, we found some between both language groups. Swimming / sport and wearing 
of clothes were less impaired in German-speaking patients (mean 0.2 each, n=61) 
compared to their English-speaking counterparts (means 0.6 and 0.5, respectively, 
n=42).  Both differences were significant when measured with a Mann-Whitney-U-test 
(*p<0.05). There were no other significant differences in any of the other single items 
and regarding the total CDLQI  scores (Table 61).  
 
 
 
CDLQI items                       Language N Mean  SD p value 
1 61 0.5 .676 Question 1 
Physical symptoms 2 42 0.4 .692 
>0.05 
1 61 0.6 .851 Question 2 
 Emotional reactions 2 42 0.3 .612 
>0.05 
1 61 0.0 .000 Question 3 
Friendships 2 42 0.0 .000 
>0.05 
1 61 0.2* .537 Question 4 
 Clothes / shoes 2 42 0.5* .773 
0.026(1) 
0.013(2) 
1 61 0.2 .490 Question 5 
Going out / playing 2 42 0.3 .715 
>0.05 
1 61 0.2* .632 Question 6 
Swimming / other sports 2 42 0.6* 1.039 
0.027(1) 
0.025(2) 
1 61 0.2 .666 Question 7 
 School works or holidays 2 42 0.2 .437 
>0.05 
1 61 0.3 .541 Question 8 
 Stigmatisation 2 42 0.4 .701 
>0.05 
1 61 0.1 .415 Question 9 
 Sleep 2 42 0.1 .297 
>0.05 
1 61 0.2 .490 Question 10 
 Treatment 2 42 0.4 .582 
>0.05 
1 61 2.5 3.218 Total CDLQI index 
  2 42 3.1 3.900 
>0.05 
 
Table 61: Analysis of CDLQI regarding language of questionnaire 
Significances measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2) 
1 – German, 2 - English 
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We then looked at the influence of an actively spent leisure time on quality of life of our 
children group. We aimed to test whether quality of life is less impaired in children who 
do sports or have a hobby. The results showed that the total CDLQI is not influenced. 
However, single items analysis revealed that children who had a hobby or were doing 
sports were less affected when it comes to wearing clothes / shoes, going out / playing, 
swimming / other sports and are less likely to perceive the treatment as something 
negative (only regarding means, p values range from 0.052 to *0.029, Independent 
Sample T-test) (Table 62). 
 
 
Doing sports or having hobbies? N Mean  SD p value 
Yes 92 0.4 .698 Question 1 
Physical symptoms No 10 0.5 .527 
>0.05 
Yes 92 0.5 .762 Question 2 
 Emotional reactions No 10 0.5 .850 
>0.05 
Yes 92 0.0 .000 Question 3 
Friendships No 10 0.0 .000 
>0.05 
Yes 92 0.3* .591 Question 4 
 Clothes / shoes No 10 0.7* .059 
0.044(1) 
0.158(2) 
Yes 92 0.2 .531 Question 5 
Going out / playing No 10 0.6 .966 
0.052(1) 
0.124(2) 
Yes 92 0.3* .764 Question 6 
Swimming / other sports No 10 0.9* 1.287 
0.029(1) 
0.084(2) 
Yes 92 0.2 .597 Question 7 
 School works or holidays No 10 0.2 .422 
>0.05 
Yes 92 0.3 .584 Question 8 
 Stigmatisation No 10 0.5 .850 
>0.05 
Yes 92 0.1 .365 Question 9 
 Sleep No 10 0.2 .422 
>0.05 
Yes 92 0.3* .483 Question 10 
 Treatment No 10 0.6* .843 
0.048(1) 
0.149(2) 
Yes 92 2.5 3.164 Total CDLQI index 
  No 10 4.7 5.677 
>0.05 
 
Table 62: Influence of an actively spent leisure time on CDLQI 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
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An interesting question was whether children would have a less impaired quality of life 
if they had somebody else in the family with vitiligo. The idea behind was whether 
other family members could act as role models and show what could possibly be 
achieved in life despite having vitiligo. 
An analysis of the total CDLQI score and all of its single items yielded no significant 
differences (p>0.05, Mann-Whitney-U-test), with one exception. Children who had 
somebody else in the family with vitiligo (n=34) were much less likely to perceive the 
treatment as a burden compared to children with negative family history (n=68, means 
0.1 vs. 0.4, *p<0.05, Mann-Whitney-U-test) (Table 63).  
 
 
Positive family history? N Mean   SD p value 
No 68 0.4 .674 Question 1 
Physical symptoms Yes 34 0.4 .705 >0.05 
No 68 0.5 .743 Question 2 
 Emotional reactions Yes 34 0.4 .824 >0.05 
No 68 0.0 .000 Question 3 
Friendships Yes 34 0.0 .000 >0.05 
No 68 0.4 .731 Question 4 
 Clothes / shoes Yes 34 0.2 .459 >0.05 
No 68 0.3 .638 Question 5 
Going out / playing Yes 34 0.2 .496 >0.05 
No 68 0.5 .937 Question 6 
Swimming / other sports Yes 34 0.2 .558 0.08 
No 68 0.2 .497 Question 7 
 School works or holidays Yes 34 0.3 .719 >0.05 
No 68 0.3 .614 Question 8 
 Stigmatisation Yes 34 0.3 .618 >0.05 
No 68 0.1 .368 Question 9 
 Sleep Yes 34 0.1 .379 >0.05 
No 68 0.4* .599 Question 10 
 Treatment Yes 34 0.1* .288 0.008
(1)(2) 
No 68 3.0 3.753 Total CDLQI index 
  Yes 34 2.2 2.952 >0.05 
 
Table 63: Quality of life depending on family history of vitiligo  
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2).   
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The next part concerned the question whether treatment for vitiligo received earlier in 
life (regardless which treatment) would affect quality of life. A comparison of children 
who were treated in the past (n=76) and those who were not (n=25) yielded that the 
treated group was surprisingly more affected regarding wearing clothes / shoes, 
swimming / other sport, and more likely to think of the current treatment as something 
negative (*p<0.05, Mann-Whitney-U-test). However, the same group’s daily life was 
less impaired in school works / holiday (also *p<0.05). In all the other single items no 
significant differences have been found (Table 64). 
 
 
Ever received treatment? N Mean  SD p value 
No 25 0.3 .627 Question 1 
Physical symptoms Yes 76 0.5 .700 >0.05 
No 25 0.4 .768 Question 2 
 Emotional reactions Yes 76 0.5 .756 >0.05 
No 25 0.0 .000 Question 3 
Friendships Yes 76 0.0 .000 >0.05 
No 25 0.1* .277 Question 4 
 Clothes / shoes Yes 76 0.4* .730 
0.047(1) 
0.041(2) 
No 25 0.2 .473 Question 5 
Going out / playing Yes 76 0.3 .624 >0.05 
No 25 0.0* .000 Question 6 
Swimming / other sports Yes 76 0.5* .945 
0.014(1) 
0.005(2) 
No 25 0.4* .764 Question 7 
 School works or holidays Yes 76 0.1* .450 
0.02(1) 
0.005(2) 
No 25 0.4 .700 Question 8 
 Stigmatisation Yes 76 0.3 .585 >0.05 
No 25 0.2 .577 Question 9 
 Sleep Yes 76 0.1 .271 >0.05 
No 25 0.1* .277 Question 10 
 Treatment Yes 76 0.4* .582 
0.025(1) 
0.024(2) 
No 25 2.1 2.798 Total CDLQI index 
  Yes 76 2.9 3.700 >0.05 
 
Table 64: Influence of earlier received treatment on quality of life   
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2).   
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An analysis of the influence of disease severity on different body parts yielded no major 
influence, except for the face. Children with extensive facial vitiligo (n=22) scored 
significantly higher in the CDLQI and in some of its single items, i.e. physical 
symptoms, wearing clothes / shoes and going out / playing, compared to participants 
with only minor vitiligo (n=57, all *p<0.05, Mann-Whitney-U-test) (Table 65).   
  
 
 
Face affected? N Mean  SD p value 
1 57 0.3* .602 Question 1 
Physical symptoms 2 22 0.7* .883 
0.02(1) 
0.025(2) 
1 57 0.4 .704 Question 2 
 Emotional reactions 2 22 0.6 .902 >0.05 
1 57 0.0 .000 Question 3 
Friendships 2 22 0.0 .000 >0.05 
1 57 0.2* .455 Question 4 
 Clothes / shoes 2 22 0.6* .858 
0.011(1) 
0.013(2) 
1 57 0.1* .350 Question 5 
Going out / playing 2 22 0.6* .854 
0.001(1) 
0.006(2) 
1 57 0.2 .549 Question 6 
Swimming / other sports 2 22 0.6 1.098 
0.035(1) 
>0.05 (2) 
1 57 0.1* .441 Question 7 
 School works or holidays 2 22 0.4* .908 
0.02(1) 
>0.05 (2) 
1 57 0.2* .423 Question 8 
 Stigmatisation 2 22 0.6* .959 
0.022(1) 
>0.05(2) 
1 57 0.1 .426 Question 9 
 Sleep 2 22 0.1 .351 >0.05 
1 57 0.2* .464 Question 10 
 Treatment 2 22 0.4* .581 
0.025(1) 
>0.05 (2) 
1 57 1.9* 2.008 Total CDLQI index 
  2 22 4.6* 5.178 
0.001(1) 
0.038(2) 
  
Table 65: Quality of life and severity of facial vitiligo  
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
 
1 – Minor facial vitiligo,  2 -  Severe facial vitiligo 
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We also tested whether there were any differences between boys and girls with severe 
or minor facial vitiligo. The results showed that girls with severely affected faces (n=8) 
scored significantly higher in the CDLQI total score (*p<0.05, Mann-Whitney-U-test) 
and also in its single items physical symptoms and going out / playing compared to girls 
with only minor facial vitiligo (n=22). There was no differences in the CDLQI total 
scores in boys, but rather in the single items wearing of clothes / shoes and 
stigmatisation (*p<0.05, Independent Sample T-Test).  
 
Boys Girls 
Face affected? N Mean  SD p value 
 
N Mean  SD p value 
1 22 0.3 .550 
 
35 0.3* .639 Question 1 
Physical symptoms 2 8 0.4 .518 
>0.05  14 0.9* .997 
0.018(1) 
0.02572) 
1 22 0.2 .395 
 
35 0.5 .817 Question 2 
 Emotional reactions 2 8 0.4 .744 
>0.05  
14 0.8 .975 
>0.05 
1 22 0.0 .000 
 
35 0.0 .000 Question 3 
Friendships 2 8 0.0 .000 
>0.05  
14 0.0 .000 
>0.05 
1 22 0.1* .294 
 
35 0.2 .531 Question 4 
 Clothes / shoes 2 8 0.5* .756 
0.0381) 
>0.05 (2)  14 0.6 .938 
>0.05 
1 22 0.2 .395 
 
35 0.1** .323 Question 5 
Going out / playing 2 8 0.4 1.061 
>0.05  
14 0.7** .726 
<0.001(1) 
0.001(2) 
1 22 0.2 .664 
 
35 0.2 .473 Question 6 
Swimming / other sports 2 8 0.5 1.069 
>0.05  
14 0.6 1.151 
>0.05 
1 22 0.1 .213 
 
35 0.2 .531 Question 7 
 School works or holidays 2 8 0.0 .000 
>0.05  
14 0.6 1.082 
>0.05 
1 22 0.2* .395 
 
35 0.3 .443 Question 8 
 Stigmatisation 2 8 0.8* 1.035 
0.035(1) 
>0.05(2)  14 0.5 .941 
>0.05 
1 22 0.1 .213 
 
35 0.2 .514 Question 9 
 Sleep 2 8 0.0 .000 
>0.05  
14 0.2 .426 
>0.05 
1 22 0.3 .550 
 
35 0.2 .406 Question 10 
 Treatment 2 8 0.1 .354 
>0.05  
14 0.5 .650 
>0.05 
1 22 1.5 1.625 
 
35 2.2* 2.184 Total CDLQI index 
  2 8 3.0 4.276 
>0.05  
14 5.6* 5.557 
0.004(1) 
0.048(2) 
 
Table 66: Differences in CDLQI between girls and boys depending on disease 
severity in face 
Significances were measured with a 2-sided Independent Sample T-test(1) and a Mann-
Whitney-U-test(2). 
 
1 -  Minor facial vitiligo, 2- Extended facial vitiligo
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The following parts concerned different levels of stigmatisation ranging from  
approaches / questions to picking on / nasty comments to bullying. 
 
Children, who had experienced other people asking questions about the disease ‘very 
often’ (n=41), were significantly more affected than those with ‘sometimes’ (n=52) and 
‘no’ (n=6) regarding school works / holiday (*p<0.05) and stigmatising encounters 
(**p<0.005, Kruskal-Wallis-test) (Table 67). The fact that children, who had 
experienced stigmatisation, scored high in question 8 (stigmatisation) can be seen as 
confirmation that the CDLQI can indeed positively identify stigmatisation. 
The whole ‘very often’ group had a significantly more affected quality of life (median 
4.0) compared to the ‘sometimes’ (1.9) and ‘no’ (1.0) groups (*p<0.05, Kruskal-Wallis-
test) (Table 67).   
 
  218
 
  Has anyone ever mentioned your 
white spots and asked what it is? N Mean  SD p value 
1 41 0.5 .745 
2 52 0.4 .664 
CDLQI question 1 
Physical symptoms 
3 6 0.3 .516 
>0.05 
1 41 0.7 .879 
2 52 0.3 .678 
CDLQI question 2 
Emotional reactions 
3 6 0.3 .516 
>0.05 
1 41 0.0 .000 
2 52 0.0 .000 
CDLQI question 3 
Friendships  
3 6 0.0 .000 
>0.05 
1 41 0.5 .840 
2 52 0.2 .509 
CDLQI question 4 
Clothes / shoes  
3 6 0.0 .000 
>0.05 
1 41 0.4* .808 
2 52 0.1* .345 
CDLQI question 5 
Going out / playing 
3 6 0.0* .000 
0.026(1) 
0.058(2) 
1 41 0.5 .978 
2 52 0.3 .776 
CDLQI question 6 
Swimming / other sports 
3 6 0.0 .000 
>0.05 
1 41 0.3* .762 
2 52 0.1* .388 
CDLQI question 7 
School works or holidays  
3 6 0.2* .408 
>0.05(1) 
0.033(2) 
1 41 0.6** .808 
2 52 0.1** .345 
CDLQI question 8 
Stigmatisation  
3 6 0.0** .000 
0.001(1) 
0.002(2) 
1 41 0.2 .422 
2 52 0.1 .334 
CDLQI question 9 
Sleep 
3 6 0.0 .000 
>0.05 
1 41 0.4 .581 
2 52 0.2 .509 
CDLQI question 10 
Treatment 
3 6 0.2 .408 
>0.05 
1 41 4.0* 4.517 
2 52 1.9* 2.378 
Total CDLQI index 
  
3 6 1.0* 1.265 
0.007(1) 
0.015(2) 
 
Table 67: Single item analysis of CDLQI regarding whether or not the children 
had experienced other people asking questions about the disease  
Significances were measured with a one-way ANOVA test(1) and a Kruskal-Wallis-
test(2).   
 
1- Yes, very often, 2 – Yes, sometimes, 3 - No 
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Another level of disease-related stigmatisation are experiences of nasty comments. This 
turned out to be a very influential factor. Children who had been picked on or who had 
experienced other people being nasty because of vitiligo ‘very often’ (n=8) scored much 
higher in the total CDLQI (**p=0.001) and in a majority of its single items compared to 
the sometimes group (n=39) and the patients who had not made these experiences 
(n=52, p values ranging from **<0.005 to *<0.05, Table 68). This was not the case 
only regarding physical symptoms, friendships, sleep and treatment (all p>0.05, 
Kruskal-Wallis-test). 
 
The third indicator of stigmatisation in children was bullying. An analysis of its 
influence on quality of life revealed that children who had received bullying ‘very often’ 
(n=2) were more affected when it comes to going out / playing compared to children 
who were bullied sometimes (n=6) or not at all (n=34, *p<0.05, Kruskal-Wallis-test) 
(Table 69). There were no significant differences in any of the other single items or 
regarding the total CDLQI score (all p>0.05, Kruskal-Wallis-test, Table 69). 
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  Have you ever been picked upon or 
has anyone ever been nasty to you 
because of your white spots? N Mean  SD p value 
1 8 0.9 .835 
2 39 0.5 .756 
Question 1 
Physical symptoms 
3 52 0.3 .585 
>0.05 
1 8 1.1** .991 
2 39 0.7** .927 
Question 2 
Emotional reactions 
3 52 0.2** .469 
0.001(1) 
0.002(2) 
1 8 0.0 .000 
2 39 0.0 .000 
Question 3 
Friendships  
3 52 0.0 .000 
>0.05 
1 8 1.3*** 1.282 
2 39 0.3*** .614 
Question 4 
Clothes / shoes  
3 52 0.2*** .430 
<0.001(1) 
0.004(2) 
1 8 1.5*** 1.195 
2 39 0.3*** .442 
Question 5 
Going out / playing 
3 52 0.1*** .235 
<0.001(1)(2) 
1 8 1.3** 1.389 
2 39 0.4** .938 
Question 6 
Swimming / other sports 
3 52 0.2** .561 
0.003(1) 
0.025(2) 
1 8 0.9** 1.356 
2 39 0.2** .522 
Question 7 
School works or holidays  
3 52 0.1** .334 
0.001(1) 
0.02(2) 
1 8 1.0*** 1.414 
2 39 0.4*** .549 
Question 8 
Stigmatisation  
3 52 0.1*** .323 
<0.001(1) 
0.006(2) 
1 8 0.3 .463 
2 39 0.1 .384 
Question 9 
Sleep 
3 52 0.1 .334 
>0.05 
1 8 0.5 .756 
2 39 0.4 .628 
Question 10 
Treatment 
3 52 0.2 .398 
>0.05 
1 8 8.8*** 6.606 
2 39 3.2*** 3.235 
Total CDLQI index 
  
3 52 1.4*** 1.685 
<0.001(1) 
0.001(2) 
 
  
Table 68: Single item analysis of CDLQI regarding whether or not the children 
had been picked on or subject to nasty comments  
Significances were measured with a one-way ANOVA test(1) and a Kruskal-Wallis-
test(2).   
 
1- Yes, very often, 2 – Yes, sometimes, 3 - No 
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  Have you ever received bullying 
because of your white spots? N Mean  SD p value 
1 2 0.5 .707 
2 6 0.8 1.329 
Question 1 
Physical symptoms 
3 34 0.3 .579 
>0.05 
1 2 0.5 .707 
2 6 0.3 .816 
Question 2 
Emotional reactions 
3 34 0.2 .496 
>0.05 
1 2 0.0 .000 
2 6 0.0 .000 
Question 3 
Friendships  
3 34 0.0 .000 
>0.05 
1 2 1.5 2.121 
2 6 0.7 .816 
Question 4 
Clothes / shoes  
3 34 0.3 .589 
0.059(1) 
>0.05(2) 
1 2 1.5** 2.121 
2 6 0.8** 1.169 
Question 5 
Going out / playing 
3 34 0.1** .327 
0.002(1) 
0.031(2) 
1 2 1.0 1.414 
2 6 0.5 1.225 
Question 6 
Swimming / other sports 
3 34 0.5 .929 
>0.05 
1 2 0.5 .707 
2 6 0.0 .000 
Question 7 
School works or holidays  
3 34 0.1 .409 
>0.05 
1 2 1.0 1.414 
2 6 0.7 1.211 
Question 8 
Stigmatisation  
3 34 0.2 .431 
>0.05 
1 2 0.0 .000 
2 6 0.0 .000 
Question 9 
Sleep 
3 34 0.1 .239 
>0.05 
1 2 1.0 1.414 
2 6 0.2 .408 
Question 10 
Treatment 
3 34 0.3 .462 
>0.05 
1 2 7.5 10.607 
2 6 4.0 4.690 
Total CDLQI index 
  
3 34 2.2 2.414 
0.055(1) 
>0.05(2) 
 
Table 69: Single item analysis of CDLQI regarding whether or not the children 
had received bullying  
Significances were measured with a one-way ANOVA test(1) and a Kruskal-Wallis-
test(2).   
 
1- Yes, very often, 2 – Yes, sometimes, 3 - No 
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The last part of the CDLQI single item analysis was the question whether quality of life 
is measurably impaired in children with different levels of disturbance by their disease. 
Children, who felt indeed bothered (n=26), were significantly more affected in their 
quality of life than children who are not (n=30) or only sometimes (n=46) bothered by 
their vitiligo (CDLQI means 5.1, 2.0 and 1.9, respectively). The differences between the 
mean and also between the median scores are highly significant (***p<0.001, one-way 
ANOVA and Kruskal-Wallis-test) (Table 70).  
Moreover, the influence of disturbance by vitiligo was particularly high on the single 
items emotional reactions and going out / playing (both ***p<0.001), but also on 
swimming / sport and stigmatisation (*p≤0.05, Kruskal-Wallis-test).   
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 Do your white spots bother you? N Mean  SD p value 
1 30 0.4 .615 
2 26 0.7 .892 
Question 1 
Physical symptoms 
3 46 0.3 .560 
>0.05 
1 30 0.2*** .664 
2 26 1.0*** .958 
Question 2 
Emotional reactions 
3 46 0.3*** .519 
<0.001(1)(2) 
1 30 0.0 .000 
2 26 0.0 .000 
Question 3 
Friendships  
3 46 0.0 .000 
>0.05 
1 30 0.3 .691 
2 26 0.5 .859 
Question 4 
Clothes / shoes  
3 46 0.2 .453 
>0.05 
1 30 0.3* .785 
2 26 0.5* .647 
Question 5 
Going out / playing 
3 46 0.1* .285 
0.007(1) 
<0.001(2) 
1 30 0.2* .664 
2 26 0.7* 1.116 
Question 6 
Swimming / other sports 
3 46 0.2* .705 
0.027(1) 
0.01(2) 
1 30 0.1 .254 
2 26 0.4 .898 
Question 7 
School works or holidays  
3 46 0.2 .486 
>0.05 
1 30 0.2 .679 
2 26 0.5 .761 
Question 8 
Stigmatisation  
3 46 0.2 .431 
>0.05(1) 
0.051(2) 
1 30 0.1 .507 
2 26 0.2 .368 
Question 9 
Sleep 
3 46 0.1 .250 
>0.05 
1 30 0.2 .504 
2 26 0.5 .647 
Question 10 
Treatment 
3 46 0.2 .467 
>0.05 
1 30 2.0*** 3.643 
2 26 5.1*** 4.408 
Total CDLQI index 
  
3 46 1.9*** 1.996 
<0.001(1)(2) 
  
 
Table 70: Single item analysis of CDLQI regarding how the children felt bothered 
by their white spots  
Significances were measured with a one-way ANOVA test(1) and a Kruskal-Wallis-
test(2).   
1 – No, 2 -  Yes, 3 - Sometimes 
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6.7.3 Correlation of CDLQI with duration of the disease 
 
Since there are conflicting reports in the literature about a correlation between duration 
of disease and adult DLQI, we wanted to know whether or not there is such correlation 
in the children population. 
 
Pearson correlation analysis of CDLQI scores and duration of disease yielded a 
correlation coefficient -0.087 (2-tailed significance p>0.05), meaning that the total score 
of the CDLQI does not correlate with duration of vitiligo. 
 
The single items of the CDLQI do also not correlate with duration, neither positively 
nor negatively (Pearson correlation coefficients ranging from -0.162 to +0.115, 2-tailed 
significance always p>0.05), except for question 7 (school works or holiday) where the 
Pearson correlation coefficient is -0.194 (2-tailed significance *p=0.05), indicating that 
there is a weak negative correlation between duration of vitiligo and level of affected 
school work or holidays. The longer the children had vitiligo the less their schoolwork / 
holiday was affected.  
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6.8 Children and their parents 
 
6.8.1 Parents’ characteristics 
 
At the same time when children filled out their questionnaire, we also asked the parents 
to participate. 
 
In total,  parents of 103 children took part (120 parents in total). In 21 cases both parents 
of a child took part, in the remaining ones (n=99) it was either the mother (71.8%, 
n=71) or the father (28.2%, n=28). Two questionnaires had to be excluded as they were 
incomplete. 
 
The mean age of the parents was 42.1 years (SD 5.439), median age was 42.0 years. 
The mothers were significantly younger than the participating fathers (mean and median 
ages 41.0 vs 45.0 years, **p=0.001, 2-sided Independent Sample T-test; **p=0.001,  
Mann-Whitney-U-test). 
 
When both parents participated, the analysis showed that more fathers (n=13, 61.9%) 
and less mothers (n=8, 38.1%) answered. The mean age was 42.1 years (SD 6.472, 
median 40.0 years) with no significant differences between mothers and fathers (42.6 
vs. 43.1 years, p>0.05, 2-sided Independent Sample T-test; median 39.0 vs. 40.0 years, 
p>0.05, Mann-Whitney-U-test). 
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6.8.2 Searching for new white spots 
 
One part of the survey concerned the question how often the parents examined their 
children for the presence of new white spots. We found that there is a considerable 
percentage of parents doing that quite often (Table 71). About 43% of the parents 
confirmed that they searched their children often for new white spots (18.6% / n=16 
quite right – 12.8% / n=11 mostly right – 11.6% / n=10 totally right). There was no 
significant difference between mothers and fathers (p>0.05, Pearson Chi-Square test) 
(Table 71). 
 
 
Parent Total  I search my child often for 
new white spots Mother Father Parents 
 N 18 6 24 
  
Not at all right 
  % 27.6 28.6 27.9 
  N 17 8 25 
  
Hardly ever right 
  % 26.2 38.1 29.1 
  N 13 3 16 
  
Quite right 
  % 20.0 14.3 18.6 
  N 10 1 11 
  
Mostly right 
  % 15.4 4.7 12.8 
  N 7 3 10 
  
Totally right 
  % 10.8 14.3 11.6 
Total N 65 21 86 
 
Table 71: Frequencies of mothers and fathers searching their children for new 
white spots 
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6.8.3 Parents’ coping with vitiligo of their children 
 
By evaluating the ACS scores it is possible to get an impression how parents cope with 
the chronic skin disease of their children.  
 
Direct comparison of patients’ parents and control group 
 
A direct comparison yielded that parents of children with vitiligo scored a median social 
anxiety / avoidance score of 26.0 (n=120), which is much higher compared to parents of 
healthy controls (15.5, n=18, ***p<0.001, Mann-Whitney-U-test). The median scores of 
helplessness were also significantly different (22.0 / n=120 vs. 10.0 / n=18, ***p<0.001, 
Mann-Whitney-U-test) (Figure 52). 
Interestingly, this difference was not present in anxious-depressive mood. Here, the 
parents of children patients scored a median of 16.0 (n=120) and the parents of healthy 
controls a median of 14.0 (n=18). The difference is not significant (p>0.05) (Figure 52).   
In this context it is again noteworthy that anxious-depressive mood is the only ACS 
scale not specified for skin diseases. 
 
In conclusion, parents of children with vitiligo have difficulties in coping with their 
children’s chronic skin disease. This is particularly the case for situations where the 
disease might be revealed to others (social anxiety / avoidance) and regarding the 
course of vitiligo (helplessness). 
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Figure 52: Median ACS scores of parents of children with vitiligo (n=120) and 
healthy controls (n=18) 
Significances were measured with a Mann-Whitney-U-test. 
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Evaluation of differences between mothers and fathers of patients and controls 
 
Next it was tempting to test for any differences in coping-related emotions between 
mothers of patients and controls and fathers of the patients and controls.  
Consequently, we directly compared their scores in social anxiety / avoidance (Figure 
53), helplessness (Figure 54) and anxious-depressive mood (Figure 55).  All three tests 
revealed that the differences regarding social anxiety / avoidance and helplessness as 
shown for the total group of parents can also be found equally in mothers (***p<0.001) 
and fathers (*p<0.05) of patients compared to the control group. Moreover, there were 
no significant differences in anxious-depressive mood, neither in mothers nor in fathers 
(p>0.05, Mann-Whitney-U-test) (Figure 56). 
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Coping depending on age of the parents 
 
An interesting question was, whether age of the parents would influence coping with 
their children’s skin disease. In order to evaluate this, we performed Pearson correlation 
analysis for each ACS score and age of the parents.  
The correlation coefficients obtained were as follows: 
 
• Social anxiety / avoidance -0.089 (mother, n=81)      0.061 (father, n=39) 
• Helplessness    -0.077 (mother, n=81)     -0.145 (father, n=39) 
• Anxious-depressive mood  -0.004 (mother, n=81)       0.164 (father, n=39) 
 
These results indicate that none of the ACS scores correlates with age of the parents 
(p>0.05). It can be concluded that coping with their children’s vitiligo does not depend 
on the age of the parents. 
 
 
Influence of disease duration 
 
The next question we wanted to answer was, whether there was any correlation between 
coping of the parents and duration of their children’s vitiligo. We again performed 
Pearson correlation analysis and obtained the following correlation coefficients: 
 
• Social anxiety / avoidance -0.185 (mothers, n=81)  -0.011 (fathers, n=39) 
• Helplessness    -0.192 (mothers, n=81)        -0.287 (fathers, n=39) 
• Anxious-depressive mood  -0.158 (mothers, n=81)  -0.139 (fathers, n=39) 
 
These results reveal that duration of the children’s skin disease does not influence 
coping-related emotions of their parents (p>0.05).  
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Influence of children’s disease status on coping of their parents 
 
This part concerned the question whether coping-related emotions of the parents were 
influenced by the disease status, i.e. whether vitiligo was currently actively spreading, 
remaining stable or improving. We analysed the ACS scores of mothers and fathers in 
relation to the mentioned states.  
The results revealed that the status of vitiligo was only influential on feelings of 
helplessness of mothers. When their children’s vitiligo was spreading (n=19), the score 
was with a median of 30.0 higher than the scores in case of stable disease (21.0, n=23) 
or improving vitiligo (26.0, n=9) (Table 72). The difference between the three scores is 
significant (*p<0.05, Kruskal-Wallis-test). Surprisingly, it seems to be that any change 
of the state (worsening or improving) made mothers more helpless compared to a stable 
disease, where the score was lowest. 
 
Disease state of children N Mean Median SD p value 
Active 19 29.8 28.0 7.850 
Stable 23 23.8 22.0 7.114 
Social anxiety / avoidance  
mother 
Re-pigmenting 9 26.7 27.0 10.524 
>0.05 
Active 19 28.8* 30.0* 8.310 
Stable 23 21.3* 21.0* 5.138 
Helplessness  
mother 
Re-pigmenting 9 24.9* 26.0* 8.609 
0.006(1) 
0.013(2) 
Active 19 20.4 19.0 5.994 
Stable 23 16.5 16.0 5.053 
Anxious-depressive mood  
mother 
Re-pigmenting 9 17.6 15.0 8.791 
>0.05 
Active 6 25.7 27.5 6.314 
Stable 14 24.1 23.0 5.196 
Social anxiety / avoidance  
father 
Re-pigmenting 5 29.2 27.0 11.520 
>0.05 
Active 6 22.7 23.5 4.676 
Stable 14 17.9 16.5 5.797 
Helplessness  
father 
Re-pigmenting 5 25.8 20.0 12.696 
>0.05 
Active 6 14.8 14.5 4.535 
Stable 14 13.7 13.5 3.791 
Anxious-depressive mood  
father  
Re-pigmenting 5 19.2 15.0 10.895 
>0.05 
 
Table 72: ACS scores of parents depending on disease state of their children 
Significances were measured with one-way ANOVA test (1) and Kruskal-Wallis-test(2). 
  235
Correlation of difficulties in parental coping and avoidant behaviour of the 
children 
 
An important part of this project was to find out whether there were any correlations 
between disturbed emotions of the parents and avoidant behaviour of their children. In 
order to evaluate this, we compared the ACS scores of mothers and fathers depending 
on the frequencies their children hide their vitiligo in front of other people.  
The results shown in Table 73 revealed that parents of children who had never hidden 
their white spots, scored lowest in social anxiety / avoidance, helplessness (fathers only) 
and anxious-depressive mood (fathers only) (p values ranging from **<0.005 to *<0.05, 
Mann-Whitney-U-test).  
From these numbers it remains unclear whether avoidant behaviour of the children 
disturbed their parents’ emotions or whether this happened the other way around. 
Therefore, it could also be concluded that children benefit from unaffected parents by 
showing an normal non-hiding behaviour.   
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 How often have you hidden your 
white spots? N Mean Median SD p value 
1 36 24.3** 23.0** 6.488 
2 23 32.0** 31.0** 9.207 
3 9 30.3** 29.0** 6.557 
Social anxiety / 
avoidance  
mother 
 4 12 31.7** 30.0** 13.937 
0.005(1) 
0.004(2) 
1 36 22.5 21.0 7.177 
2 23 27.4 26.0 7.272 
3 9 24.1 24.0 8.358 
Helplessness  
mother 
 
4 12 28.0 29.0 9.899 
>0.05 
1 36 16.4 16.0 5.857 
2 23 17.6 15.0 7.445 
3 9 15.7 14.0 7.297 
 
Anxious-
depressive mood  
mother  4 12 20.4 20.5 7.428 
>0.05 
       
1 18 22.8** 23.0* 4.870 
2 13 29.6** 28.0* 7.911 
3 6 33.7** 32.0* 9.416 
Social anxiety / 
avoidance  
father  
  4 2 30.5** 30.5* 2.121 
0.005(1) 
0.008(2) 
1 18 17.7 17.0* 4.800 
2 13 2387 21.0* 8.814 
3 6 23.0 20.5* 6.693 
Helplessness  
father 
4 2 26.5 26.5* .707 
0.052(1) 
0.039(2) 
1 18 12.4* 12.5* 3.556 
2 13 18.2* 17.0* 6.699 
3 6 17.5* 17.0* 4.037 
Anxious-
depressive mood  
father  
  4 2 16.5* 16.5* 6.364 
0.037(1) 
0.046(2) 
 
Table 73: ACS scores of parents depending on hiding vitiligo  
Significances were measured with one-way ANOVA test (1) and Kruskal-Wallis-test(2). 
 
1 - Never, 2 – Very few times, 3 – Quite often, 4 – Very often 
 
 
 
  237
Coping emotions and searching for new white spots 
 
As shown above, there were considerable parts of the parents frequently examining their 
children for new white spots. It was tempting to test whether those parents who search 
for white spots often were more affected in their coping. 
The results are very clear. The stronger mothers agreed that they searched their children 
often for new white spots, the higher they score in all ACS sub-scales. The differences 
between levels of agreement are highly significant as measured with a Kruskal-Wallis-
test (***p<0.001, Figure 56). 
The stronger fathers agreed that they search their children often for new white spots, the 
higher they score in helplessness (*p<0.05) and anxious-depressive mood (***p<0.001). 
There was no difference in social anxiety / avoidance (p>0.05) (Figure 57). 
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Figure 56: ACS scores of mothers depending on frequencies of searching for new 
white spots (n=65) 
 
 
 
 
 
 
 
Figure 57: ACS scores of fathers depending on frequencies of searching for new white 
spots (n=21) 
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6.8.4 Parents’ beliefs about what causes vitiligo 
 
Since there are many factors suggested in the literature as either triggering or worsening 
vitiligo, it was our interest what parents think is influential on their children’s vitiligo 
and whether there were any differences between the parents. 
 
There were only a few parents thinking that psychological stress (41%, n=31/76), other 
diseases (22%, n=8/37) or injuries (23%, n=10/44) are involved in vitiligo (Figure 58). 
There were no significant differences between fathers and mothers (data not shown, 
p>0.05, Pearson Chi-Square test). 
 
 
 
 
 
 
 
Figure 58: Beliefs of parents about trigger factors 
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6.8.5 Influence of parents’ beliefs on their ACS scores 
 
Next we wanted to know whether parents’ beliefs regarding a possible involvement of 
psychological stress, other diseases and injuries in vitiligo influence their ACS scores. 
There was no association found regarding injuries (p>0.05, data not shown). Some 
correlations were found regarding psychological stress (Table 74) and other diseases 
(Table 75).  
Mothers who think that psychological stress is influential (n=23), showed a higher mean 
anxious-depressive mood score (19.8) compared to mothers who did not think this way 
(n=37, mean 15.7). The difference was significant (*p<0.05, Independent Sample T-
test). The same applied to the fathers, but even stronger in anxious-depressive mood and 
additionally regarding social anxiety / avoidance (*p<0.05, Table 74). 
Mothers, who think that other diseases are involved showed higher anxious-depressive 
mood scores (*p<0.05). There were no other differences (p>0.05, Table 75). 
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 Psychological stress 
influential in vitiligo? N Mean Median SD p value  
Yes 23 29.1 28.0 10.207 Social anxiety / avoidance  
mothers No 37 25.4 24.0 6.534 >0.05 
Yes 23 25.1 22.0 9.160 Helplessness  
mothers No 37 23.9 23.0 5.629 >0.05 
Yes 23 19.8* 16.0 7.493 Anxious-depressive mood  
mothers No 37 15.7* 16.0 4.730 
0.012(1) 
0.065(2) 
Yes 14 30.1* 30.0* 8.033 Social anxiety / avoidance  
fathers No 18 23.7* 23.0* 5.120 
0.011(1) 
0.018(2) 
Yes 14 22.3 21.0 7.311 Helplessness  
fathers No 18 18.7 17.0 5.367 >0.05 
Yes 14 17.2** 17.0* 4.228 Anxious-depressive mood  
fathers No 18 12.7** 12.0* 3.461 
0.002(1) 
0.006(2) 
 
Table 74: ACS scores of parents and perceived influence of psychological stress 
Significances were measured with 2-sided Independent Sample T-test(1) and Mann-
Whitney-U-test(2). 
 
 
 
 
Other diseases involved in vitiligo? N Mean Median SD p value 
Yes 7 27.14 27.0 10.040 Social anxiety / avoidance  
mothers  No 25 25.88 24.0 7.513 
>0.05 
Yes 7 26.57 26.0 7.254 Helplessness  
mothers No 25 24.12 23.0 5.637 
>0.05 
Yes 7 21.29* 20.0* 5.678 Anxious-depressive mood  
mothers No 25 16.28* 16.0* 5.062 
0.032(1) 
0.023(2) 
Yes 4 30.00 27.0 12.055 Social anxiety / avoidance  
fathers No 12 25.42 24.5 5.435 
>0.05 
Yes 4 25.75 21.5 12.606 Helplessness  
fathers No 12 20.75 20.0 5.225 
>0.05 
Yes 4 17.75 16.0 6.652 Anxious-depressive mood  
fathers No 12 14.00 13.5 3.357 
>0.05 
 
Table 75: ACS scores of parents regarding belief that other diseases are involved 
in vitiligo 
Significances were measured with 2-sided Independent Sample T-test (1) and Mann-
Whitney-U-test(2). 
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6.8.6 ACS scores of both parents 
 
As mentioned above, in 21 cases both parents of a child with vitiligo filled out the 
questionnaires. This offered the chance to compare both scores and also to test whether 
they correlate. 
A direct comparison of both parents’ ACS scores yielded that they differ in helplessness 
and anxious-depressive mood. Here, mothers had significantly higher median scores 
compared to their partners / spouses (helplessness 26.0 vs. 20.0 and anxious-depressive 
mood 19.0 vs. 14.0, *p<0.05, Wilcoxon signed-rank test) (Table 76).  
 
This was followed by correlation analysis, which revealed that the scores of mothers 
and fathers positively correlated in social anxiety / avoidance (**p=0.001) and 
helplessness (*p=0.02), but not in anxious-depressive mood (p>0.05) (Table 76).   
 
 
 
Table 76: Comparison and correlation analysis of ACS scores of both parents 
(1) Paired samles T-test (2)Wilcoxon signed-rank test 
 
  
 
 
 
 
 
 Mean Median N SD p value difference  
Pearson 
correlation 
coefficient 
p value 
correlation 
Social anxiety / avoidance mother  28.8 28.0 21 7.661  
Social anxiety / avoidance father 26.7 27.0 21 7.457 
>0.05(1)(2) 0.679 **0.001 
Helplessness mother 25.6* 26.0* 21 7.580  
Helplessness father 21.3* 20.0* 21 7.716 
0.019(1) 
0.037(2) 
0.504 *0.02 
Anxious-depressive mood mother 18.8 19.0* 21 6.774  
Anxious-depressive mood father 16.0 14.0* 21 6.233 
>0.05(1) 
0.045(2) 
0.190 >0.05 
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6.8.7 Correlations between parents’ scores and CDLQI scores 
 
Finally, it was our interest to find out whether an impaired quality of life of the children 
correlated to disturbed coping-related emotions of the parents, because that would 
indicate that both scores (and parents’ and children’s feelings) influence each other. 
For this purpose we utilised Pearson correlation analysis, which showed that there were 
positive and significant correlations between mothers’ scores in social anxiety / 
avoidance (n=82, ***p<0.001) and helplessness (*p<0.01) with the CDLQI scores of 
their children. There were no correlations of the CDLQI with any of the father’s ACS 
scores and mother’s anxious-depressive mood (p>0.05) (Table 77). 
 
 
 
 
 
 
 
 
 
Parents’ scores N 
Pearson correlation 
coefficient to CDLQI 
p value 
Social anxiety / avoidance (mother) 82 0.440*** <0.001 
Social anxiety / avoidance (father) 39 0.242 >0.05 
Helplessness (mother) 82 0.264* 0.017 
Helplessness (father) 39 0.229 >0.05 
Anxious-depressive mood (mother) 82 0.161 >0.05 
Anxious-depressive mood (father) 38 0.111 >0.05 
 
Table 77: Correlation analysis of parents’ scores and CDLQI scores 
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7 Discussion 
 
7.1 Adult patients characteristics 
 
7.1.1 Demographical and clinical features 
 
With regards to most of the demographic features, our adult patient population is not 
particularly different from others.  
 
It is very common that more women than men participate in studies on vitiligo (Behl 
and Bhatia 1972; Hann and Lee 1996; Tawade et al. 1997; Al-Mutairi and Sharma 
2006), although rarely there is a male predominance (Dutta and Mandal 1969; Sarin and 
Kumar 1977; Kar 2001). A female predominance could be explained because women 
are more likely to visit a doctor for their vitiligo (Ongenae et al. 2004) and since most of 
the studies available are in any way associated with dermatological clinics, it seems 
realistic that often more women took part then men. Hence, the relatively high 
proportion of women in our study (67.8%) is not exceptionally high as there are other 
reports with similar (Alkhateeb et al. 2003; Wu et al. 2008) or even higher proportions 
(Mason and Gawkrodger 2005; Hallaji et al. 2006).  
 
The mean / median age of our patient group is high. However, this is not exceptional in 
the field of vitiligo (Alkhateeb et al. 2003). 
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Our results revealed a mean / median age of disease onset of about 24 years with a peak 
between 10 and 19 years. This is in agreement with other reports confirming that 
although vitiligo can occur at any time in life, the onset tends to be in the first third of 
the life span. Our finding of an earlier disease onset in male patients is in agreement 
with earlier reports (Das et al. 1985; Majumder et al. 1993). 
A very interesting finding is that patients who think that psychological stress is 
influential in vitiligo have a much higher age of disease onset. This cannot be explained 
by a gender factor as there is no significant difference between female and male patients 
regarding beliefs that psychological stress is involved (Pearson Chi-Square test, p>0.05, 
data not shown). It is tempting to speculate that older patients link their vitiligo to 
certain life events and experiences.   
It seems that in the case of an earlier disease onset patients avoid certain situations more 
often because of their vitiligo, while a later onset does not affect patients that much as 
many will have settled by then and physical appearance will have become less 
important. 
 
The predominance of fair skin phototypes (I-III) in our study can be explained by the 
geographical location of the Institute for Pigmentary Disorders in Western Europe 
(Greifswald / Germany and Bradford / UK). Although patients from five continents are 
enrolled with the institute, the majority is from Germany and the UK with 
predominantly Caucasian populations. 
 
To the best of our knowledge there are no studies available comparing English and 
German speaking patients. There are reports from South Africa where different 
languages and cultures are included (Jobanputra and Bachmann 2000). It is noteworthy 
that many of our patients filled out our questionnaires without having English or 
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German as first language, so that the obtained data may only be of limited value to 
conclude anything about the countries involved (Germany vs. UK / USA / Australia). 
 
A positive family history of 37.8% in our patient group is in agreement with other 
publications with a range from 1 to 48% (Singh et al. 1985; Al-Khawajah 1997). Our 
finding that the parents of children in our group often had vitiligo themselves supports 
earlier reports that there is an increased risk for children to develop vitiligo when their 
parents also suffer from this disease (Majumder et al. 1993; Shah et al. 2008). 
 
The state of disease (spreading, stable, re-pigmenting) is difficult to compare to other 
studies as this would also depend on the success rates of treatment modalities associated 
with the studies. A proportion of 46% having progressing vitiligo seems neither 
exceptional high nor low (Sarin and Kumar 1977). In the subgroup of patients enrolled 
with the Institute for Pigmentary Disorders there are less patients having actively 
spreading disease compared to those not enrolled (39% vs. 53%, p=0.059) reflecting the 
medical success of this modality. 
 
The initial sites of disease onset in our population are not different from those reported 
in the literature as they also are predominatly on exposed parts of a patient’s body 
(hands, face, neck). However, hands as most frequently mentioned site of onset has only 
been reported once before (Lerner 1959). When face and neck are counted as one part as  
commonly done in the literature (Kanwar et al. 1993; Handa and Kaur 1999; Al-Mutairi 
et al. 2005), these locations would be the most frequently mentioned part where the first 
vitiliginious spot appeared. 
 
Pruritus in association with vitiligo has rarely been reported. Hence, our prevalence 
number of 34.3% adds another piece of information to the knowledge about vitiligo.  
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The prevalence of grey hair on scalp and in eyelashes / eyebrows was about 40% in the 
younger patients. A link to vitiligo was suggested earlier (Lerner 1959). 
 
 
7.1.2 Experiences and behaviour – role of stigmatisation 
 
As discussed earlier, stress, life events and emotional problems have often been 
suggested as being influential on onset and / or course of vitiligo. Our patient population 
is no exception with a majority thinking that psychological stress is influential on their 
vitiligo. Our proportion of 72% of patients is higher than reported anywhere else.  
One reason could be that the term psychological stress is only one of several used in the 
literature so far; in other reports it has often been ‘stress’, ‘emotional undertones’, ‘life 
events’, ‘nervouseness’ and similar, all with less patients reporting them. Another 
reason might be the high number of stigmatisation experiences in our group. Almost 
90% have experienced that other people approached them and asked questions about 
their white spots. This number is higher than reported in the literature so far, where 72% 
was the highest (Porter et al. 1979). Since it is well established that stigmatisation leads 
to impaired quality of life, this could explain why many of our patients link 
psychological stress to vitiligo. 
 
About 38% linked their vitiligo to injuries (Koebner phenomenon) and 18% related 
vitiligo to other diseases. These numbers are slightly higher compared to earlier reports 
(Table 4) (Dutta and Mandal 1969; Papadopoulos et al. 1998). 
 
As already mentioned above there is a high prevalence of patients reporting 
stigmatisation experiences. Almost 90% stated that they have been approached and / or 
asked questions about the disease by others. Less, but still a quarter of our patients said 
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that they had been subject to nasty comments or that they were picked on because of the 
disease. This is the highest prevalence reported so far. While Porter et al found that 50% 
in their group had experienced rude remarks, this was 16% only in another study (Porter 
et al. 1979; Porter et al. 1987).  
 
Interestingly, female patients and those with hands and / or legs severely affected are 
more likely to experience approaches / questions by others. The gender difference is in 
contradiction to other reports (Kent 1999; McLeod 2004), but one of those studies used 
less patients (n=45 in McLeod’s study) with a probably reduced statistical sensitivity or 
different ways to measure stigmatisation (Kent 1999). The increased likelihood for 
patients with severely affected hands could be explained by a correlation between 
visibility of vitiligo and level of stigmatisation (Kent 1999). Since hands (and legs at 
least sometimes) are exposed parts, it can be expected that patients with severe vitiligo 
will also experience stigmatisation more often. The problem is that hands are apparently 
difficult to treat (Schallreuter et al. 2008b), so that there are not many medical options 
left to do something about it. The same applies to our finding that patients with severely 
affected arms are more likely to be picked on or to become subject to nasty comments.  
 
Interestingly, when looking at groups of age at disease onset, patients with an onset in 
their teenage years were most often picked on or subjects to nasty comments because of 
their vitiligo, compared to younger and older patients. It might be the nature of 
adolescence / puberty (appearance becoming more important, peer pressure, mood 
swings) that such differences will be mentioned more often by others in the same age.  
Taken together, since there are only a handful of publications available containing 
prevalence data on stigmatisation, our data add some more important information to this 
field.  
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7.1.3 Avoidant behaviour - hiding of the disease 
 
63% of our patient population have quite often or very often hidden their white spots in 
front of other people in the past, 65% had avoided certain situations where an exposure 
of the disease was feared. This number is lower than the 76% reported in a comparable 
publication (McLeod 2004). Porter et al reported that about half of their patients felt 
forced to hide their white spots (Porter et al. 1979).  
 
About 40% of our patients preferred a combination of multiple strategies over just one. 
However, hiding the white spots under clothes was most popular, followed by 
camouflage and using of body positions. This is in agreement with earlier reports 
(McLeod 2004). In our group, female patients are more likely to hide their spots very 
often and less likely to do this never or very rarely, which confirms earlier findings of a 
gender-difference (McLeod 2004; Ongenae et al. 2004).  
 
Avoided situations were most often shaking hands / undressing in changing rooms and 
swimming / bathing. These situations have also been reported earlier as commonly 
avoided ones (McLeod 2004). In contrast to our findings McLeod found undressing in 
changing roms the least avoided activity in their group. We found no further differences 
between any subgroups in our patients population regarding frequencies of avoided 
situations.  
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7.2 Dermatology Life Quality Index 
 
The median Dermatology Life Quality Index (DLQI) for our patients population as a 
whole is 4.0 (mean is 5.5), and this is significantly increased compared to healthy 
controls.  
It is consistent that all DLQI scores of patients with vitiligo are much higher than those 
published for healthy controls (about 0.5) (Finlay and Khan 1994). Compared to other 
mean scores from the literature, this is rather in the lower part of the range. The lowest 
DLQI score reported so far is 3.7 and it is of a group associated with an Australian 
dermatologic practice (Chee et al. 2008), the highest is about 15 of a group of Saudi 
college students (Al Robaee 2007) and a group of patients in the beginning of a trial 
into the effects of cognitive-behavioural therapy in vitiligo (Papadopoulos et al. 1999). 
However, an exact comparison is not possible as all the groups mentioned will differ 
regarding state and severity of vitiligo, treatment and also cultural backgrounds.  
 
Interestingly, about 60% of our patients did not have or had an only slightly impaired 
quality of life (DLQI scores from 0-5). This is more than one would expect when 
looking at our mean and median DLQI scores. However, 16% of the participants 
suffered from a severly or even extremely reduced quality of life as indicated by high 
DLQI scores from 11 to 30. The question remains whether all patients had filled out this 
questionnaire honestly. It can be expected that more than 16% suffer from limitations in 
essential parts of their daily lives.  
 
There is a significant difference between patients enrolled with the Institute for 
Pigmentary Disorders and those not enrolled, with the latter group having higher mean 
scores. That confirms that the treatment modality offered by the institute (narrow-band 
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UVB activated pseudocatalase PC-KUS) is not only medically effective, it also 
improves quality of life. This association, however, is significant only when using mean 
DLQI scores, it is not measurable with non-parametric measurements. Single item 
analysis showed that patients enrolled with the institute benefit particularly regarding 
their daily activities, such as shopping or gardening. 
 
According to our results there is no difference between female and male patients 
regarding quality of life. This is in agreement only with a minority of publications, 
whereas most of earlier reports emphasised such difference.  
Although female patients are more likely to experience stigmatisation, i.e. approaches / 
questions by others, this apparently has not lead to a more impaired quality of life in our 
group. It might be that a certain level of stigmatisation can be compensated by support 
by friends, which women are more likely to receive (Porter and Beuf 1994). 
 
It has been reported earlier that perceived stigmatisation is influential on quality of life. 
In our group, however, we found that those who had never been approached by others 
had the highest DLQI scores (in female and male patients equally, data not shown). The 
lowest total DLQI score and the lowest scores in the DLQI items partners / friends / 
relatives and sexual relationships were found in those patients who had sometimes 
experienced approaches / questions.  
This result seems to be the opposite of Moss’ inverted-U-relationship regarding severity 
of a general disfigurement, where patients with moderate severity suffered most when 
compared to those with lower and higher extreme of severity. This was explained by 
that in the latter cases other peoples’ reactions are more predictable as with moderate 
severity where such reactions are more varied and ambigious (Rumsey and Harcourt 
2004; Moss 2005). 
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In our group, however, moderate (‘sometimes’) and thus less predictable reactions by 
other people (approaches / questions) did not have such profound impact on quality of 
life as with no approaches at all or those happened very often. It might be that patients 
who had never experienced stigmatisation do fear such encounters and will do 
everything they can to prevent them from happening. This could be done for example 
by avoiding situations, which automatically leads to a more impaired quality of life. 
Strikingly, stigma-related experiences of patients such as being picked on or being 
subjects to nasty comments had no influence at all on DLQI scores, in spite of being 
more malignant than “just” approaches / questions by others. Perhaps, there are different 
coping strategies attached to either kind of experience. Taken together, we could not 
confirm earlier findings that perceived stigma and DLQI scores correlate (Kent and Al-
Abadie 1996a) and it may be that stigmatisation is not that influential, at least in some 
patient groups. 
 
Severity of vitiligo on different body parts is not influential on DLQI scores, except for 
the trunk, where severe vitiligo goes along with higher DLQI scores compared to just 
slight vitiligo. This result is in agreement with earlier reports (Ongenae et al. 2005b).  
Given that the trunk is the biggest of all body parts mentioned in the questionnaire, we 
can assume that having severe vitiligo there most often means that the total vitiligo of 
these patients can be judged as severe. Therefore, severity of vitiligo can be regarded as 
influential on DLQI scores. This correlation has been reported earlier (Kent and Al-
Abadie 1996a; Ongenae et al. 2005a; Ongenae et al. 2005b; Dolatshahi et al. 2008). 
Overall, we can only partially confirm that disease severity on different body parts is a 
good predictor that DLQI scores will be increased.  
 
Surprisingly, skin colour has no influence on the total DLQI score. This contradicts 
earlier reports where it was found that patients with dark skin have a more impaired 
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quality of life (Kent and Al-Abadie 1996a; Dolatshahi et al. 2008). As shown by 
McLeod’s study and Porter’s group, darker skin correlates with an increased frequency 
of stigmatisation (Porter and Beuf 1991; McLeod 2004). The fact that this has not been 
the case in our group (Table 17 and Table 18) explains why quality of life is not more 
affected in our patients with skin phototypes IV-VI. However, single item analysis 
showed that these patients are more affected when it comes to sport activities. An 
increased visibility of white spots on darker skin apparently obviously prevents those 
patients from doing this. 
 
Interestingly, patients who think that psychological stress influences their vitiligo had 
much higher DLQI scores (p=0.002). This could mean that those patients with an 
impaired quality of life are aware of this fact, and thus link this skin disease to their 
mindset. This is not only influential on the total score, it also affects 7 out of 10 single 
items, which are more than any other factor explored in this thesis. 
However, since the term psychological stress is a very general one and since we have 
not asked our patients for more specific details about why they think that there is a link, 
the data obtained cannot provide conclusive answers. 
 
There is a clear association between avoidant behaviour and DLQI scores. Patients who 
had avoided certain situations because of their vitiligo, have significantly increased 
DLQI scores, and they are particularly affected in daily activities (shopping / 
gardening), wearing clothes and also doing sports. Hiding white spots influenced the 
total DLQI score as there are higher DLQI scores with increasing frequencies of hiding.  
Data on this subject are scarce in the literature. Kent and Al-Abadie found in their 
investigation that patients who avoided certain situation had higher scores in the 
General Health Questionnaire (GHQ) indicating higher levels of psychiatric morbidity 
(Kent and Al-Abadie 1996b). Although not really the same dimension, it is clear that 
  254
avoidant behaviour and impaired well-being correlate. Such correlation can be expected, 
because both avoidant behaviour and impaired quality of life can be seen as disability 
according to the WHO: ‘any restriction or lack (resulting from an impairment) of ability 
to perform an activity in the manner or within the range considered normal for a human 
being’ (Finlay 1997). 
 
Interestingly, patients with a positive family history of vitiligo were less affected in 
sexual relationships according to DLQI single item analysis. This has never been 
reported before. It could be that growing up with somebody in the family, who, in spite 
of having white spots, leads a normal life in a partnership, makes patients more easy-
going in sexual relationships. Otherwise, family history has not been found as being 
influentiual on quality of life. 
 
Of all the single items of the DLQI, our patients were most affected in their emotional 
reaction to vitiligo (embarrassment, self-consciousness, DLQI item 2). This is in 
agreement with other publications (Ongenae et al. 2005a; Ongenae et al. 2005b; Al 
Robaee 2007). However, we could not find any differences between female and male 
patients as reported earlier (Ongenae et al. 2005b; Borimnejad et al. 2006; Al Robaee 
2007). Our data show that those with shorter disease duration and patients who think 
that psychological stress influences vitiligo are very affected. This has not been reported 
so far in the literature.  
 
Second-most affected area according to DLQI single item analysis was item 4 (influence 
on clothes patients wear). Our data are in agreement with earlier publications (Ongenae 
et al. 2005a; Ongenae et al. 2005b; Al Robaee 2007). There are no differences between 
male and female patients which has previously been reported (Aghaei et al. 2004), but 
not consistenly (Ongenae et al. 2005b; Borimnejad et al. 2006; Al Robaee 2007). 
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Moreover, we found that this item affects particularly patients who think that 
psychological stress influences their vitiligo, those who had avoided situations because 
of the disease and patients with severe vitiligo on arms. This has not been reported in 
the literature before. 
 
Our data show that the third-most impaired parts of daily life were social or leisure 
activities and relationships with partners, friends and relatives (items 5 and 8). Our 
patients seem to be more affected compared to other patient groups (Ongenae et al. 
2005a; Ongenae et al. 2005b; Borimnejad et al. 2006; Al Robaee 2007). There are no 
differences between male and female patients, but we found that those patients were 
more affected who think that psychological stress influences the disease. 
 
The overriding factor influencing these DLQI items in our patients population is their 
impression that psychological stress influences their vitiligo. As shown before, it also 
strongly influences the total DLQI score.   
 
The least affected part of daily life in our patient population was doing sports / work 
and studying (items 6 and 7). However, patients with darker skin phototypes IV-VI had 
avoided situations because of their vitiligo. Moreover, patients with severe vitiligo on 
face and neck were also more affected.   
 
There have been contradicting data published so far regarding a possible correlation 
between DLQI scores and duration of vitiligo. Some authors detected such correlation 
(Gajur et al. 2007), whilst others could not confirm this (Kent and Al-Abadie 1996a; 
Ongenae et al. 2005b; Dolatshahi et al. 2008). Our results clearly support the latter 
groups with no measurable correlation between DLQI scores and time since diagnosis. 
It can be expected that other factors have a much greater influence on quality of life. 
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7.3 Adjustment to Chronic Skin Disorders Questionnaire 
 
The Adjustment to Chronic Skin Disorders Questionnaire (ACS) has rarely been used in 
the English-language literature in the field of vitiligo. There are only a few reports 
available (Rehme 2002; Stangier et al. 2003; Cordalija 2004; Jecht 2005; Schmid-Ott et 
al. 2007), some of them in German and with limitations15.  
 
This minimises the options to compare our results to other reports. However, the 
obtained data will introduce some new aspects into vitiligo-related research, especially 
since the ACS’s main scales social anxiety / avoidance, helplessness and anxious-
depressive mood have not been widely investigated. A recent survey on 1023 German 
patients with vitiligo associated with several self-support organisations rated for 
example reduction of helplessness as one of their most important goals (Gajur et al. 
2007). 
 
7.3.1 Comparison to healthy controls and other groups 
 
First of all, our patients feel significantly more socially anxious / avoidant, helpless and 
anxious-depressive compared to healthy controls, and thus patients show difficulties to 
cope with this chronic skin disease (***p<0.001). To the best of our knowledge there is 
only one study available which included ACS scores of healthy controls and patients 
with vitiligo (Cordalija 2004). The results of this study indicate a significant difference 
                                                 
 
15 Jecht and Rehme used the same patient population as Schmid-Ott et al (all n=363 of a hospital at Castle 
Friedenburg in Germany); Rehme’s work is an unpublished medical thesis; Cordalija used a patient group 
mixed of vitiligo and psoriasis patients and, unfortunately, some of the results are only stated for the 
whole of the group and not seperately for each disease. 
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between both groups16. Other studies on vitiligo published so far, included only 
comparisons to other skin disease such as psoriasis (Stangier et al. 2003). 
 
All scores of our group are comparable to those from Schmid Ott’s / Jecht’s group and 
Stangier’s report (Stangier et al. 2003; Jecht 2005; Schmid-Ott et al. 2007), except for 
social anxiety / avoidance, where our population showed slightly increased scores 
(mean 38.7 / median 37.0 vs. means 34.817 and 35.518).  
These scores were lower compared to other skin diseases, such as psoriasis (mean 40.2, 
n=75) (Jecht 2005) or epidermolysis (41.9, n=30) (Stangier et al. 2003). Even lower 
than the scores of the vitiligo groups were those of patients with contact eczema (33.0, 
n=42) and acne (31.02, n=50) (Stangier et al. 2003). 
 
All of the cited studies have been conducted on patients of dermatology clinics. Since 
our group is of a mixed nature19, it can be expected that a certain proportion of untreated 
sufferers in our group scored higher than treated patients.  This assumption could not be 
confirmed since both groups (enrolled or not enrolled with the Institute for Pigmentary 
Disorders) do not differ regarding their scores, except for anxious-depressive mood.  
In the latter case we could show that patients who are enrolled with the Institute for 
Pigmentary Disorders and are undergoing treatment for vitiligo with narrow-band UVB 
activated pseudocatalase PC-KUS, are less anxious-depressive than those not enrolled. 
This further supports that this treatment modality is not only effective in re-gaining skin 
colour, it is also beneficial regarding patients’ well-being. 
                                                 
 
 
16 However, scores are only provided in diagrams; and to make it even more difficult, the control group’s 
scores read 1.25 and 1.7 which cannot be correct as this should be at least 15, 9 or 8 depending on the 
scale.  It can only be suspected that the point has (consistently) been put at the wrong decimal rank 
(Cordalija 2004). 
17 n=363 (Jecht, 2004) 
18 n=33 (Stangier et al. 2003) 
19 as shown above: patients enrolled with the IFPD and undergoing treatment, and patients not enrolled  
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7.3.2 Influence of gender, age, visibility and duration of the 
disease 
 
There is a significant difference between male and female patients in all three ACS sub-
scales with women having higher mean and median scores. This is only partially in 
agreement with earlier results.  
Although Stangier et al reported consistently higher scores of female patients in all sub-
scales, this applied to all of their participants regardless of skin disease. Unfortunately, 
it is not stated in the publication whether or not there was a gender difference in the 
vitiligo group (n=33) (Stangier et al. 2003).  
Schmid-Ott’s group found a significant difference only regarding helplessness, but not 
in social anxiety / avoidance and anxious-depressive mood (both p=0.11), even though 
this group shared some demographic features with our population, i.e. majority were 
women and the mean age of 43.5 years (Schmid-Ott et al. 2007). 
 
According to an earlier study, visibility of vitiligo correlates with ACS sub-scores 
(Schmid-Ott et al. 2007). This is also the case in our population, at least regarding 
severity of vitiligo on visible parts such as arms (valid for all sub-scores), legs (all but 
anxious-depressive mood) and neck (social anxiety / avoidance only), but not face. 
Patients with extended vitiligo on the mentioned body parts scored significantly higher.  
 
Earlier it has been reported that age does not correlate with ACS sub-scores (Stangier et 
al. 2003; Schmid-Ott et al. 2007). These results are in contradiction to our results, 
because we found a negative correlation. Older patients have less difficulties in coping 
with this chronic skin disease. This confirms Cordalija’s finding that patients younger 
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than 32 years were more affected than those older than 32 years (Cordalija 2004). It 
might be that either accumulating experiences when getting older supports coping with 
vitiligo, or it is just that appearance becomes less important with age. 
In addition to this, we also found a negative correlation between age at disease onset 
and social anxiety / avoidance, but not for the other main scales. This correlation means 
that the younger patients were when they developed vitiligo, the more they were 
affected at the time when filling out the questionnaire. There was no correlation 
between duration of vitiligo and any of the ACS scales. 
Taken together, the older patients are, and the later their disease onset in life, the better 
they cope with vitiligo, independently of duration of their disease. 
 
 
7.3.3 Influence of stigmatisation and avoidant behaviour  
 
Social anxiety / avoidance, but not the other sub-scales, are influenced by frequencies of 
stigmatising encounters (approaches / questions by others) in a similar manner as the 
Dermatology Life Quality Index. Those who had never experienced such approaches 
showed the highest scores, followed by the ‘very often’ group. The lowest scores 
showed those patients who had experienced sometimes approaches and questions by 
others. However, the significance is weak. It is only significant when using means, 
whereas it is only borderline significant when the Kruskal-Wallis-test is employed. 
Further investigations with probably a greater number of patients are needed to clarify 
this association. 
Contrary to the DLQI evaluation, there is an influence on ACS scores after including 
stigmatisation experiences, such as when patients were picked on or subject to nasty 
comments. Patients who had indeed experienced stigmatisation scored significantly 
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higher in social anxiety / avoidance and anxious-depressive mood. It can be concluded 
that stigmatisation of that kind increases fear of situations where patients think that their 
vitiligo might be exposed to others. 
 
Similar to quality of life, there is a positive correlation between all ACS sub-scales and 
avoidant behaviour, especially hiding of the white spots. The more often patients had 
hidden their vitiligo in front of other people, the more socially anxious / avoidant, 
helpless and anxious-depressive they feel. There is also a significant difference between 
patients who had avoided certain situations because of their disease and those had never 
done this. 
This seems obvious especially for social anxiety / avoidance as his scale is about fear of 
situations where patients think that their skin disease might be revealed to others. 
Therefore, this can be seen as confirmation that the Adjustment to Chronic Skin 
Disorders questionnaire can indeed identify correctly those patients who are avoidant in 
their daily life. 
 
Strikingly, as in our quality of life measurements there are again significant differences 
between patients who were thinking that psychological stress is involved in vitiligo and 
those who did not think so, especially regarding anxious-depressive mood. Patients, 
who think that psychological stress is involved, were found to be much more affected in 
all three sub-scales. It can be assumed that those patients either had experienced 
situations that indeed triggered or exacerbated their vitiligo, or they were just aware that 
their emotions are disturbed directly by the disease or indirectly via vitiligo-related 
experiences. 
Again, the term psychological stress is a very general one, so that more focussed 
research is needed. 
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7.4 Beck Depression Inventory 
 
Many of the results obtained with the Beck Depression Inventory are similar to those of 
the above mentioned questionnaires with one important difference. 
 
It can be concluded that our patients are not much more depressed than healthy controls. 
When comparing means, there is no significant difference at all. When utilising the 
Mann-Whitney-U-test there is a weak significance20.  
A comparison of numbers of patients and controls with mild to severe depression 
(27.6% vs. 17.7%) does not reveal any significant difference (p>0.05).  
Therefore, our data can contribute only little to clarify the inconsisting reports on 
depression in vitiligo so far. To date, there is no conclusive agreement whether patients 
are more depressed than healthy controls. One reason might be that all the reports that 
showed indeed a difference had been conducted with other tools than the BDI, for 
example Zung Depression Scale (Kökçam et al. 1999) or the depression subscale of the 
Minnesota Multiphasic Personality Inventory (Elgoweini et al. 2003). Further 
investigations involving a bigger number of patients and controls as well as the parallel 
use of the BDI and other instruments are needed to clarify this matter in more detail.  
 
A comparison of the results from the English-speaking vs. German-speaking patients 
showed that the English-speaking patients were less depressed than the German group. 
Since we used validated translations, this result might indicate that cultural background 
influences the outcome. 
                                                 
 
20 The Mann-Whitney-U-test as a non-parametric method is the more appropriate one as our BDI scores 
are considerably skewed (skewing coefficient is 1.114) 
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We could show that female patients are more depressed than males. This was not only 
the case regarding mean / median scores, there were also more female patients within 
the BDI categories, whereas more men were in the not depressed category. This 
contradicts some of the earlier reports (Lee et al. 2000), but supports our finding in the 
anxious-depressive mood section of the ACS questionnaire. 
 
One earlier study claimed that the longer patients had vitiligo the less depressed they 
became (Gieler et al. 2000)21. Our results cannot support this data, because longer 
duration of the disease does not correlate with depression. Moreover, our finding that 
there was no difference between patients younger and older than 35 years are not novel. 
The same was already reported earlier (Lee et al. 2000)22. We could neither find 
negative nor positive correlations of BDI scores with age and age of disease onset, so 
that it can be concluded that if patients are depressed because of their vitiligo, it happens 
independently of how old they are at the time of the survey, how old they were when 
they got vitiligo and how long they had their disease. Other factors must therefore be 
more important. One could be patients’ perception that psychological stress is involved 
in the disease, which in turn could either be caused by actual experiences and 
observations (stress / life events followed by disease onset) or awareness that vitiligo 
can affect psychosocial well-being.  It is not the case that this particular patient group 
has experienced more stigmatisation (both Chi-square tests, p>0.05, data not shown). In 
any case, perceived psychological stress is highly influential on all questionnaires and 
their sub-scales.  
                                                 
 
21 Strangely, in the abstract of Gieler’s publication it says that ‘depression scores tended to increase with 
the duration of illness’, but this contradicts their own finding in the text, where it reads ‘there was a 
significant negative correlation between BDI scales and the duration of disease. Patients suffering longer 
from vitiligo showed lower depression scores’ (bold by this author). The latter must be correct as the 
correlation coefficient is -0.41 (Gieler et al. 2000). 
22 Lee used younger and older than 30 years of age 
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The same applies to severity of vitiligo. Patients with widely spread vitiligo on the trunk 
scored significantly higher in the BDI as well as in all the other questionnaires. As 
already mentioned above, if patients have extended vitiligo on the trunk as the biggest 
of all body parts mentioned in the questionnaire, then the total disease of these patients 
becomes severe. Therefore, it can be concluded that the more extended somebody’s 
vitiligo is, the more are these patients at risk to become depressive. This result is 
surprising because one would think that especially patients with exposed vitiligo would 
be more affected. 
 
Our data also show that levels of depression are linked to avoidant behaviour. There is a 
highly significant increase of the median BDI scores the more often patients had hidden 
their white spots in the past (***p<0.001). Moreover, none of the patients who had 
never hidden their vitiligo were depressed, whereas this was only the case in half of 
those who had hidden their white spots very often.  
Furthermore, patients who avoided certain situations because of their vitiligo showed 
higher median BDI scores. However, there is no difference between both groups 
regarding distribution within BDI categories. 
Taken together, we could show that increased levels of depression go along with a 
tendency to avoid situations because of the disease and to hide the white spots in front 
of other people. This result can be expected as depression normally involves episodes of 
retreat and loss of interest in usual activities (Gupta and Gupta 2003). 
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7.5  Comparison of Adults questionnaires in general 
 
1. Correlation analysis showed that there is a positive and significant correlation  
between all questionnaires. That means for example that patients with an impaired 
quality of life are also more likely to be socially anxious / avoidant, helpless, anxious-
depressive and depressive. 
 
This can additionally be seen as confirmation that: 
 
• Social anxiety / avoidance is related to quality of life. Both involve the influence of 
a skin disease on social situations. The ACS addresses this item in general and the 
DLQI regarding relationships with friends, partners, daily activities such as 
shopping or sport. 
• Depression is indeed present when the ACS reveals increased anxious-depressive 
mood levels. 
 
2. In all but one questionnaire, no significant difference has been found between the 
German and English-language questionnaires’ scores. As mentioned before, the BDI 
showed that English-speaking patients were less depressed than the German-speaking 
ones. This difference could not be caused by translation mistakes as we used official 
versions of the BDI, but might indeed have been caused by cultural issues.  The lack of 
differences in the other scores also showed that our own translation of the ACS has not 
lead to severe differences between the original German version and the translated 
English one. 
 
3. In our study we included active leisure time (sports or hobby), because we wanted to 
know whether spending the leisure time actively could improve any of the 
questionnaires’ scores. We postulated that this own activity could have a positive effect 
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on patients’ quality of life. Unfortunately, this could not be proven. There were no 
significant differences between patients with an actively spent leisure time and those 
who did not do anything special. 
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7.6 Children’s characteristics 
 
7.6.1 Demographic and clinical features 
 
The majority of our children were girls (n=63, 61.2%), but this is not uncommon in the 
field of vitiligo. Other studies have reported similar distributions (Jaisankar et al. 1992; 
Njoo et al. 2000) or even higher ones (Grimes and Billips 2000; Iacovelli et al. 2005). 
However, the question remains whether this is the case only within the groups seeking 
treatment or in all children with this disease23. It might be that the awareness of good 
appearance may be higher in girls. 
 
While there were only 10% of adult patients with darker skin phototypes IV-VI, the 
proportion was higher in our children group (n=31, about 30%).  Although most of the 
younger patients were still from around the main geographical areas where the Institute 
for Pigmentary Disorders is operating (Middle and Western Europe), there were a  
considerable number of children from ethnic minorities. Some were taking part during 
an annual meeting of the American Vitiligo Research Foundation (AVRF).  This charity 
does not only raise funds for research, they also organise meetings for affected children 
and their parents, and many of those children were African-Americans or of other non-
Caucasian origin. 
 
                                                 
 
 
23 Strikingly, an extensive examination of 12,586 school children aged 6-14 from Northern India stated 
vitiligo and pityriasis alba as the only dermatologic disorders with significant female predominance. 
Since all children in the mentioned age group in selected schools were examined, certain issues such as 
gender-related awareness of appearance can be ruled out. This indicates at least for this part of the world 
that there might be indeed a predominance of girls within the children population with vitiligo (Dogra and 
Kumar, 2003). 
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When asked for their children’s disease severity on different body parts, the parents 
stated that the legs were affected most often severely, followed by the trunk. This is 
different from our findings in the adults group, where hands were most often mentioned. 
If we take into account that many patients develope vitiligo on sites after an injury 
(Koebner phenomenon), then this could explain a good part why legs as a common site 
of injuries in children were mentioned so often by the parents. 
The face was least often mentioned as being severly affected, which was the same in the 
adults group. This was followed equally by the neck and arms (but legs and trunk in 
adults). 
One of the reasons that the face is less of a problem when it comes to severity of 
vitiligo, might be that it obviously responds better to certain treatment modalities such 
as narrow-band UVB activated pseudocatalase PC-KUS (Schallreuter et al. 2008b). 
 
There are similarities to the adult population regarding positive family history and 
affected relatives. Both groups do not differ much with 33% of the children (n=34) and 
38% of adults (n=111) claiming somebody else in the family positive for vitiligo. When 
asked for who exactly has got vitiligo, then children and adults name either of their 
parents most often (in both groups about 34%), followed mainly by their siblings and 
grand-parents.  
Since both our groups have different median ages of disease onset, but apparently a 
comparable percentage of positive family history and affected relatives, we cannot 
confirm earlier reports that there is an extended family history in those patients with 
earlier disease onset (Schallreuter et al. 1993; Pajvani et al. 2006). 
 
The vast majority of our children (>90%, n=94) had been to a doctor because of vitiligo 
and more than 80% (n=76) of them received treatment. These are numbers similar to 
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adult populations, where 98.3% of patients (n=362) had been to a doctor and had tried 
on average of 2-5 doctors (Uesseler 2002).  
The broad range of at least 38 different treatment modalities / combinations that had 
been tried by our children and their parents reflects the current situation regarding 
medical treatment for the disease. Since to date there is no agreement about what 
exactly causes vitiligo, it is no surprise that there is a plethora of more or less effective 
treatments on the market with none of them dominating the field. Even corticosteroids 
or psoralens + UVA (PUVA) as popular treatments in the past were not mentioned 
particularly more often than others24. 
 
 
7.6.2 Attitudes, activities and experiences  
 
Our children population can be characterised as an active group, well integrated into 
their social environment. 
 
Almost 90% of participants (n=92) stated to have a hobby or that they were doing sports 
in their leisure time with no differences between boys and girls. Of those who 
confirmed that more than 83% preferred one or two hobbies / sports (n=55), the 
remaining did even more. This is a rather high proportion when compared to a 
representative sample of German children (n=1,592, aged 8-11 years) where 81% were 
found to actively spend their leisure time (Hurrelmann and Andresen 2007).  
This particular study also stated that an actively spent leisure time is found in children 
of middle or upper classes rather than in those of lower classes (Hurrelmann and 
                                                 
 
24 There is, however, 13.7% of children who stated just ‘cream’ as their treatment modality with no 
further differentiation. 
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Andresen 2007). Whether that means that our children are more from middle or upper 
class environments is difficult to assess as this was not part of our questionnaire. 
A break-down of what exactly was done revealed that surprisingly few children 
preferred inactive or quiet ways to spend their leisure time (only 2 out of 66 stated 
fishing or reading), all the other ones did something actively including sport or anything 
in arts (music, dancing).  
 
When we asked the children which season of the year they liked best, a majority of 
more than 80% (n=81) said that it was spring or summer. Since people tend to wear 
shorther clothes during those seasons, these answers were surprising, because there was 
apparently no fear with regards to their vitiligo. In our opinion this is a positive sign and 
this answer clearly indicates that the daily life of our children was not completely 
influenced by their white spots.   
There are no comparable data available in the literature. Only McLeod addressed  
something similar by asking adult patients about the significance of the summer months. 
However, this was more related to sun exposure and how much patients were avoiding 
sun. The majority of female patients did avoid such situations, whereas this was not the 
case in men (McLeod 2004).  
These different kind of questions makes it difficult to compare both groups. However, 
in general it seems that summertime is more an issue in the adult group than in children. 
This issue is frequently mentioned by patients attending the Institute for Pigmentary 
Disorders for the first time (Prof. KU Schallreuter, personal observation). 
 
About two thirds of our children group had many friends, one third had just a few and 
only one child claimed not to have a single friend. In the German study mentioned 
above, there were less children with a few friends (15%) and more who had many 
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friends (Hurrelmann and Andresen 2007). However, it still seems that the vast majority 
of our children group is well integrated into their social environment, at least in terms of 
friends. This is important as friends are potential sources of support for psychosocial 
well-being. 
 
Other indicators for level of integration are stigma-related experiences such as bullying 
or approaches / questions by others. About 94% (n=93) had experienced approaches / 
questions by others, almost half had been picked on or subjects to nasty comments 
(n=47) and about 20% reported that they had been bullied because of their vitiligo 
(n=8). Only one child had experienced physical violence because of vitiligo. There were 
no differences between girls and boys. 
These numbers seem to be rather high. By comparison, only 34% of German children in 
a representative study (n=1,592) stated to have experienced bullying, nasty comments or 
physical violence within the last year (Hurrelmann and Andresen 2007). Taking this 
number into consideration, the proportion of bullying in our group is smaller than in the 
German study, but if taken together with nasty comments, it is actually increased, and it 
can be expected that vitiligo is one of the reasons for it. 
 
When compared to our adult group, it can be concluded that the proportion of children 
that had been approached / asked questions is only slightly bigger than in our adult 
population (Table 78) where in addition women are more likely to be asked questions. 
However, children are more likely to be picked on or to become subjects to nasty 
comments (only 24% of adults, Table 78). It seems to be that this kind of stigmatisation 
is age-related. This is also confirmed by those adults patients with disease onset in their 
teenage year. In all age groups there is no differences between female and male patients.  
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Children Adults Stigmatisation experiences 
% N % N 
Questions / approaches by others 94 99 90 123 
Picked on / nasty comments 47 99 25 123 
Bullying 19 42 n.d. -- 
Physical violence 2 47 n.d. -- 
 
Table 78: Comparison of our children and adult groups regarding frequencies of 
stigmatisation 
  
There are studies available on levels of support patients with vitiligo have received 
(Porter et al. 1979; Cordalija 2004). This has never been investigated in children, 
therefore our results contribute something novel to the field.  
Our results revealed that in situations where children had a problem with somebody else 
because of their vitiligo, they were helped particularly often by friends and members of 
the family. Less often mentioned were teachers and others. However, about one third 
had not received help in such situations. Considering that this question had been asked 
semi-openly, we are certain that we provided the right choices to answer, because the 
open answer ‘others’ was only chosen by one participant. 
The importance of friends and family as sources of support is strenghtened by the 
children’s answers whom they would contact first when they had experienced disease-
related problems. Here again, members of the family (especially the mother) and best 
friends were mentioned most often. The importance of the mother is more pronounced 
compared to the father. It seems to be that mothers either can empathise better with their 
children or that they are just in closer contact compared to the fathers. It can also be that 
the father is not as present as the mother, be it due to work commitment or complete 
absence, for instance after a divorce. These findings are absolutely relevant, although 
the possibility to answer this item was an open one. 
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Only 5% of the children said that they would never tell anybody when they just had a 
problem related to vitiligo. Seeking somebody else’s support is important for coping 
and obviously it is not the case that the majority of  children lack this source. 
 
When asked directly for their attitudes towards vitiligo, about 70% of our children 
group said that they are at least sometimes bothered by their white spots. There are no 
differences between girls and boys. 
It seems to be that the children are generally concerned about vitiligo, not just about 
their relationships to others, because when asked about which spots should disappear 
first, only 16% (n=16) said that it should be only those spots visible to others. About 
three quarters of our population (n=72) whished that all patches should go away. 
A vast majority of our children (79%, n=79) said that it is important to them that their 
disease would eventually disappear one day, only 4% (n=4) denied that. That means that 
even though a considerable proportion said that they are currently not bothered by their 
vitiligo, they still wished to get rid off the disease sometime later on in life.  
Taken together, in all the three questions there was a consisting majority of at least 70% 
of the children who showed difficulties with having white spots – they felt not only 
bothered and wanted that their spots should disappear one day, they also wanted all of 
them to go away. 
 
There are 30% (n=27) of our children group that have avoided certain situations because 
of their vitiligo. Here, girls are more likely to do that compared to boys and so are 
young patients who have experienced that they had been picked on. Also, there is a 
strong link between avoidant behaviour and feelings of disturbance by the disease, 
because we found that especially those had avoided situations who felt bothered by their 
vitiligo. These results weaken our finding about the positive attitudes of our children 
toward summer and spring. It is obviously the case that children do like the warm 
  273
seasons of the year, but this has nothing to do with their actual behaviour and tendency 
to hide the white spots. 
Most often avoided were situations where an exposure of the disease to other children 
was very likely, i.e. swimming / bathing and getting undressed in changing rooms. Less 
often mentioned were social situations such as shaking hands and talking to other 
people.
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7.7 Children’s Dermatology Life Quality Index 
 
The Children’s Dermatology Life Quality Index has rarely been used in young patients 
with vitiligo. Therefore, there are not many possibilities to compare our results with 
others.  
 
Children with vitiligo have a more impaired quality of life compared to healthy 
controls. Other authors reported similar low scores for healthy controls, for example 
Chuh et al with a mean score of 0.6 (n=30) or Lewis-Jones and Finlay with mean scores 
of 0.4 and 0.7 (n= 47 and n=55) (Lewis-Jones and Finlay 1995; Chuh 2003). 
To the best of our knowledge, this thesis includes the first direct comparison between 
children with vitiligo and healthy controls using the Children’s Dermatology Life 
Quality Index (CDLQI). The results show that this skin disease influences essential 
parts of young patients’ daily life, which is the same as in adult patients. 
 
Compared to other publications, our mean score of 2.7 (median 1.0) is rather low.  
Njoo reported a mean CDLQI score of 5.6 in 51 children with vitiligo prior to treatment 
with narrow-band UVB over one year. After the therapy this score decreased to 2.1 and 
was only then comparable to our group’s score (Njoo et al. 2000).  
Agarwal et al included 18 children with vitiligo in their study and reported median 
CDLQI scores of 1.0, 1.5 and 3.0 in two groups at the beginning and the end of a 
medical trial (Agarwal et al. 2005), the latter two are increased compared to our group.  
Guttman reported that 21 children with vitiligo scored a mean of 3.8 in an unpublished  
study by Schwartz and Sepulveda (Guttman 2007). 
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Beattie and Lewis-Jones provided a score for children with ‘pigmentary abnormality’ of 
1.5 (n=7). It remains unclear whether any cases of vitiligo were included (Beattie and 
Lewis-Jones 2006). There are no other publications available for the use of the CDLQI 
in children with vitiligo25. 
 
In addition, when compared to other skin diseases including viral warts, molluscum or 
psoriasis, the CDLQI score of our group is still low (Chuh 2003; Holme et al. 2003). 
Higher scores have also been reported for scabies, eczema, acne, epidermolysis bullosa 
or urticaria. Naevi was the only condition where a lower CDLQI score was reported  
(Lewis-Jones and Finlay 1995; Chuh 2003; Holme et al. 2003; Guttman 2007). 
 
Single item analysis showed that vitiligo had the strongest impact on emotional 
reactions, followed by sport / swimming and, equally, physical symptoms. Similar 
tendencies have been reported from groups of children with various skin diseases 
(n=107) (Lewis-Jones and Finlay 1995; Holme et al. 2003).  
Surprisingly, not a single one of our children said that vitiligo had affected their 
friendships to other children during the week prior to answering the questionnaire. This 
is in sharp contrast to our adult group. Our results suggest that friendships between 
children are hardly influenced by physical appearance. Similar findings have been 
reported for children with various skin diseases (Lewis-Jones and Finlay 1995; Holme 
et al. 2003). In our group it remains unclear why so many of the children reported that 
their skin disease had caused them any kind of physical sensations (pain, soreness etc) 
during the last week. 
 
 
                                                 
25 A search in www.pubmed.com using ‘CDLQI’ and ‘vitiligo’ as keywords yielded only Njoo et al’s 
report 
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Interestingly, children who had somebody else with vitiligo in the family did complain 
less about that the treatment itself poses a problem. Since in many cases children’s 
parents also had vitiligo, it could mean that if both parts do the treatment together in a 
certain way, then quality of life can be improved. At the same time, the treatment is also 
less annoying to the children.  
 
Stigmatising encounters such as other people asking questions about the disease, proved 
more influential in young patients compared to adult patients. Children who had been 
approached by others and asked questions, showed significantly increased CDLQI 
scores. Single item analysis showed that especially daily activities such as going out, 
playing and doing sports were impaired. 
This effect is even stronger when the children were subjects to nasty comments or when 
they had been picked on. Those children scored much higher in the CDLQI, and 
particularly in emotional reactions, essential daily activities, their performance in 
school and their choices of clothes to wear. 
 
Similar to the adult population, disease severity influenced the outcome of the CDLQI 
scores. Girls with severely affected faces scored significantly higher in the CDLQI and 
particularly regarding physical symptoms and going out / playing. This was not the case 
in boys, who would still go out and play. Hence it can be concluded that a good 
appearance is more important to girls compared to boys. 
 
Having received treatment for vitiligo earlier or being enrolled with the Institute for 
Pigmentary Disorders alone does not make a difference for children regarding their 
quality of life. However, our results indicate that children who underwent treatment are 
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more concerned about choice of clothes / shoes, swimming / sports and by the treatment 
itself, whereas  their school work is less likely affected.  
It can be concluded that severity of vitiligo or certain stigmatising experiences are much 
more influential on children’s quality of life. 
 
 
7.8 Children and their parents 
 
To the best of our knowledge there have never been any investigations into the child-
parent relationship in the field of vitiligo using questionnaires for both sides as it was 
done in other skin diseases, for instance atopic dermatitis (Lawson et al. 1998)26. 
 
Our results suggest that parents of children with vitiligo are also more socially anxious / 
avoidant, helpless and anxious-depressive, when it comes to views on their children’s 
skin disease. This group scored much higher in all subscales than parents of healthy 
children. That means that those parents show a similar behaviour pattern as adult 
patients. They have in common that they fear situations where vitiligo might be exposed 
to other people, and they also feel helpless with regards to the disease’s course.  
This is confirmed by our findings that parents whose children had never hidden their 
white spots felt least socially anxious / avoidant. There were differences between 
fathers and mothers with fathers being additionally less helpless and anxious-
depressive. 
In general, levels of anxious-depressive mood, a sub-scale not directly linked to skin 
diseases, are increased in parents of patients compared to healthy controls. 
                                                 
 
26 Guttman reported that Schwartz and Sepulveda used children with vitiligo and their parents and asked 
each group to fill out separate questionnaires. However, this has not been published properly, only by a 
third person in an article based on interviews with the researchers in the Dermatology Times (Guttman 
2007) 
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There is a correlation between mothers’ and fathers’ scores, meaning that if one parent 
is more socially anxious / avoidant or helpless, then it is very likely that the other parent 
is affected as well. This could be the results of inter-parental relation and interaction, 
especially regarding their child’s disease. 
There is no correlation in the anxious-depressive mood subscale, which, interestingly, is 
the only one not specified for skin diseases. That means that parents often feel (and fear) 
the same when it comes to their child’s skin disease, but they do not have to have the 
same basic personality structures or problems. 
 
Despite the mentioned correlations between mothers and fathers, only the social anxiety 
/ avoidance and helplessness scores of the mother do correlate with the CDLQI scores 
of their children. It could be that mothers are more sensitive about their childrens’ 
quality of life, but it could also mean that an increased fear of situations where vitiligo 
might be exposed to others leads to an impaired quality of life of the children.  
Here again, there is no correlation regarding anxious-depressive mood and CDLQI, as 
this scale is not disease-related, but about a basic personality structure.  
 
Something completely new in the field of vitiligo are our findings about parents’ 
searching their children for new white spots. We found that more than 40% admitted to 
do that often with no differences between mothers and fathers. Also, higher scores in all 
ACS sub-scales correlate with an increased frequency that parents search their children 
for new white spots (except for fathers in social anxiety / avoidance). It might be that 
this habit reflects helplessness regarding and also concern about the course of the 
disease as if parents seek reassurance or hope that the disease has gone better.  
 
  279
All scores do not depend on the age of parents or duration of their child’s disease. 
Moreover, there was no strong influence of disease status, whether the vitiligo of their 
children was actively spreading, stable or improving except for helplessness of mothers. 
They felt much more helpless when the disease was progressing, whereas mothers were 
hardly affected when the disease was stable. Obviously mothers feel more secure and 
less helpless when there is no change in their children’s vitiligo at all, not even an 
improvement. 
 
Parents differ from patients with vitiligo regarding their beliefs about possible causes 
for vitiligo. While patients strongly believe that psychological stress, but not other 
diseases or injuries, are involved in triggering or exacerbating vitiligo, this is not the 
case in parents. None of these factors play a role according to parents’ beliefs. There 
were no differences between mothers and fathers. Since we did not offer the possibility 
of an open answer, we cannot conclude whether any other causes come ito the picture 
by parents.  
 
Interestingly, those fathers who did believe that psychological stress is involved, scored 
significantly higher in social anxiety / avoidance and anxious-depressive mood. This 
could be caused by actual observations that the disease onset followed certain live 
events or experiences. It is puzzling why this is not the case for mothers. 
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8 Summary 
 
 
Vitiligo is a common depigmentation disorder known for thousands of years. Only from 
the 20th century some progress has been made to find the cause and an appropriate 
treatment for this disease. However, less effort has been spent on the psychological 
effects of the disease. Although many aspects, such as quality of life, depression, self-
consciousness or embarrassment have been covered since the 1970s, this has not been 
the case for social anxiety / avoidance, helplessness and anxious-depressive mood. 
There is even less known about the influence of vitiligo on children. Therefore we felt it 
was in need to close some of these gaps and to further substantiate earlier findings. 
 
In this cross-sectional study we investigated 422 adult patients and 103 children with 
vitiligo for disease-related experiences, behaviours and well-being. Our results can add 
some more pieces to the knowledge about the psychosocial effects of this disease. 
 
Adults 
 
1. The adult patient group was socio-demographically not different from other groups 
in the literature. There was a majority of women, a median age of 43 years and a 
peak of disease onset between 10 and 19 years of age. However, hands as most often 
mentioned site of onset has only once reported before. 
2. We found that this patients group had experienced a high degree of stigmatisation 
(90%). Women and patients with extended vitiligo on their hands and legs were more 
likely to get stigmatised.  
3. Two thirds of our patients showed avoidant behaviour, especially hiding the white 
spots and avoiding situations because of vitiligo. 
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4. Quality of life was limited compared to healthy controls, but less impaired compared 
to other groups. Our patients were mostly affected regarding their emotional 
reactions (upset, embarrassment). Levels of quality of life were not influenced by 
stigmatisation, duration of the disease or skin colour, but by disease severity on trunk 
and presence of avoidant behaviour. 60% had an only slightly impaired quality of 
life, wheras this was severely or even extremely reduced in another 16% of the 
patients. 
5. There were severe problems in coping with this chronic skin disease. Our patients 
were significantly more socially-anxious, helpless and anxious-depressive compared 
to healthy controls on a level comparable to other groups in the literature. Female 
patients, individuals who had been picked on or had become subjects to nasty 
comments as well as patients with extended disease on their trunks, arms, necks and 
legs had more difficulties in coping. Older patients were less affected. Impaired 
coping and avoidant behaviour correlate.  
6. Patients with vitiligo were more depressed than healthy controls. However, there was 
only a weak significance of this difference as the number of patients was too small. 
Depression is more common in female patients. Disease severity on trunk and 
avoidant behaviour are influencing factors. German-speaking patients showed higher 
levels of depression.  
7. Correlation analysis of the three questionnaires revealed that all of these limitations 
are very likely to occur together in one patient. Women were generally more 
affected. Hiding behaviour and levels of stigmatisation were highly influential on 
coping.  
8. Three quarters of our patients believed that psychological stress is influential on the 
disease. This group had a later disease onset and a reduced quality of life. They were 
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also much more socially anxious / avoidant, helpless, anxious-depressive and 
depressed.  
9. Treatment with narrow-band UVB activated pseudocatalase PC-KUS is medically 
successful. There were less patients with spreading vitiligo compared to untreated 
patients. The treatment also improves quality of life and eases anxious-depressive 
mood. 
 
Children and their parents 
 
1. Our group included more girls than boys which is not uncommon in this field. Earlier 
reports of an extended family history with earlier disease onset could not be 
confirmed by our results. 
2. When compared to a representative sample of German children, members of our 
groups were slightly more active in their leisure time, but had less often many best 
friends.  
3. Almost everybody had experienced stigmatisation (questions), half of our children 
had been picked on and every fifth had received bullying. However, physical 
violence because of vitiligo is very rare. Picking on / nasty comments and bullying 
were much more common compared to the general German children population. 
4. Family members and friends are important sources of support in critical situations, 
and were most often sought as contact of first choice after such incidents. Mothers 
were more important than any other person mentioned.  
5. More than two thirds of our children were bothered by their disease. Every third 
child had avoided situations because of vitiligo. Girls were more likely to do so 
compared to boys. 
6. Quality of life was significantly more impaired in our young patients compared to  
healthy children. Vitiligo had the strongest effect on emotional reactions. 
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Surprisingly, friendships to other children were not affected at all. Influential factors 
were levels of stigmatisation and disease severity in the face.  
7. The parents of our young patients were considerably socially anxious / avoidant and 
helpless in their views towards their children’s skin disease. Children of parents with 
lowest social anxiety / avoidance scores were least likely to hide their white spots.  
8. Mothers’ and fathers’ scores correlated in the disease-related scores of the ACS, but 
not in anxious-depressive mood as the only disease-independent scale. 
9. Parents’ ACS and children’s CDLQI scores correlated only in social anxiety / 
avoidance and helplessness scores of the mother. 
10. More than 40% of parents examine their children often for new white spots. 
11. Any change in their children’s vitiligo (improving or worsening) affected 
negatively feelings of helplessness of mothers, whereas stable vitiligo made them 
feeling less helpless.  
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Future work 
 
 
Some of the results of this project as well as some of its limitations invite to more work 
that should be done in the future. 
 
1. Since our results regarding depression in vitiligo could not clarify the inconsistent 
reports in the literature so far, the Beck Depression Inventory should be used again, but 
probably with more patients and together with other validated tools to measure 
depression levels. By doing so, it should be possible to determine whether the results 
obtained with the BDI are comparable to those of other depression questionnaires. 
 
2. It should be avoided to introduce certain questionnaires later after the project has 
started. Our results which are based on the Adjustment to Chronic Skin Disorders 
questionnaire, are clearly valid for our total patient group, whereas this is less certain for 
the DLQI and BDI measurements, because these were not used in all patients. 
 
3. Parents of children with vitiligo should be included more often in any future research 
on quality of life or coping with vitiligo. Our results clearly underlined the importance 
of the parents, especially as sources of support in critical situations or as role models. 
Despite this importance, parents of children with vitiligo have never really been used in 
studies undertaken so far. Therefore, there is a need for future work including the role of 
the parents and possible support for them by providing a better insight in the parents-
children relationships. 
4. The socio-economic status of the parents should be considered in any future studies 
on vitiligo in children. This could help to recommend different strategies of supporting 
the affected children if there are indeed differences between the economic classes. 
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9.1  Adults’ questionnaire 
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9.2  Children’s questionnaire 
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